<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Hematology Part 2 - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        DocTutorial / qBank / Medicine
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">23</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x31277a=_0x5d42;(function(_0x4a3969,_0x4bd750){const _0x3ce9bc=_0x5d42,_0x3cc1c9=_0x4a3969();while(!![]){try{const _0x5cfa76=parseInt(_0x3ce9bc(0x212))/0x1*(-parseInt(_0x3ce9bc(0x2b6))/0x2)+parseInt(_0x3ce9bc(0x37e))/0x3*(-parseInt(_0x3ce9bc(0x15d))/0x4)+-parseInt(_0x3ce9bc(0x320))/0x5+parseInt(_0x3ce9bc(0x263))/0x6*(-parseInt(_0x3ce9bc(0x1e6))/0x7)+-parseInt(_0x3ce9bc(0x276))/0x8*(-parseInt(_0x3ce9bc(0x325))/0x9)+-parseInt(_0x3ce9bc(0x290))/0xa+parseInt(_0x3ce9bc(0x230))/0xb;if(_0x5cfa76===_0x4bd750)break;else _0x3cc1c9['push'](_0x3cc1c9['shift']());}catch(_0xe899df){_0x3cc1c9['push'](_0x3cc1c9['shift']());}}}(_0x1ca1,0x61f69));const _0x21bd51=(function(){let _0x4cdb00=!![];return function(_0xdbc4da,_0xb23f83){const _0x381a87=_0x4cdb00?function(){if(_0xb23f83){const _0x2fafff=_0xb23f83['apply'](_0xdbc4da,arguments);return _0xb23f83=null,_0x2fafff;}}:function(){};return _0x4cdb00=![],_0x381a87;};}()),_0x38b592=_0x21bd51(this,function(){const _0x1bc84d=_0x5d42,_0x302eb5={'OePHz':_0x1bc84d(0x365)};return _0x38b592[_0x1bc84d(0x267)]()['search'](_0x302eb5['OePHz'])[_0x1bc84d(0x267)]()[_0x1bc84d(0x213)](_0x38b592)[_0x1bc84d(0x189)](_0x302eb5[_0x1bc84d(0x342)]);});_0x38b592();const _0x539883=(function(){const _0x3e45e5=_0x5d42,_0x2872fa={'Wolyg':_0x3e45e5(0x3ee),'oILWg':'5|0|1|4|3|2','XKnxQ':_0x3e45e5(0x265),'MZeWr':_0x3e45e5(0x3db),'aUxRz':_0x3e45e5(0x36f),'bzsbM':_0x3e45e5(0x144),'etUke':_0x3e45e5(0x2f5),'YPFiX':'HOgwE','UQYjy':function(_0xeba258,_0x19bde9){return _0xeba258!==_0x19bde9;},'LHCfh':_0x3e45e5(0x367),'gegKU':_0x3e45e5(0x235),'DvGPJ':_0x3e45e5(0x395)};let _0x3afa2e=!![];return function(_0x5eb2a1,_0x122fb6){const _0x59ccb9=_0x3e45e5,_0x328446={'vpMtX':_0x2872fa['gegKU'],'pazMt':_0x2872fa[_0x59ccb9(0x329)]},_0x4ad22d=_0x3afa2e?function(){const _0x4b8834=_0x59ccb9,_0x423439={'uviof':_0x2872fa['Wolyg'],'OsQUO':_0x2872fa['oILWg'],'GviId':_0x2872fa[_0x4b8834(0x1b8)],'Oaqbl':_0x2872fa[_0x4b8834(0x3fb)],'ErOyi':_0x2872fa[_0x4b8834(0x183)],'RZqPb':_0x2872fa['bzsbM']};if(_0x2872fa[_0x4b8834(0x287)]===_0x2872fa['YPFiX']){const _0x3d34fd=_0x195f71[_0x4b8834(0x388)](_0x5c0b65[_0x4b8834(0x266)](_0x328446['vpMtX']))||{};_0x3d34fd[_0x7881d2]&&(delete _0x3d34fd[_0x497ae9],_0x2af718[_0x4b8834(0x232)](_0x328446[_0x4b8834(0x16f)],_0x6a70c6[_0x4b8834(0x3dc)](_0x3d34fd)),_0x1e9000[_0x4b8834(0x229)](_0x328446[_0x4b8834(0x16a)]));}else{if(_0x122fb6){if(_0x2872fa['UQYjy'](_0x4b8834(0x367),_0x2872fa[_0x4b8834(0x1d9)])){const _0x414fdf=_0x210a87['parse'](_0x1997a0[_0x4b8834(0x266)](_0x423439[_0x4b8834(0x2b7)]));if(_0x414fdf){const _0x5abf26=_0x423439[_0x4b8834(0x22d)][_0x4b8834(0x24b)]('|');let _0x4f70cc=0x0;while(!![]){switch(_0x5abf26[_0x4f70cc++]){case'0':_0x287f49=_0x414fdf['name'];continue;case'1':_0x49c3bf=_0x414fdf[_0x4b8834(0x176)];continue;case'2':_0x49caa0[_0x4b8834(0x3e7)](_0x423439[_0x4b8834(0x402)])[_0x4b8834(0x177)]=_0x28c63d[_0x4b8834(0x3da)](_0x423439[_0x4b8834(0x3b6)]);continue;case'3':_0x29d81a[_0x4b8834(0x3e7)](_0x423439[_0x4b8834(0x2b8)])[_0x4b8834(0x177)]=_0x3a7c1e[_0x4b8834(0x237)];continue;case'4':_0x2140b7[_0x4b8834(0x3cf)]=_0x5b45cb+_0x423439[_0x4b8834(0x17b)];continue;case'5':_0x240e57=_0x414fdf[_0x4b8834(0x2d5)];continue;}break;}}}else{const _0x280c58=_0x122fb6[_0x4b8834(0x14d)](_0x5eb2a1,arguments);return _0x122fb6=null,_0x280c58;}}}}:function(){};return _0x3afa2e=![],_0x4ad22d;};}()),_0x1a3a8c=_0x539883(this,function(){const _0xdd70bb=_0x5d42,_0x471388={'zPkdu':function(_0x54a146,_0x5cf68e){return _0x54a146-_0x5cf68e;},'NxLaS':function(_0xafc12b){return _0xafc12b();},'TtPNY':function(_0x300d0f){return _0x300d0f();},'cyxgp':function(_0x52744c,_0x20f3cc){return _0x52744c!==_0x20f3cc;},'YSjiI':'JwkcX','eoALN':function(_0x274140,_0x507502){return _0x274140(_0x507502);},'jjdnI':function(_0x2860de,_0x2c5bf2){return _0x2860de+_0x2c5bf2;},'fszAo':_0xdd70bb(0x148),'vNVwW':'SBSSo','kKsUC':_0xdd70bb(0x229),'MLrEE':_0xdd70bb(0x3b1),'FsxJM':'info','cELIY':_0xdd70bb(0x154),'AzocL':_0xdd70bb(0x25c),'esdWE':function(_0x416c77,_0x168931){return _0x416c77<_0x168931;},'MtnAF':function(_0x2a72ee,_0x2391e5){return _0x2a72ee===_0x2391e5;},'KZKMn':_0xdd70bb(0x1f7)};let _0x2579df;try{if(_0x471388['cyxgp'](_0x471388[_0xdd70bb(0x29a)],_0xdd70bb(0x3f5)))_0x423d56[_0x63975f][_0xdd70bb(0x3e1)]+=_0x471388[_0xdd70bb(0x197)](_0x5b3add['now'](),_0x3048ff),_0x49576a=_0x1a4429['now']();else{const _0x2b6ca0=_0x471388[_0xdd70bb(0x31e)](Function,_0x471388['jjdnI']('return\x20(function()\x20',_0x471388['fszAo'])+');');_0x2579df=_0x471388[_0xdd70bb(0x35d)](_0x2b6ca0);}}catch(_0x5277bf){'dQCmi'!==_0x471388[_0xdd70bb(0x34f)]?_0x2579df=window:(_0x5a13c5=0x0,_0x471388['NxLaS'](_0x45b6a3),_0x471388[_0xdd70bb(0x1cd)](_0x2d0d6f));}const _0xa2c792=_0x2579df[_0xdd70bb(0x2e6)]=_0x2579df[_0xdd70bb(0x2e6)]||{},_0x686a42=[_0x471388[_0xdd70bb(0x3af)],_0x471388[_0xdd70bb(0x182)],_0x471388[_0xdd70bb(0x207)],_0xdd70bb(0x291),_0x471388[_0xdd70bb(0x248)],_0xdd70bb(0x3f4),_0x471388[_0xdd70bb(0x38f)]];for(let _0x311bbf=0x0;_0x471388[_0xdd70bb(0x328)](_0x311bbf,_0x686a42['length']);_0x311bbf++){if(_0x471388[_0xdd70bb(0x3ca)]('fYNHN',_0x471388[_0xdd70bb(0x3eb)])){if(!_0x3ec255)_0x1dadcf();_0x11d589[_0xdd70bb(0x1ba)][_0xdd70bb(0x2f9)]=_0x2f3b8c[_0xdd70bb(0x339)]||'index.html';}else{const _0x2a505d=_0x539883[_0xdd70bb(0x213)][_0xdd70bb(0x305)]['bind'](_0x539883),_0x5ece24=_0x686a42[_0x311bbf],_0x436a96=_0xa2c792[_0x5ece24]||_0x2a505d;_0x2a505d[_0xdd70bb(0x1b9)]=_0x539883[_0xdd70bb(0x262)](_0x539883),_0x2a505d[_0xdd70bb(0x267)]=_0x436a96[_0xdd70bb(0x267)]['bind'](_0x436a96),_0xa2c792[_0x5ece24]=_0x2a505d;}}});_0x1a3a8c();let questionsData=[{'id':0x1,'choices':[{'id':0x1,'text':_0x31277a(0x3d8)},{'id':0x2,'text':_0x31277a(0x13f)},{'id':0x3,'text':_0x31277a(0x3ac)},{'id':0x4,'text':_0x31277a(0x363)}],'text':_0x31277a(0x233),'unique_key':'DT1198101','question_audio':null,'question_video':null,'map_id':0x124815,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x1d5),'correct_choice_id':0x3,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x2,'choices':[{'id':0xb,'text':_0x31277a(0x355)},{'id':0xc,'text':_0x31277a(0x162)},{'id':0xd,'text':_0x31277a(0x25e)},{'id':0xe,'text':_0x31277a(0x2a0)}],'text':_0x31277a(0x221),'unique_key':_0x31277a(0x2ed),'question_audio':null,'question_video':null,'map_id':0x12481b,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>Triple\x20hit\x20lymphoma\x20involves\x20chromosomal\x20rearrangements\x20in\x20MYC,\x20BCL-2,\x20and\x20BCL-6.</p>\x0a<ul>\x0a<li><strong>Double-hit\x20lymphomas</strong>\x20are\x20a\x20subset\x20of\x20B-cell\x20lymphomas\x20and\x20are\x20defined\x20by\x20chromosomal\x20rearrangements\x20involving\x20the\x20<strong>MYC\x20gene</strong>\x20along\x20with\x20either\x20<strong>BCL2</strong>\x20or<strong>\x20BCL6</strong>.</li>\x0a<li>These\x20genetic\x20alterations\x20are\x20associated\x20with\x20a\x20highly\x20aggressive\x20clinical\x20course\x20and\x20<strong>very\x20poor\x20prognosis</strong>.</li>\x0a<li>Triple-hit\x20lymphomas,\x20although\x20even\x20rarer\x20and\x20not\x20yet\x20formally\x20categorized\x20by\x20the\x20WHO,\x20exhibit\x20additional\x20chromosomal\x20rearrangements\x20involving\x20<strong>MYC,\x20BCL2,\x20and\x20BCL6</strong>.</li>\x0a<li>These\x20lymphomas\x20share\x20intermediate\x20features\x20between\x20DLBCL\x20and\x20Burkitt\x20lymphoma\x20(BL)\x20in\x20terms\x20of\x20morphology,\x20immunophenotype,\x20and\x20genetics.</li>\x0a<li>Their\x20prognosis\x20is\x20significantly\x20worse\x20than\x20either\x20DLBCL\x20or\x20BL\x20alone,\x20making\x20their\x20identification\x20clinically\x20crucial\x20since\x20they\x20require\x20different\x20therapeutic\x20approaches.</li>\x0a<li>Accurate\x20diagnosis\x20often\x20involves\x20<strong>cytogenetic\x20studies</strong>,\x20especially\x20in\x20cases\x20presenting\x20with\x20high-grade\x20features\x20and\x20a\x20high\x20proliferative\x20index.</li>\x0a</ul><p><a\x20href=\x22https://pmc.ncbi.nlm.nih.gov/articles/PMC3954668/\x22\x20target=\x22_blank\x22>https://pmc.ncbi.nlm.nih.gov/articles/PMC3954668/</a></p>','correct_choice_id':0xe,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x3,'choices':[{'id':0x15,'text':_0x31277a(0x3c4)},{'id':0x16,'text':_0x31277a(0x22c)},{'id':0x17,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Hemoglobin\x20H\x20(HbH)\x20disease</span></p>'},{'id':0x18,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Hydrops\x20fetalis</span></p>'}],'text':_0x31277a(0x252),'unique_key':_0x31277a(0x1a5),'question_audio':null,'question_video':null,'map_id':0x124866,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x28f),'correct_choice_id':0x17,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x4,'choices':[{'id':0x1f,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Haemarthrosis</span></p>'},{'id':0x20,'text':_0x31277a(0x3b4)},{'id':0x21,'text':_0x31277a(0x2ae)},{'id':0x22,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Oral\x20mucosal\x20bleeding</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x20patient\x20with\x20systemic\x20lupus\x20erythematosus\x20(SLE)\x20and\x20immune\x20thrombocytopenic\x20purpura\x20(ITP)\x20presents\x20with\x20a\x20platelet\x20count\x20of\x205000/&mu;L.\x20Which\x20of\x20these\x20is\x20the\x20most\x20likely\x20presenting\x20symptom?</span></p>','unique_key':'DT1198191','question_audio':null,'question_video':null,'map_id':0x12486f,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>A\x20patient\x20with\x20immune\x20thrombocytopenic\x20purpura\x20and\x20SLE\x20is\x20likely\x20to\x20present\x20with\x20oral\x20mucosal\x20bleeding\x20due\x20to\x20the\x20low\x20platelet\x20count.</p>\x0a<ul>\x0a<li>A\x20platelet\x20count\x20below\x20150,000/&mu;L\x20is\x20considered\x20thrombocytopenia.\x20When\x20levels\x20fall\x20between\x2020,000\x20to\x2050,000/&mu;L,\x20there\x20is\x20increased\x20risk\x20of\x20bleeding\x20after\x20trauma.</li>\x0a<li>Counts\x20under\x2020,000/&mu;L\x20can\x20lead\x20to\x20spontaneous,\x20nontraumatic\x20bleeding.\x20In\x20isolated\x20thrombocytopenia,\x20prothrombin\x20time\x20(PT)\x20and\x20partial\x20thromboplastin\x20time\x20(PTT)\x20remain\x20normal.</li>\x0a<li>Hemorrhages\x20tend\x20to\x20affect\x20small\x20vessels,\x20with\x20frequent\x20bleeding\x20seen\x20in\x20the\x20<strong>skin\x20</strong>and\x20<strong>mucosal\x20surfaces</strong>\x20of\x20the\x20gastrointestinal\x20and\x20genitourinary\x20tracts.\x20The\x20most\x20serious\x20risk\x20is\x20intracranial\x20hemorrhage,\x20especially\x20in\x20those\x20with\x20severely\x20low\x20platelet\x20counts.</li>\x0a<li>Chronic\x20ITP\x20is\x20an\x20autoimmune\x20condition\x20characterized\x20by\x20the\x20destruction\x20of\x20platelets\x20due\x20to\x20autoantibodies,\x20most\x20commonly\x20of\x20the\x20IgG\x20type.</li>\x0a<li>These\x20antibodies\x20target\x20platelet\x20membrane\x20glycoproteins\x20(mainly\x20IIb-IIIa\x20or\x20Ib-IX),\x20leading\x20to\x20opsonization\x20and\x20phagocytosis\x20by\x20splenic\x20macrophages.</li>\x0a<li>It\x20may\x20occur\x20without\x20an\x20identifiable\x20trigger\x20(primary)\x20or\x20secondary\x20to\x20<strong>systemic\x20lupus\x20erythematosus</strong>,\x20HIV,\x20or\x20B-cell\x20malignancies\x20like\x20CLL.</li>\x0a<li>The\x20antibodies\x20bind\x20to\x20platelets\x20in\x20the\x20circulation\x20and\x20are\x20recognized\x20by\x20Fc\x20receptors\x20on\x20phagocytes,\x20<strong>promoting\x20platelet\x20clearance</strong>,\x20especially\x20in\x20the\x20spleen.</li>\x0a<li><strong>Splenectomy\x20</strong>often\x20improves\x20platelet\x20counts\x20by\x20removing\x20the\x20site\x20of\x20destruction\x20and\x20a\x20source\x20of\x20antibody\x20production.</li>\x0a<li>It\x20typically\x20affects\x20adult\x20women\x20under\x2040,\x20with\x20a\x203:1\x20female-to-male\x20ratio.\x20The\x20disease\x20develops\x20gradually\x20and\x20is\x20marked\x20by\x20mucocutaneous\x20bleeding\x20such\x20as\x20petechiae,\x20ecchymoses,\x20easy\x20bruising,\x20epistaxis,\x20gum\x20bleeding,\x20melena,\x20hematuria,\x20or\x20heavy\x20menstrual\x20bleeding.</li>\x0a<li>Serious\x20bleeding\x20like\x20intracerebral\x20hemorrhage\x20is\x20rare.\x20Splenomegaly\x20and\x20lymphadenopathy\x20are\x20usually\x20absent\x20in\x20primary\x20ITP\x20and\x20suggest\x20alternative\x20diagnoses.</li>\x0a<li>Isolated\x20thrombocytopenia\x20is\x20seen\x20with\x20<strong>normal\x20PT\x20and\x20PTT</strong>.\x20Bone\x20marrow\x20may\x20show\x20increased\x20or\x20normal\x20megakaryocytes,\x20and\x20the\x20presence\x20of<strong>\x20large\x20platelets</strong>\x20in\x20peripheral\x20smear\x20is\x20considered\x20supportive.\x20Platelet\x20autoantibody\x20tests\x20lack\x20reliability\x20and\x20are\x20not\x20routinely\x20used.\x20Diagnosis\x20is\x20made\x20by\x20excluding\x20other\x20causes.</li>\x0a<li>Clotting\x20disorders,\x20whether\x20inherited\x20or\x20acquired,\x20often\x20present\x20with\x20<strong>large\x20bruises</strong>\x20(ecchymoses),<strong>\x20deep\x20hematomas</strong>,\x20or\x20prolonged\x20bleeding\x20following\x20trauma\x20or\x20surgery.</li>\x0a<li>Unlike\x20thrombocytopenia,\x20these\x20disorders\x20tend\x20to\x20cause\x20bleeding\x20<strong>into\x20the\x20</strong>gastrointestinal\x20and\x20urinary\x20systems,\x20as\x20well\x20as\x20into\x20joints\x20(hemarthrosis),\x20especially\x20after\x20minimal\x20stress.\x20(Options\x20A,\x20B,\x20and\x20C\x20ruled\x20out)</li>\x0a<li>Common\x20examples\x20include\x20extended\x20bleeding\x20after\x20dental\x20procedures\x20or\x20joint\x20bleeds\x20from\x20minor\x20activities.</li>\x0a</ul><br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250912848bcf87-0195-442b-96df-352df4b10e43.png\x22>','correct_choice_id':0x22,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x5,'choices':[{'id':0x29,'text':_0x31277a(0x273)},{'id':0x2a,'text':_0x31277a(0x19c)},{'id':0x2b,'text':_0x31277a(0x2fe)},{'id':0x2c,'text':_0x31277a(0x1dc)}],'text':_0x31277a(0x32d),'unique_key':_0x31277a(0x23f),'question_audio':null,'question_video':null,'map_id':0x124880,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x191),'correct_choice_id':0x2c,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x6,'choices':[{'id':0x33,'text':_0x31277a(0x3f7)},{'id':0x34,'text':_0x31277a(0x3fa)},{'id':0x35,'text':_0x31277a(0x236)},{'id':0x36,'text':_0x31277a(0x17f)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2030-year-old\x20woman\x20presents\x20with\x20fatigue,\x20fever,\x20and\x20confusion.\x20Laboratory\x20investigations\x20reveal\x20anemia,\x20thrombocytopenia,\x20elevated\x20lactate\x20dehydrogenase\x20(LDH),\x20and\x20schistocytes\x20on\x20peripheral\x20smear.\x20Coombs\x20test\x20is\x20negative.\x20Renal\x20function\x20is\x20mildly\x20impaired.\x20Which\x20of\x20the\x20following\x20best\x20explains\x20the\x20pathophysiology\x20of\x20this\x20patient’s\x20condition?</span></p>','unique_key':'DT1198215','question_audio':null,'question_video':null,'map_id':0x124887,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x1e3),'correct_choice_id':0x34,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x7,'choices':[{'id':0x3d,'text':_0x31277a(0x321)},{'id':0x3e,'text':_0x31277a(0x33b)},{'id':0x3f,'text':_0x31277a(0x39c)},{'id':0x40,'text':_0x31277a(0x1b4)}],'text':_0x31277a(0x1bb),'unique_key':_0x31277a(0x172),'question_audio':null,'question_video':null,'map_id':0x12488a,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p><p>Idarucizumab\x20is\x20used\x20for\x20the\x20reversal\x20of\x20effect\x20of\x20dabigatran\x20which\x20is\x20an\x20orally\x20active\x20<strong>direct\x20thrombin\x20inhibitor</strong>.</p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240327e39307e4-b7ea-4402-85f2-4a8d2703bd16.jpg\x22>\x0a<p>PCC:\x20Prothrombin\x20Complex\x20Concentrates</p>\x0a<p>FFP:\x20Fresh\x20Frozen\x20Plasma</p>\x0a<p><strong>Explanation\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Vitamin\x20K\x20antagonism\x20(Option\x20A):\x20</strong>Describes\x20the\x20mechanism\x20of\x20action\x20of\x20warfarin.\x20Reversal\x20agents\x20used\x20for\x20warfarin\x20toxicity\x20include\x20vitamin\x20K,\x20prothrombin\x20complex\x20concentrates,\x20and\x20fresh\x20frozen\x20plasma.</p>\x0a<p><strong>Direct\x20factor\x20X\x20inhibition\x20(Option\x20B):</strong>\x20Exhibited\x20by\x20rivaroxaban,\x20apixaban,\x20and\x20edoxaban\x20for\x20which\x20andexanet\x20alfa\x20is\x20used\x20for\x20reversal.</p>\x0a<p><strong>Indirect\x20factor\x20X\x20inhibition\x20(Option\x20C):</strong>\x20Shown\x20by\x20heparin,\x20LMWH,\x20and\x20fondaparinux.\x20Protamine\x20sulfate\x20is\x20used\x20to\x20reverse\x20effects\x20of\x20heparin.</p>','correct_choice_id':0x40,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x8,'choices':[{'id':0x47,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Alcoholic\x20liver\x20disease</span></p>'},{'id':0x48,'text':_0x31277a(0x171)},{'id':0x49,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Primary\x20myelofibrosis</span></p>'},{'id':0x4a,'text':_0x31277a(0x38d)}],'text':_0x31277a(0x3f0),'unique_key':_0x31277a(0x163),'question_audio':null,'question_video':null,'map_id':0x12488d,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x3c6),'correct_choice_id':0x4a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x9,'choices':[{'id':0x51,'text':_0x31277a(0x1da)},{'id':0x52,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Chronic\x20lymphocytic\x20leukemia</span></p>'},{'id':0x53,'text':_0x31277a(0x24e)},{'id':0x54,'text':_0x31277a(0x288)}],'text':_0x31277a(0x39a),'unique_key':_0x31277a(0x33d),'question_audio':null,'question_video':null,'map_id':0x124892,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x1ad),'correct_choice_id':0x51,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xa,'choices':[{'id':0x5b,'text':_0x31277a(0x3a3)},{'id':0x5c,'text':_0x31277a(0x34c)},{'id':0x5d,'text':_0x31277a(0x3ba)},{'id':0x5e,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Eltrombopag</span></p>'}],'text':_0x31277a(0x234),'unique_key':_0x31277a(0x28d),'question_audio':null,'question_video':null,'map_id':0x124895,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x1d2),'correct_choice_id':0x5b,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xb,'choices':[{'id':0x65,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Chronic\x20gastrointestinal\x20tract\x20bleeding</span></p>'},{'id':0x66,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>High\x20hepcidin\x20levels\x20inhibiting\x20iron\x20export\x20from\x20macrophages</span></p>'},{'id':0x67,'text':_0x31277a(0x32b)},{'id':0x68,'text':_0x31277a(0x2d7)}],'text':_0x31277a(0x14a),'unique_key':_0x31277a(0x2b2),'question_audio':null,'question_video':null,'map_id':0x124898,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p><strong>High\x20hepcidin\x20levels\x20inhibiting\x20iron\x20release\x20from\x20storage\x20sites\x20</strong>contributes\x20to\x20the\x20development\x20of\x20anemia\x20of\x20chronic\x20disease.</p>\x0a<ul>\x0a<li>Anemia\x20of\x20chronic\x20disease,\x20also\x20termed\x20anemia\x20of\x20inflammation\x20(AI),\x20is\x20a\x20common\x20anemia\x20associated\x20with\x20inflammatory,\x20infectious,\x20or\x20neoplastic\x20conditions.</li>\x0a<li>It\x20is\x20characterized\x20by<strong>\x20normal\x20or\x20increased\x20iron\x20stores</strong>\x20but\x20impaired\x20iron\x20utilization\x20due\x20to\x20restricted\x20iron\x20delivery\x20to\x20the\x20marrow.</li>\x0a<li>Laboratory\x20findings\x20typically\x20include\x20low\x20serum\x20iron,\x20<strong>elevated\x20serum\x20ferritin</strong>,\x20reduced\x20transferrin\x20saturation\x20(15\x20-\x2020%),\x20and\x20low\x20red\x20cell\x20protoporphyrin,\x20with\x20a\x20<strong>hypoproliferative\x20marrow</strong>.</li>\x0a<li><strong>Interleukin-1\x20(IL-1)</strong>\x20reduces\x20the\x20production\x20of\x20erythropoietin\x20(EPO)\x20in\x20response\x20to\x20anemia.\x20It\x20also\x20<strong>impairs\x20the\x20erythroid\x20marrow\x27s\x20responsiveness\x20to\x20EPO</strong>\x20by\x20promoting\x20the\x20release\x20of\x20interferon-gamma\x20(IFN-&gamma;)\x20from\x20accessory\x20cells.</li>\x0a<li>This\x20suppression\x20can\x20be\x20reversed\x20with\x20<strong>EPO\x20administration</strong>\x20both\x20in\x20vitro\x20and\x20in\x20vivo.\x20Additionally,\x20tumor\x20necrosis\x20factor\x20(TNF)\x20diminishes\x20EPO\x20responsiveness\x20by\x20stimulating\x20marrow\x20stromal\x20cells\x20to\x20release\x20interferon-beta\x20(IFN-&beta;).</li>\x0a</ul><br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250912cf8680cf-b480-4974-8a24-8f4c2a07073a.png\x22><br><ul>\x0a<li><strong>Hepcidin</strong>,\x20a\x20key\x20iron\x20regulatory\x20hormone\x20<strong>elevated\x20via\x20IL-6\x20</strong>in\x20inflammation,\x20<strong>suppresses\x20iron\x20absorption\x20and\x20release</strong>,\x20while\x20cytokines\x20like\x20IL-1\x20and\x20TNF\x20reduce\x20erythropoietin\x20(EPO)\x20responsiveness,\x20leading\x20to\x20impaired\x20erythropoiesis\x20and\x20shortened\x20red\x20cell\x20lifespan.</li>\x0a<li>In\x20patients\x20with\x20chronic\x20conditions\x20like\x20cancer,\x20anemia\x20is\x20usually\x20<strong>normocytic\x20and\x20normochromic</strong>,\x20whereas\x20in\x20long-standing\x20inflammatory\x20diseases\x20such\x20as\x20rheumatoid\x20arthritis\x20or\x20tuberculosis,\x20it\x20may\x20present\x20as\x20<strong>microcytic\x20hypochromic\x20anemia</strong>.</li>\x0a<li>Though\x20hypoproliferative\x20in\x20both,\x20the\x20variation\x20in\x20red\x20cell\x20indices\x20arises\x20from\x20differing\x20iron\x20availability\x20for\x20hemoglobin\x20synthesis.</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Chronic\x20gastrointestinal\x20tract\x20bleeding\x20(Option\x20A):\x20</strong>Leads\x20to\x20iron\x20deficiency\x20anemia</p>\x0a<p><strong>Reduced\x20EPO\x20production(Option\x20C):\x20</strong>Explains\x20anemia\x20due\x20to\x20chronic\x20kidney\x20disease.</p>\x0a<p><strong>Gastrectomy\x20(Option\x20D):\x20</strong>Gastrectomy\x20can\x20cause\x20both\x20iron\x20deficiency\x20anemia\x20and\x20megaloblastic\x20anemia.</p>','correct_choice_id':0x66,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xc,'choices':[{'id':0x6f,'text':_0x31277a(0x292)},{'id':0x70,'text':_0x31277a(0x344)},{'id':0x71,'text':_0x31277a(0x1b5)},{'id':0x72,'text':_0x31277a(0x2af)}],'text':_0x31277a(0x384),'unique_key':_0x31277a(0x24c),'question_audio':null,'question_video':null,'map_id':0x12489e,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x21a),'correct_choice_id':0x71,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xd,'choices':[{'id':0x79,'text':_0x31277a(0x27b)},{'id':0x7a,'text':_0x31277a(0x1cf)},{'id':0x7b,'text':_0x31277a(0x243)},{'id':0x7c,'text':_0x31277a(0x269)}],'text':_0x31277a(0x3bc),'unique_key':_0x31277a(0x23d),'question_audio':null,'question_video':null,'map_id':0x1248aa,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p><strong>Sideroblastic\x20anemia\x20</strong>results\x20in\x20a\x20microcytic\x20anemia\x20with\x20a\x20normal/high\x20ferritin.</p>\x0a<p>The\x20following\x20table\x20distinguishes\x20the\x20different\x20causes\x20of\x20microcytic\x20anemia.</p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509123f82c1ad-59f0-4982-8f70-74caa71ec501.png\x22><p><strong>Explanation\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Iron\x20Deficiency\x20(Option\x20A):\x20</strong>Iron\x20deficiency\x20anemia\x20is\x20characterised\x20by\x20reduced\x20serum\x20ferritin\x20levels.</p>\x0a<p><strong>Vitamin\x20B12\x20deficiency\x20(Option\x20B):\x20</strong>Vitamin\x20B12\x20deficiency\x20causes\x20megaloblastic\x20macrocytic\x20anemia.</p>\x0a<p><strong>Warm\x20type\x20autoimmune\x20hemolytic\x20anemia\x20(Option\x20D):\x20</strong>Hemolytic\x20anemias\x20usually\x20lead\x20to\x20<strong>macrocytosis</strong>.</p>','correct_choice_id':0x7b,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xe,'choices':[{'id':0x83,'text':_0x31277a(0x375)},{'id':0x84,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x20single\x20lesion\x20in\x20bone\x20or\x20soft\x20tissue\x20confirmed\x20by\x20biopsy,\x20showing\x20the\x20presence\x20of\x20clonal\x20plasma\x20cells</span></p>'},{'id':0x85,'text':_0x31277a(0x3cb)},{'id':0x86,'text':_0x31277a(0x31a)}],'text':_0x31277a(0x3a5),'unique_key':'DT1198256','question_audio':null,'question_video':null,'map_id':0x1248b0,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>Among\x20the\x20given\x20options,\x20low\x20levels\x20of\x20lgG\x20monoclonal\x20protein\x20with\x20clonal\x20bone\x20marrow\x20cells\x20&lt;\x2010%\x20is\x20consistent\x20with\x20the\x20diagnosis\x20of\x20monoclonal\x20gammopathy\x20of\x20undetermined\x20significance.<strong><br\x20/>\x20</strong></p>\x0a<ul>\x0a<li><strong>Monoclonal\x20Gammopathy\x20of\x20Undetermined\x20Significance\x20(MGUS)</strong>\x20is\x20the\x20most\x20common\x20plasma\x20cell\x20disorder,\x20seen\x20in\x20about\x203%\x20of\x20individuals\x20over\x2050\x20and\x205%\x20of\x20those\x20over\x2070\x20years.</li>\x0a<li>It\x20is\x20characterized\x20by\x20serum\x20monoclonal\x20protein\x20(non-IgM\x20type)\x20levels\x20below<strong>\x2030\x20g/L</strong>,\x20bone\x20marrow\x20clonal\x20plasma\x20cells\x20under<strong>\x2010%</strong>,\x20and\x20<strong>absence\x20of\x20myeloma-defining\x20events</strong>\x20or\x20amyloidosis\x20related\x20to\x20plasma\x20cell\x20proliferation.</li>\x0a<li>Patients\x20are\x20asymptomatic\x20by\x20definition,\x20but\x20about\x201%\x20per\x20year\x20progress\x20to\x20symptomatic\x20plasma\x20cell\x20neoplasms,\x20usually\x20multiple\x20myeloma.</li>\x0a<li>The\x20clonal\x20plasma\x20cells\x20in\x20MGUS\x20often\x20carry\x20chromosomal\x20abnormalities\x20similar\x20to\x20those\x20in\x20multiple\x20myeloma,\x20indicating\x20MGUS\x20as\x20a\x20precursor\x20stage.</li>\x0a<li>Therefore,\x20regular\x20monitoring\x20of\x20serum\x20M\x20protein\x20and\x20Bence\x20Jones\x20proteinuria\x20is\x20recommended.</li>\x0a</ul>\x0a<p><strong>Explanations\x20of\x20other\x20options:</strong></p>\x0a<p><strong>IgA\x20levels\x20of\x2040\x20g/L\x20with\x20no\x20myeloma\x20defining\x20events\x20(Option\x20A):\x20</strong>Consistent\x20with\x20<strong>smoldering\x20multiple\x20myeloma</strong>,\x20also\x20called\x20asymptomatic\x20myeloma\x20which\x20defined\x20by\x20the\x20presence\x20of\x20serum\x20monoclonal\x20protein\x20(IgG\x20or\x20IgA)<strong>\x20&ge;30\x20g/L\x20</strong>or\x20urinary\x20monoclonal\x20protein\x20&ge;500\x20mg\x20in\x2024\x20hours\x20and/or\x20clonal\x20bone\x20marrow\x20plasma\x20cells\x20ranging\x20between<strong>\x2010\x20-\x2060%,</strong>\x20in\x20the\x20<strong>absence\x20of\x20any\x20myeloma-defining\x20event</strong>s\x20or\x20amyloidosis.</p>\x0a<p><strong>A\x20single\x20lesion\x20in\x20bone\x20or\x20soft\x20tissue\x20confirmed\x20by\x20biopsy,\x20showing\x20the\x20presence\x20of\x20clonal\x20plasma\x20cells\x20(Option\x20B):\x20</strong>Suggestive\x20of<strong>\x20solitary\x20plasmacytom</strong>a\x20which\x20is\x20defined\x20by\x20a\x20single,\x20biopsy-confirmed\x20lesion\x20in\x20bone\x20or\x20soft\x20tissue\x20containing\x20clonal\x20plasma\x20cells,\x20while\x20the\x20remaining\x20<strong>bone\x20marrow\x20shows\x20no\x20clonal\x20involvement</strong>.\x20Imaging\x20studies\x20such\x20as\x20skeletal\x20survey\x20and\x20spine/pelvis\x20MRI\x20or\x20CT\x20appear\x20normal\x20except\x20at\x20the\x20primary\x20lesion\x20site.\x20There\x20is\x20no\x20evidence\x20of\x20CRAB\x20features\x20which\x20are\x20hypercalcemia,\x20renal\x20failure,\x20anemia,\x20or\x20other\x20bone\x20lesions\x20which\x20can\x20be\x20linked\x20to\x20a\x20lymphoplasmacytic\x20proliferative\x20disorder.</p>\x0a<p><strong>Bone\x20marrow\x20plasmacytosis\x20&gt;\x2010%\x20with\x20no\x20M\x20protein\x20in\x20urine\x20or\x20serum\x20(Option\x20D):\x20</strong>Points\x20to\x20a\x20diagnosis\x20of\x20<strong>nonsecretory\x20myeloma\x20</strong>which\x20is\x20characterized\x20by\x20the\x20absence\x20of\x20detectable\x20M\x20protein\x20in\x20both\x20serum\x20and\x20urine\x20despite\x20immunofixation\x20testing.\x20It\x20involves\x20&ge;10%\x20clonal\x20plasma\x20cells\x20in\x20the\x20bone\x20marrow\x20or\x20the\x20presence\x20of\x20a\x20plasmacytoma,\x20along\x20with\x20evidence\x20of\x20myeloma-associated\x20organ\x20damage.</p>','correct_choice_id':0x85,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xf,'choices':[{'id':0x8d,'text':_0x31277a(0x1c1)},{'id':0x8e,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Fresh\x20frozen\x20plasma</span></p>'},{'id':0x8f,'text':_0x31277a(0x27f)},{'id':0x90,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Prothrombin\x20complex\x20concentrate</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2022-year-old\x20man\x20is\x20admitted\x20following\x20a\x20severe\x20road\x20traffic\x20accident.\x20He\x20suffered\x20significant\x20blood\x20loss\x20at\x20the\x20scene.\x20He\x20is\x20resuscitated\x20with\x20IV\x20crystalloid\x20and\x20group\x20O\x20negative\x20packed\x20red\x20cells.\x20Intra-operatively\x20the\x20anesthetist\x20phones\x20you\x20for\x20advice.\x20Bloods\x20show:\x20Hb:\x206.6\x20g/dL;\x20WBC:\x2011200/&mu;L;\x20platelet\x20count\x2083000/&mu;L;\x20PT\x2028\x20seconds;\x20APTT:\x2072\x20seconds;\x20fibrinogen:\x201.9\x20g/L.\x20What\x20is\x20most\x20appropriate\x20to\x20use\x20to\x20reduce\x20his\x20bleeding\x20risk?</span></p>','unique_key':_0x31277a(0x227),'question_audio':null,'question_video':null,'map_id':0x1248b4,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x31277a(0x26c),'correct_choice_id':0x8e,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x10,'choices':[{'id':0x97,'text':_0x31277a(0x29f)},{'id':0x98,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Hairy\x20cell\x20leukemia</span></p>'},{'id':0x99,'text':_0x31277a(0x38c)},{'id':0x9a,'text':_0x31277a(0x2ca)}],'text':_0x31277a(0x2bc),'unique_key':_0x31277a(0x1d3),'question_audio':null,'question_video':null,'map_id':0x1248b8,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x147),'correct_choice_id':0x98,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x11,'choices':[{'id':0xa1,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Dexamethasone</span></p>'},{'id':0xa2,'text':_0x31277a(0x1c5)},{'id':0xa3,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>ATRA</span></p>'},{'id':0xa4,'text':_0x31277a(0x3d2)}],'text':_0x31277a(0x188),'unique_key':_0x31277a(0x2a4),'question_audio':null,'question_video':null,'map_id':0x1248bb,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x303),'correct_choice_id':0xa1,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x12,'choices':[{'id':0xab,'text':_0x31277a(0x209)},{'id':0xac,'text':_0x31277a(0x13e)},{'id':0xad,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>CLL</span></p>'},{'id':0xae,'text':_0x31277a(0x3b8)}],'text':_0x31277a(0x253),'unique_key':'DT1198268','question_audio':null,'question_video':null,'map_id':0x1248bc,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x31277a(0x1ee),'correct_choice_id':0xab,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x13,'choices':[{'id':0xb5,'text':_0x31277a(0x14f)},{'id':0xb6,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Flow\x20cytometry</span></p>'},{'id':0xb7,'text':_0x31277a(0x34a)},{'id':0xb8,'text':_0x31277a(0x3c3)}],'text':_0x31277a(0x376),'unique_key':_0x31277a(0x27a),'question_audio':null,'question_video':null,'map_id':0x1248c0,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>This\x20patient\x20presents\x20with\x20the\x20classic\x20signs,\x20symptoms,\x20and\x20laboratory\x20abnormalities\x20of\x20paroxysmal\x20nocturnal\x20hemoglobinuria\x20(PHN)\x20which\x20is\x20diagnosed\x20by\x20<strong>flow\x20cytometry</strong>.</p>\x0a<ul>\x0a<li>PNH\x20is\x20an\x20<strong>acquired\x20chronic\x20hemolytic\x20anemia</strong>\x20characterized\x20by\x20persistent\x20<strong>intravascular\x20hemolysis</strong>,\x20sometimes\x20punctuated\x20by\x20<strong>recurrent\x20exacerbations</strong>.</li>\x0a<li>It\x20commonly\x20presents\x20with\x20a\x20triad\x20of<strong>\x20hemolysis</strong>,\x20cytopenias,\x20and\x20a\x20predisposition\x20to\x20venous\x20thrombosis.</li>\x0a<li>Diagnosis\x20is\x20often\x20delayed\x20due\x20to\x20variable\x20manifestations,\x20though\x20it\x20is\x20confirmed\x20through\x20laboratory\x20investigations.\x20It\x20affects\x20<strong>both\x20sexes\x20equally</strong>,\x20can\x20occur\x20at\x20any\x20age\x20but\x20often\x20arises\x20in\x20young\x20adults,\x20and\x20is\x20not\x20inherited.</li>\x0a<li>Patients\x20may\x20report<strong>\x20passing\x20dark\x20or\x20blood-stained\x20urine</strong>,\x20typically\x20in\x20the\x20morning,\x20though\x20this\x20is\x20not\x20always\x20noticed.</li>\x0a<li>Many\x20present\x20with\x20nonspecific\x20signs\x20of\x20anemia,\x20which\x20may\x20be\x20discovered\x20incidentally.\x20Cytopenias\x20such\x20as\x20<strong>neutropenia</strong>\x20and<strong>\x20thrombocytopenia</strong>\x20may\x20indicate\x20marrow\x20involvement.</li>\x0a<li><strong>Abdominal\x20pain</strong>\x20may\x20occur\x20due\x20to\x20thrombosis,\x20and\x20hepatic\x20vein\x20thrombosis\x20may\x20result\x20in\x20Budd-Chiari\x20syndrome.</li>\x0a<li>Thrombosis\x20is\x20a\x20major\x20cause\x20of\x20death\x20in\x20PNH.</li>\x0a<li>Bone\x20marrow\x20findings\x20often\x20reveal\x20<strong>erythroid\x20hyperplasia</strong>,\x20but\x20in\x20some\x20cases\x20may\x20be\x20hypocellular\x20or\x20aplastic.\x20Laboratory\x20features\x20include\x20normocytic\x20or\x20macrocytic\x20anemia,\x20<strong>elevated\x20LDH</strong>,\x20low\x20haptoglobin,\x20and\x20hemoglobinuria.</li>\x0a<li>The\x20disorder\x20arises\x20from\x20a\x20somatic\x20mutation\x20in\x20the<strong>\x20PIGA\x20</strong>gene\x20affecting\x20the\x20GPI\x20anchor,\x20which\x20results\x20in\x20deficient\x20expression\x20of\x20surface\x20proteins\x20like<strong>\x20CD55\x20</strong>and\x20<strong>CD59\x20</strong>that\x20normally\x20protect\x20red\x20cells\x20from\x20complement.</li>\x0a<li>This\x20leads\x20to\x20uncontrolled\x20<strong>complement-mediated\x20hemolysis</strong>.\x20The\x20absence\x20of\x20CD59\x20particularly\x20contributes\x20to\x20<strong>formation\x20of\x20the\x20membrane\x20attack\x20complex\x20(MAC)</strong>,\x20causing\x20red\x20cell\x20lysis.</li>\x0a<li>Platelet\x20activation\x20due\x20to\x20CD59\x20deficiency\x20also\x20contributes\x20to\x20thrombosis.</li>\x0a<li><strong>Flow\x20cytometry</strong>\x20is\x20the\x20<strong>diagnostic\x20gold\x20standard</strong>,\x20identifying\x20the\x20absence\x20of\x20GPI-anchored\x20proteins\x20on\x20granulocytes\x20and\x20red\x20cells.\x20A\x20PNH\x20diagnosis\x20requires\x20at\x20least\x205%\x20of\x20red\x20cells\x20and\x2020%\x20of\x20granulocytes\x20lacking\x20these\x20proteins.</li>\x0a<li>Historically,\x20treatment\x20options\x20were\x20limited\x20to\x20bone\x20marrow\x20transplantation\x20or\x20supportive\x20care.\x20Introduction\x20of\x20<strong>eculizumab</strong>,\x20a\x20monoclonal\x20antibody\x20against\x20C5,\x20has\x20significantly\x20improved\x20outcomes\x20by\x20reducing\x20hemolysis\x20and\x20thrombosis.\x20Bone\x20marrow\x20transplantation\x20is\x20still\x20considered\x20for\x20young\x20patients\x20or\x20those\x20with\x20marrow\x20failure.</li>\x0a</ul>\x0a<p><strong>Explanations\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Blood\x20cultures\x20(Option\x20A):\x20</strong>Blood\x20cultures\x20would\x20identify\x20septicemia\x20which\x20can\x20contribute\x20to\x20intravascular\x20hemolysis.\x20The\x20clinical\x20features\x20in\x20the\x20given\x20scenario\x20does\x20not\x20suggest\x20sepsis.</p>\x0a<p><strong>Gene\x20analysis\x20for\x20G6PD\x20deficiency\x20(Option\x20C):\x20</strong>Mutations\x20in\x20the\x206-phosphate\x20dehydrogenase\x20(G6PD)\x20gene\x20lead\x20to\x20G6PD\x20deficiency,\x20which\x20can\x20lead\x20to\x20hemolysis\x20with\x20certain\x20drugs,\x20fava\x20beans,\x20and\x20other\x20<strong>oxidative\x20agents</strong>.</p>\x0a<p><strong>Donath-Landsteiner\x20antibody\x20(Option\x20D):\x20Paroxysmal\x20cold\x20hemoglobinuria</strong>\x20is\x20a\x20rare\x20type\x20of\x20autoimmune\x20hemolytic\x20anemia\x20(AIHA)\x20that\x20mainly\x20affects<strong>\x20children\x20</strong>and\x20is\x20often\x20preceded\x20by\x20a\x20viral\x20infection.\x20It\x20is\x20usually\x20a\x20self-limiting\x20condition\x20and\x20is\x20identified\x20by\x20the\x20presence\x20of\x20the\x20Donath-Landsteiner\x20antibody,\x20which\x20typically\x20targets\x20the\x20P\x20antigen\x20on\x20red\x20cells.</p>','correct_choice_id':0xb6,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x14,'choices':[{'id':0xbf,'text':_0x31277a(0x331)},{'id':0xc0,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Isolated\x20activated\x20partial\x20thromboplastin\x20time\x20(aPTT)</span></p>'},{'id':0xc1,'text':_0x31277a(0x24f)},{'id':0xc2,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Normal\x20PT\x20and\x20aPTT</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Factor\x20VII\x20deficiency\x20should\x20be\x20considered\x20with\x20which\x20of\x20the\x20following\x20coagulation\x20abnormalities?</span></p>','unique_key':_0x31277a(0x33f),'question_audio':null,'question_video':null,'map_id':0x1248c3,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x13b),'correct_choice_id':0xbf,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x15,'choices':[{'id':0xc9,'text':_0x31277a(0x3e4)},{'id':0xca,'text':_0x31277a(0x381)},{'id':0xcb,'text':_0x31277a(0x30b)},{'id':0xcc,'text':_0x31277a(0x167)}],'text':_0x31277a(0x155),'unique_key':'DT1198282','question_audio':null,'question_video':null,'map_id':0x1248ca,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x3f6),'correct_choice_id':0xcc,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x16,'choices':[{'id':0xd3,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Eculizumab</span></p>'},{'id':0xd4,'text':_0x31277a(0x1bf)},{'id':0xd5,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Emicizumab</span></p>'},{'id':0xd6,'text':_0x31277a(0x313)}],'text':_0x31277a(0x20d),'unique_key':'DT1198284','question_audio':null,'question_video':null,'map_id':0x1248cc,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x387),'correct_choice_id':0xd5,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x31277a(0x36e),'tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x17,'choices':[{'id':0xdd,'text':_0x31277a(0x2e7)},{'id':0xde,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Aplastic\x20Anemia</span></p>'},{'id':0xdf,'text':_0x31277a(0x289)},{'id':0xe0,'text':_0x31277a(0x218)}],'text':_0x31277a(0x164),'unique_key':_0x31277a(0x29c),'question_audio':null,'question_video':null,'map_id':0x1248d0,'difficulty_level':_0x31277a(0x2ab),'subjects_id':[0x1],'solution':_0x31277a(0x19a),'correct_choice_id':0xdd,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x31277a(0x2e3)],'explanation_video':null,'question_images':[],'explanation_images':[]}],quizName=_0x31277a(0x1af);const quizFilename=_0x31277a(0x205);let hierarchy=[_0x31277a(0x27e),_0x31277a(0x3fc),_0x31277a(0x3d5)];if(window[_0x31277a(0x1ba)][_0x31277a(0x385)][_0x31277a(0x36b)](_0x31277a(0x1d0))){const customData=JSON[_0x31277a(0x388)](localStorage[_0x31277a(0x266)](_0x31277a(0x3ee)));if(customData){const HEkpsa=_0x31277a(0x175)[_0x31277a(0x24b)]('|');let pwhpjW=0x0;while(!![]){switch(HEkpsa[pwhpjW++]){case'0':hierarchy=customData[_0x31277a(0x176)];continue;case'1':quizName=customData[_0x31277a(0x2cc)];continue;case'2':document[_0x31277a(0x3cf)]=quizName+_0x31277a(0x144);continue;case'3':document[_0x31277a(0x3e7)](_0x31277a(0x36f))[_0x31277a(0x177)]=questionsData[_0x31277a(0x237)];continue;case'4':questionsData=customData[_0x31277a(0x2d5)];continue;case'5':document[_0x31277a(0x3e7)](_0x31277a(0x265))[_0x31277a(0x177)]=hierarchy[_0x31277a(0x3da)](_0x31277a(0x3db));continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x31277a(0x268),timer=null,timeRemaining=0x0,questionStartTime=Date['now'](),quizStartTime=Date['now'](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x31277a(0x237)])['fill'](null)[_0x31277a(0x296)](()=>({'status':'not_attempted','bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x31277a(0x237)]};function saveProgress(){const _0x395416=_0x31277a,_0x516781={'jZPtt':_0x395416(0x235),'jLErh':'incomplete'};if(isQuizCompleted)return;const _0x1627fd=JSON['parse'](localStorage['getItem'](_0x516781[_0x395416(0x1fa)]))||{};_0x1627fd[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x516781[_0x395416(0x2d6)],'lastSeen':new Date()[_0x395416(0x28c)]()},localStorage[_0x395416(0x232)](_0x516781[_0x395416(0x1fa)],JSON['stringify'](_0x1627fd));}function loadProgress(){const _0x2e340d=_0x31277a,_0x5ace79={'PRFkH':_0x2e340d(0x235),'MRpmz':_0x2e340d(0x309)},_0x4be426=JSON[_0x2e340d(0x388)](localStorage['getItem'](_0x5ace79[_0x2e340d(0x2a2)]))||{},_0x41e00d=_0x4be426[quizFilename];if(_0x41e00d){const _0x3e3f94=_0x2e340d(0x21d)[_0x2e340d(0x24b)]('|');let _0x126ca4=0x0;while(!![]){switch(_0x3e3f94[_0x126ca4++]){case'0':currentQuestionIndex=_0x41e00d[_0x2e340d(0x2c9)];continue;case'1':questionStates=_0x41e00d[_0x2e340d(0x37f)];continue;case'2':stats=_0x41e00d[_0x2e340d(0x14e)];continue;case'3':console['log'](_0x5ace79[_0x2e340d(0x17e)]);continue;case'4':return!![];case'5':currentMode=_0x41e00d[_0x2e340d(0x1be)];continue;}break;}}return![];}function clearProgress(){const _0x4f1fb9=_0x31277a,_0x3efcc7={'vUKDi':'userHistory','xSElZ':_0x4f1fb9(0x395)},_0x20bba6=JSON['parse'](localStorage[_0x4f1fb9(0x266)](_0x3efcc7[_0x4f1fb9(0x348)]))||{};_0x20bba6[quizFilename]&&(delete _0x20bba6[quizFilename],localStorage['setItem'](_0x3efcc7[_0x4f1fb9(0x348)],JSON[_0x4f1fb9(0x3dc)](_0x20bba6)),console[_0x4f1fb9(0x229)](_0x3efcc7['xSElZ']));}function markQuizAsCompleted(){const _0x2881cc=_0x31277a,_0x4ed5c1={'KhdMa':_0x2881cc(0x235),'ADajD':'completed'},_0x49a74b=JSON[_0x2881cc(0x388)](localStorage[_0x2881cc(0x266)](_0x4ed5c1['KhdMa']))||{},_0xb63a1b=questionsData[_0x2881cc(0x237)],_0x564438=stats[_0x2881cc(0x1c4)]||0x0;_0x49a74b[quizFilename]={'score':_0x564438,'total':_0xb63a1b,'status':_0x4ed5c1[_0x2881cc(0x2be)],'completedOn':new Date()['toISOString']()},localStorage[_0x2881cc(0x232)](_0x2881cc(0x235),JSON[_0x2881cc(0x3dc)](_0x49a74b));}const urlParams=new URLSearchParams(window[_0x31277a(0x1ba)][_0x31277a(0x189)]),startAt=parseInt(urlParams[_0x31277a(0x354)]('startAt')),resume=urlParams[_0x31277a(0x354)](_0x31277a(0x1a9))===_0x31277a(0x15f);function goBack(){const _0x89d001=_0x31277a,_0x360737={'HtsyC':function(_0x43e0f0){return _0x43e0f0();},'lKSui':_0x89d001(0x370)};if(!isQuizCompleted)_0x360737[_0x89d001(0x2b5)](saveProgress);window[_0x89d001(0x1ba)][_0x89d001(0x2f9)]=document[_0x89d001(0x339)]||_0x360737[_0x89d001(0x3e5)];}function selectMode(_0xdc2cf2){const _0x4ac5e1=_0x31277a,_0x48db67={'uwiII':_0x4ac5e1(0x2b0),'VKyUf':_0x4ac5e1(0x22a)};currentMode=_0xdc2cf2,document[_0x4ac5e1(0x3e7)](_0x48db67[_0x4ac5e1(0x16b)])[_0x4ac5e1(0x256)][_0x4ac5e1(0x23b)]=_0x48db67[_0x4ac5e1(0x1ac)],initializeQuiz();}function _0x1ca1(){const _0xeb5586=['bind','6pFABCQ','VDemg','quizHierarchy','getItem','toString','study','<p><span\x20style=\x22font-size:12.0pt;\x22>Warm\x20type\x20autoimmune\x20hemolytic\x20anemia</span></p>','SyUTl','aklSq','<p><strong>Explanation:</strong></p>\x0a<p>The\x20likely\x20diagnosis\x20based\x20on\x20the\x20given\x20scenario\x20is\x20disseminated\x20intravascular\x20coagulation\x20for\x20which<strong>\x20fresh\x20frozen\x20plasma\x20</strong>is\x20to\x20be\x20administered.</p>\x0a<ul>\x0a<li><strong>Disseminated\x20Intravascular\x20Coagulation\x20</strong>(DIC)\x20is\x20an\x20acquired,\x20systemic\x20disorder\x20marked\x20by\x20widespread\x20<strong>activation\x20of\x20the\x20coagulation\x20cascade</strong>,\x20resulting\x20in\x20fibrin\x20deposition,\x20thrombus\x20formation\x20in\x20small\x20and\x20midsize\x20vessels,\x20and\x20subsequent\x20organ\x20dysfunction.</li>\x0a<li>This\x20ongoing\x20coagulation\x20leads\x20to\x20the\x20<strong>consumption\x20of\x20clotting\x20factors\x20and\x20platelets</strong>,\x20often\x20accompanied\x20by\x20secondary\x20hyperfibrinolysis,\x20culminating\x20in\x20both\x20thrombotic\x20and\x20hemorrhagic\x20complications.</li>\x0a<li>Clinical\x20features\x20vary\x20depending\x20on\x20severity\x20and\x20include\x20<strong>petechiae</strong>,\x20ecchymoses,\x20bleeding\x20from\x20venipuncture\x20sites,\x20gastrointestinal\x20or\x20CNS\x20hemorrhage,\x20and\x20signs\x20of\x20microvascular\x20thrombosis\x20causing\x20multi-organ\x20dysfunction.</li>\x0a<li>Laboratory\x20findings\x20typically\x20reveal<strong>\x20thrombocytopenia</strong>,\x20<strong>prolonged\x20PT\x20</strong>and\x20<strong>aPTT</strong>,\x20elevated\x20D-dimer,\x20<strong>decreased\x20fibrinogen\x20levels</strong>,\x20and\x20schistocytes\x20(fragmented\x20red\x20cells)\x20on\x20peripheral\x20smear.\x20Chronic\x20DIC\x20may\x20show\x20compensated\x20parameters\x20with\x20mild\x20thrombocytopenia\x20and\x20red\x20cell\x20fragmentation.</li>\x0a<li>DIC\x20arises\x20secondary\x20to\x20a\x20wide\x20variety\x20of\x20clinical\x20conditions.\x20The\x20most\x20common\x20precipitating\x20factor\x20is\x20<strong>sepsis</strong>\x20(bacterial,\x20viral,\x20mycotic,\x20parasitic,\x20or\x20rickettsial).\x20Other\x20causes\x20include\x20extensive\x20burns,\x20<strong>abruptio\x20placentae</strong>,\x20amniotic\x20fluid\x20embolism,\x20septic\x20abortion,\x20snake\x20bites,\x20and\x20ARDS.</li>\x0a<li><strong>Malignancies</strong>,\x20especially\x20mucin-producing\x20adenocarcinomas\x20and\x20acute\x20promyelocytic\x20leukemia\x20are\x20also\x20key\x20triggers.</li>\x0a<li>Diagnosis\x20is\x20guided\x20by\x20clinical\x20suspicion\x20and\x20confirmed\x20using\x20scoring\x20systems\x20that\x20evaluate\x20platelet\x20count,\x20PT,\x20aPTT,\x20D-dimer,\x20and\x20fibrinogen\x20levels.</li>\x0a<li>Patients\x20experiencing\x20active\x20bleeding\x20or\x20at\x20significant\x20risk\x20of\x20bleeding\x20such\x20as\x20those\x20undergoing\x20invasive\x20procedures\x20or\x20receiving\x20chemotherapy\x20should\x20be\x20given\x20transfusion\x20support.\x20However,\x20transfusions\x20should\x20not\x20be\x20used\x20solely\x20to\x20correct\x20mild\x20to\x20moderate\x20abnormalities\x20in\x20coagulation\x20tests.\x20(Option\x20A\x20ruled\x20out_</li>\x0a<li>Platelet\x20transfusions\x20are\x20appropriate\x20when\x20platelet\x20counts\x20fall\x20below\x2010,000-20,000/&mu;L.\x20(Option\x20C\x20ruled\x20out)</li>\x0a<li>If\x20there\x20is\x20a\x20need\x20to\x20restore\x20fibrinogen\x20and\x20clotting\x20factors,\x20<strong>fresh\x20frozen\x20plasma</strong>\x20(FFP),\x20<strong>cryoprecipitate</strong>,\x20or\x20fibrinogen\x20concentrates\x20can\x20be\x20used,\x20with\x20the\x20required\x20amounts\x20based\x20on\x20the\x20extent\x20of\x20abnormalities\x20in\x20PT,\x20aPTT,\x20and\x20fibrinogen\x20levels.</li>\x0a<li>Fibrinogen\x20levels\x20should\x20be\x20maintained\x20above\x20150\x20mg/dL,\x20and\x20PT\x20should\x20not\x20be\x20more\x20than\x203\x20seconds\x20above\x20the\x20normal\x20range.\x20Vitamin\x20K\x20administration\x20is\x20advised.</li>\x0a<li>Antifibrinolytics\x20may\x20be\x20considered\x20in\x20those\x20with\x20severe\x20bleeding\x20and\x20a\x20primary\x20hyperfibrinolytic\x20state,\x20especially\x20in\x20chronic\x20DIC\x20associated\x20with\x20tumors\x20or\x20protein\x20C\x20pathway\x20deficiencies.</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Prothrombin\x20complex\x20concentrate\x20(Option\x20D):\x20</strong>Prothrombin\x20complex\x20concentrates\x20(PCCs)\x20are\x20plasma-derived\x20factor\x20preparations\x20that\x20were\x20originally\x20developed\x20to\x20provide\x20factor\x20VIII\x20or\x20IX\x20for\x20individuals\x20with\x20hemophilia.\x20However,\x20since\x20they\x20include\x20vitamin\x20K-dependent\x20clotting\x20factors,\x20they\x20are\x20also\x20utilized\x20for<strong>\x20reversing\x20the\x20effects\x20of\x20warfarin</strong>\x20therapy.</p>','dataset','xLtrK','Kwpzl','avgTimeResult','oGERK','round','<p><span\x20style=\x22font-size:12.0pt;\x22>Apixaban</span></p>','nJVAk','kBtFx','64ixYDCW','\x22\x20data-option-index=\x22','explanation_audio_hin','YBirg','DT1198272','<p><span\x20style=\x22font-size:12.0pt;\x22>Iron\x20Deficiency</span></p>','uizkr','KSXUX','DocTutorial','<p><span\x20style=\x22font-size:12.0pt;\x22>Platelets</span></p>','border-red-500','bfJKG','<div\x20class=\x22mt-4\x22><img\x20src=\x22','Wrooh','UlpVe','explanation_images','Tjgfp','etUke','<p><span\x20style=\x22font-size:12.0pt;\x22>Follicular\x20lymphoma</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Hypothyroidism</span></p>','BWfpR','removeItem','toISOString','DT1198229','OIWeZ','<p><strong>Explanation:</strong></p>\x0a<p>The\x20clinical\x20picture\x20is\x20most\x20consistent\x20with\x20hemoglobin\x20H\x20(HbH)\x20diseases.</p>\x0a<ul>\x0a<li><strong>Alpha-thalassemia</strong>\x20arises\x20due\x20to\x20inherited\x20deletions\x20that\x20impair\x20or\x20abolish\x20the\x20synthesis\x20of\x20<strong>alpha-globin\x20chains</strong>.</li>\x0a<li>Each\x20person\x20normally\x20has<strong>\x20four\x20alpha-globin\x20genes</strong>.\x20The\x20disease\x20severity\x20is\x20directly\x20proportional\x20to\x20the\x20number\x20of\x20affected\x20genes.\x20Unlike\x20beta-thalassemia,\x20<strong>gene\x20deletions</strong>\x20and\x20not\x20point\x20mutations\x20are\x20the\x20usual\x20culprits.</li>\x0a<li>Alpha-thalassemia\x20is\x20predominantly\x20found\x20in\x20people\x20from<strong>\x20tropical</strong>\x20and\x20subtropical\x20regions\x20including\x20South\x20and\x20Southeast\x20Asia,\x20Africa,\x20and\x20China.\x20A\x20particularly\x20important\x20clinical\x20variant,\x20HbH\x20disease,\x20is\x20most\x20common\x20in<strong>\x20Southern\x20China</strong>\x20and\x20<strong>Southeast\x20Asia</strong>.</li>\x0a<li>The\x20condition\x20is\x20classified\x20based\x20on\x20how\x20many\x20alpha-globin\x20genes\x20are\x20deleted\x20or\x20malfunctioning:</li>\x0a</ul><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250912b528f398-7f8d-4050-a489-06ab15fce54e.png\x22><ul>\x0a<li>The\x20lack\x20of\x20alpha\x20chains\x20results\x20in\x20unpaired\x20globins\x20(&gamma;\x20in\x20fetuses\x20and\x20&beta;\x20in\x20adults),\x20forming\x20<strong>unstable\x20tetramers</strong>\x20(Hb\x20Bart\x27s\x20or\x20HbH)\x20that\x20are\x20inefficient\x20in\x20oxygen\x20delivery\x20and\x20prone\x20to\x20precipitating\x20in\x20red\x20cells.\x20This\x20leads\x20to\x20hemolysis,\x20splenic\x20sequestration,\x20and\x20impaired\x20erythropoiesis.</li>\x0a<li>Alpha-thalassemia\x20is\x20suspected\x20when\x20there\x20is\x20<strong>microcytic\x20hypochromic\x20anemia</strong>\x20with\x20<strong>near-normal\x20hemoglobin</strong>\x20and\x20no\x20iron\x20deficiency.</li>\x0a<li>HbH\x20disease\x20is\x20identified\x20by\x20the\x20presence\x20of\x20HbH\x20or\x20Hb\x20Bart\x27s\x20(detected\x20by\x20HPLC),\x20and\x20the\x20characteristic\x20<strong>red\x20cell\x20inclusions</strong>\x20visible\x20with\x20brilliant\x20cresyl\x20blue\x20stain.\x20Antenatal\x20diagnosis\x20requires\x20genetic\x20analysis.</li>\x0a<li>HbH\x20disease\x20presents\x20with\x20variable\x20severity\x20and\x20can\x20include\x20<strong>hepatosplenomegaly</strong>,\x20<strong>jaundice</strong>,\x20facial\x20bone\x20changes,\x20and\x20growth\x20delay\x20in\x20many\x20cases.</li>\x0a<li>Hydrops\x20fetalis\x20leads\x20to\x20fetal\x20anemia,\x20generalized\x20edema,\x20and\x20hepatosplenomegaly,\x20requiring\x20transfusions\x20for\x20survival\x20and\x20potentially\x20hematopoietic\x20stem\x20cell\x20transplantation.\x20(Option\x20C\x20ruled\x20out)</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20other\x20options:</strong></p>\x0a<p>&beta;\x20-Thalassemia\x20major\x20(Option\x20A):\x20A\x20transfusion\x20dependent\x20form\x20of\x20&beta;\x20-Thalassemia\x20which\x20also\x20requires\x20iron\x20chelation\x20to\x20prevent\x20toxicity.\x20HbA2\x20levels\x20are\x20elevated.</p>\x0a<p><strong>Homozygosity\x20for\x20hemoglobin\x20E\x20(HbEE)\x20(Option\x20B):</strong>\x20Hemoglobin\x20E\x20(HbE),\x20characterized\x20by\x20a\x20glutamic\x20acid\x20to\x20lysine\x20substitution\x20at\x20position\x2027\x20of\x20the\x20beta\x20chain,\x20is\x20a\x20prevalent\x20variant.\x20HbE\x20disease\x20is\x20characterized\x20by\x20an\x20HbE\x20fraction\x20of\x2085\x20-\x2095%.</p>','7897230djfTWv','error','<p><span\x20style=\x22font-size:12.0pt;\x22>Aplastic\x20crisis</span></p>','Not\x20Attempted','nav-btn-correct','pkBZB','map','OOlmC','KsFzF','KwpSP','YSjiI','Bookmarked','DT1198288','strokeDashoffset','uRnDK','<p><span\x20style=\x22font-size:12.0pt;\x22>Acute\x20lymphocytic\x20leukemia</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>BCL-1</span></p>','dVuGL','PRFkH','PakoK','DT1198267','CJgdp','KKkBA','ghvlW','sxjTh','addEventListener','incorrectCount','intermediate','PmpVO','lsPXV','<p><span\x20style=\x22font-size:12.0pt;\x22>Muscular\x20haematoma</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Painful\x20vaso-occlusive\x20crisis</span></p>','modeModal','OzRCJ','DT1198232','FgWKh','jzeok','HtsyC','92kqQnXw','uviof','ErOyi','bznuA','Heqbm','gkbtn','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2056-year-old\x20man\x20presents\x20to\x20his\x20physician\x20complaining\x20of\x20chronic\x20fatigue.\x20He\x20also\x20notes\x20that\x20he\x20has\x20had\x20a\x20nonproductive\x20cough\x20for\x20about\x202\x20weeks,\x20and\x20has\x20experienced\x20several\x20episodes\x20of\x20drenching\x20night\x20sweats.\x20On\x20examination,\x20he\x20has\x20several\x20large\x20bruises\x20on\x20his\x20extremities\x20but\x20recalls\x20no\x20injuries.\x20Abdominal\x20examination\x20reveals\x20massive\x20enlargement\x20of\x20both\x20the\x20liver\x20and\x20the\x20spleen,\x20without\x20any\x20lymphadenopathy.\x20Laboratory\x20tests\x20show:<br>WBC:\x2012,000/mm3\x20(Neutrophils\x2058%\x20Eosinophils\x207%\x20Lymphocytes\x2030%\x20Monocytes\x200%\x20Basophils\x205%)<br>Hemoglobin\x207.5\x20mg/dL<br>Platelet\x20count\x2018,000/mm3<br>Peripheral\x20blood\x20smear\x20on\x20staining\x20shows\x20folded\x20nuclei\x20and\x20on\x20phase\x20contrast\x20microscopy\x20reveals\x20cells\x20with\x20cytoplasmic\x20projections.\x20<br>What\x20is\x20the\x20patient\x27s\x20most\x20likely\x20diagnosis?</span></p>','JbwIZ','ADajD','tLXZB','ArrowLeft','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','siDpI','</span></div>','FJmgp','FEQBp','questionNav','contains','currentQuestionIndex','<p><span\x20style=\x22font-size:12.0pt;\x22>Infectious\x20mononucleosis</span></p>','TqCLw','name','UjWGi','HvoOW','UNGOU','LJbXz','selected','XhNln','Amgnn','testModeReviewLegend','questions','jLErh','<p><span\x20style=\x22font-size:12.0pt;\x22>Gastrectomy</span></p>','bowQB','xNzla','question_images','yxhJe','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','lASqJ','NXnBb','zIciC','jIXBp','TeYmt','pfDqf','Factual','querySelectorAll','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','console','<p><span\x20style=\x22font-size:12.0pt;\x22>B12\x20deficiency</span></p>','OjfXi','LMnCM','reviewQuestionsContainer','preventDefault','navBtn_','DT1198107','dVKEW','Ztcma','qRIQv','cWJNM','CulqE','explanation_video','NxJQj','EVyWK','BCUAc','YwDwn','mCYNp','href','XPIrb','RHdrZ','closest','bookmarkedQuestions','<p><span\x20style=\x22font-size:12.0pt;\x22>Dabigatran</span></p>','yUYnN','XOxKv','UEtle','htWaX','<p><strong>Explanation:</strong></p>\x0a<p>The\x20given\x20clinical\x20scenario\x20is\x20consistent\x20with<strong>\x20differentiation\x20syndrome</strong>\x20seen\x20in\x20acute\x20promyelocytic\x20leukemia\x20after\x20treatment\x20with\x20<strong>all-trans\x20retinoic\x20acid\x20(ATRA)</strong>\x20which\x20is\x20treated\x20with\x20<strong>dexamethasone</strong>.</p>\x0a<ul>\x0a<li><strong>Acute\x20promyelocytic\x20leukemia</strong>\x20is\x20a\x20treatable\x20AML\x20subtype\x20with\x20high\x20cure\x20rates,\x20especially\x20due\x20to\x20the\x20introduction\x20of\x20all-trans\x20retinoic\x20acid\x20(ATRA),\x20which\x20promotes\x20differentiation\x20of\x20leukemic\x20cells\x20with\x20the<strong>\x20t(15;17)</strong></li>\x0a<li>ATRA\x20has\x20significantly\x20reduced\x20early\x20deaths\x20from\x20DIC,\x20though\x20it\x20can\x20cause\x20APL\x20(differentiation)\x20syndrome.\x20(Option\x20C\x20ruled\x20out)</li>\x0a<li>APL\x20syndrome\x20typically\x20arises\x20within\x20the<strong>\x20first\x20three\x20weeks\x20</strong>of\x20initiating\x20treatment\x20and\x20presents\x20with\x20symptoms\x20such\x20as\x20fever,\x20fluid\x20buildup,\x20breathing\x20difficulty,\x20chest\x20discomfort,\x20lung\x20infiltrates,\x20and\x20pleural\x20or\x20pericardial\x20effusions,\x20often\x20accompanied\x20by\x20low\x20oxygen\x20levels.</li>\x0a<li>The\x20condition\x20results\x20from\x20the\x20<strong>adherence\x20of\x20differentiated\x20leukemic\x20cells</strong>\x20to\x20the\x20pulmonary\x20blood\x20vessel\x20lining.</li>\x0a<li>Management\x20involves<strong>\x20glucocorticoids</strong>,\x20cytoreductive\x20chemotherapy,\x20and\x20supportive\x20care.\x20(Option\x20B\x20ruled\x20out)</li>\x0a<li>In\x20severe\x20cases,\x20such\x20as\x20when\x20patients\x20develop\x20kidney\x20failure\x20or\x20require\x20ICU\x20admission\x20for\x20respiratory\x20distress,\x20ATRA\x20should\x20be\x20temporarily\x20withheld.</li>\x0a<li>The\x20syndrome\x20has\x20an\x20approximate\x20mortality\x20rate\x20of\x2010%\x20and\x20can\x20occasionally\x20also\x20be\x20triggered\x20by\x20arsenic\x20trioxide\x20(ATO)\x20therapy\x20in\x20APL.\x20(Option\x20D\x20ruled\x20out)</li>\x0a</ul>','uUxnk','prototype','CkGEA','anfRi','testModeLegend','Progress\x20loaded.','pPdHW','<p><span\x20style=\x22font-size:12.0pt;\x22>5%</span></p>','</span><span>','XCkTP','SVmdP','NizTH','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','fromCharCode','hFbYQ','<p><span\x20style=\x22font-size:12.0pt;\x22>Abciximab</span></p>','timerContainer','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','EZezL','disabled','IYmyf','ZTQac','<p><span\x20style=\x22font-size:12.0pt;\x22>Bone\x20marrow\x20plasmacytosis\x20>\x2010%\x20with\x20no\x20M\x20protein\x20in\x20urine\x20or\x20serum</span></p>','lqWye','statsBar','KTJCI','eoALN','VVthT','5260xgtZMF','<p><span\x20style=\x22font-size:12.0pt;\x22>Vitamin\x20K\x20antagonism</span></p>','Gozlz','KMByp','hTzxV','154431OCqNYO','WOQsX','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','esdWE','DvGPJ','XijYr','<p><span\x20style=\x22font-size:12.0pt;\x22>Reduced\x20EPO\x20production</span></p>','QJNKo','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20anticoagulants\x20has\x20a\x20mechanism\x20of\x20action\x20involving\x20antithrombin-dependent\x20inhibition\x20of\x20thrombin\x20and\x20factor\x20Xa?</span></p>','gknqo','AwBIa','omhYD','<p><span\x20style=\x22font-size:12.0pt;\x22>Isolated\x20abnormal\x20prothrombin\x20time\x20(PT)</span></p>','VCNSb','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','jrEId','AWMYc','oeVRr','-600\x20text-white\x22>','GlwOR','referrer','OBupz','<p><span\x20style=\x22font-size:12.0pt;\x22>Direct\x20factor\x20X\x20inhibition</span></p>','totalTimeResult','DT1198226','kkKVC','DT1198275','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','ixoID','OePHz','GNKCE','<p><span\x20style=\x22font-size:12.0pt;\x22>Sequestration\x20crisis</span></p>','eTCVn','not-attempted','UmRJc','vUKDi','gRlLB','<p><span\x20style=\x22font-size:12.0pt;\x22>Gene\x20analysis\x20for\x20G6PD\x20deficiency</span></p>','jzszW','<p><span\x20style=\x22font-size:12.0pt;\x22>Immunosuppressive\x20therapy\x20with\x20high-dose\x20glucocorticoids</span></p>','src','choices','vNVwW','kFtLE','timed_study','correct_choice_id','EHMql','get','<p><span\x20style=\x22font-size:12.0pt;\x22>MYC</span></p>','OSXzs','AlqSW','FZEyu','eOSFL','loDAJ','isArray','eCkBz','NxLaS','JWYdS','gqzft','AOFbL','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','YqhZx','<p><span\x20style=\x22font-size:12.0pt;\x22>Trisomy\x2012</span></p>','KlvOU','(((.+)+)+)+$','notAttemptedResult','jJCDR','target','kpufn','className','endsWith','gumkT','qPdFo','bottom','totalQuestions','index.html','status','UzPkj','totalAttempted','AovUe','<p><span\x20style=\x22font-size:12.0pt;\x22>IgA\x20levels\x20of\x2040\x20g/L\x20with\x20no\x20myeloma\x20defining\x20events</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2047-year-old\x20woman\x20comes\x20to\x20your\x20OPD\x20with\x20complaints\x20of\x20passing\x20blood\x20in\x20urine\x20in\x20the\x20mornings.\x20She\x20denies\x20any\x20other\x20symptoms\x20except\x20for\x20occasional\x20recurrent\x20attacks\x20of\x20severe\x20abdominal\x20pain\x20for\x20which\x20she\x20has\x20had\x20other\x20urgent\x20care\x20visits\x20but\x20no\x20etiology\x20was\x20found.\x20She\x20has\x20no\x20other\x20past\x20medical\x20history.\x20You\x20repeat\x20a\x20complete\x20blood\x20count.\x20The\x20results\x20are\x20below:\x20White\x20blood\x20cell\x20count\x202900/mm<sup>3</sup><br>Hemoglobin\x2010.2\x20g/dL<br>Platelet\x20count\x20119000/mm<sup>3</sup><br>Her\x20complete\x20blood\x20count\x201\x20year\x20ago\x20was\x20normal.\x20Investigations\x20also\x20revealed\x20elevated\x20unconjugated\x20bilirubin\x20and\x20a\x20markedly\x20elevated\x20lactate\x20hydrogenase.\x20Which\x20of\x20the\x20following\x20diagnostic\x20test\x20results\x20would\x20you\x20consider\x20in\x20this\x20patient?</span></p>','dltYY','tjkhm','xWpYj','text','open','pWWvd','Bjqxt','4467yKyYOl','questionStates','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','<p><span\x20style=\x22font-size:12.0pt;\x22>10%</span></p>','selectedAnswer','zXwHV','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2016-year-old\x20boy\x20with\x20known\x20sickle-cell\x20disease\x20is\x20brought\x20to\x20the\x20emergency\x20department\x20profoundly\x20unwell.\x20He\x20has\x20a\x20temperature\x2039&deg;C,\x20pulse\x20rate\x20160\x20beats/min\x20and\x20blood\x20pressure\x2070/40\x20mmHg.\x20Examination\x20reveals\x20neck\x20rigidity.\x20Laboratory\x20investigations\x20reveal\x20elevated\x20WBC\x20count,\x20Hb\x20levels\x20of\x208.6,\x20and\x20platelet\x20count\x20of\x20200,000/\x20mm3.</span></p>','pathname','DDCav','<p><strong>Explanation:</strong></p>\x0a<p><strong>Emicizumab\x20is\x20a\x20monoclonal\x20antibody\x20</strong>approved\x20for\x20patients\x20with\x20hemophilia\x20A\x20with\x20or\x20without\x20inhibitors</p>\x0a<ul>\x0a<li>Emicizumab\x20is\x20a\x20bispecific\x20monoclonal\x20antibody\x20that<strong>\x20bridges\x20activated\x20factor\x20IX</strong>\x20(FIXa)\x20and<strong>\x20factor\x20X</strong>\x20(FX),\x20enabling\x20the\x20activation\x20of\x20FX\x20by\x20FIXa\x20without\x20the\x20involvement\x20of\x20factor\x20VIII\x20(FVIII).</li>\x0a<li>This\x20mimics\x20the\x20function\x20of\x20FVIII\x20and\x20allows\x20thrombin\x20generation\x20and\x20clot\x20formation.\x20It\x20is\x20particularly\x20effective\x20in\x20patients\x20with\x20<strong>severe\x20hemophilia\x20A</strong>,\x20including\x20those\x20who\x20have\x20developed\x20<strong>FVIII\x20inhibitors</strong>.</li>\x0a<li>Treatment\x20begins\x20with\x20<strong>weekly\x20subcutaneous\x20injections\x20</strong>for\x20four\x20weeks,\x20followed\x20by\x20maintenance\x20dosing\x20once\x20a\x20month\x20to\x20prevent\x20spontaneous\x20bleeding\x20episodes.</li>\x0a<li>This\x20regimen\x20offers\x20a\x20substantial\x20improvement\x20in\x20quality\x20of\x20life\x20compared\x20to\x20traditional\x20intravenous\x20FVIII\x20infusions.</li>\x0a<li>However,\x20caution\x20is\x20required,\x20as\x20rare\x20<strong>thrombotic\x20event</strong>s\x20and\x20fatal\x20thrombotic\x20microangiopathy\x20have\x20been\x20reported\x20in\x20patients\x20receiving\x20bypassing\x20agents\x20like\x20activated\x20prothrombin\x20complex\x20concentrate\x20(aPCC)\x20or\x20recombinant\x20FVIIa\x20in\x20conjunction\x20with\x20emicizumab.</li>\x0a</ul>\x0a<p><strong>Explanations\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Eculizumab\x20(Option\x20A):\x20</strong>Eculizumab\x20is\x20a\x20monoclonal\x20antibody\x20that\x20targets\x20complement\x20protein\x20C5,\x20thereby\x20blocking\x20the\x20formation\x20of\x20the\x20membrane\x20attack\x20complex\x20(C5b-9).\x20It\x20is\x20employed\x20in\x20the\x20management\x20of\x20<strong>atypical\x20hemolytic\x20uremic\x20syndrome</strong>\x20and\x20<strong>paroxysmal\x20nocturnal\x20hemoglobinuria</strong>.</p>\x0a<p><strong>Adalimumab\x20(Option\x20B):\x20</strong>Adalimumab\x20is\x20a\x20genetically\x20engineered\x20monoclonal\x20antibody\x20that\x20targets\x20tumor\x20necrosis\x20factor-alpha\x20(TNF-&alpha;)\x20and\x20is\x20utilized\x20in\x20the\x20treatment\x20of\x20autoimmune\x20disorders\x20such\x20as\x20<strong>Crohn&rsquo;s\x20disease</strong>\x20and\x20<strong>rheumatoid\x20arthritis</strong>.</p>\x0a<p><strong>Abciximab\x20(Option\x20C):\x20</strong>Abciximab\x20is\x20an\x20inhibitor\x20of\x20glycoprotein\x20IIb/IIIa\x20receptors\x20that\x20blocks\x20platelet\x20aggregation\x20and\x20is\x20employed\x20in\x20treating\x20acute\x20coronary\x20syndromes,\x20particularly\x20during\x20percutaneous\x20coronary\x20interventions.</p>','parse','createElement','uzGiH','TaTJW','<p><span\x20style=\x22font-size:12.0pt;\x22>Idiopathic\x20thrombocytopenic\x20purpura</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Hyposplenism</span></p>','rOotW','AzocL','cvfSq','xQEez','bookmarkBtn','KVHAj','cvqmE','Previous\x20progress\x20cleared.','FeNLx','correct','YbQvZ','FoCoU','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2068\x20year\x20old\x20man\x20presents\x20to\x20his\x20family\x20physician\x20with\x20fever,\x20night\x20sweats\x20and\x20unexplained\x20weight\x20loss.\x20Which\x20one\x20of\x20the\x20following\x20is\x20defined\x20by\x20low-grade,\x20small\x20lymphocytes\x20with\x20cleaved\x20nuclear\x20contours\x20that\x20are\x20CD5\x20and\x20cyclin\x20D1\x20positive\x20but\x20CD23\x20negative?</span></p>','bookmarked','<p><span\x20style=\x22font-size:12.0pt;\x22>Indirect\x20factor\x20X\x20inhibition</span></p>','tvrDt','CAioV','No\x20solution\x20provided','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','OiVYw','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','<p><span\x20style=\x22font-size:12.0pt;\x22>Hematopoietic\x20stem\x20cell\x20transplantation</span></p>','vdBwH','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20situations\x20would\x20be\x20in\x20keeping\x20with\x20a\x20diagnosis\x20of\x20monoclonal\x20gammopathy\x20of\x20uncertain\x20significance\x20(MGUS)?</span></p>','flex','dOZGK','XRUCZ','LtZui','rgqCH','dyGBv','<p><span\x20style=\x22font-size:12.0pt;\x22>Deletion\x2013</span></p>','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','nav-btn-current','kKsUC','UBWRy','warn','submitSection','EuRrk','<p><span\x20style=\x22font-size:12.0pt;\x22>Bleeding\x20into\x20the\x20gastrointestinal\x20tract</span></p>','classList','Oaqbl','hSGiT','<p><span\x20style=\x22font-size:12.0pt;\x22>AML</span></p>','dgfii','<p><span\x20style=\x22font-size:12.0pt;\x22>Immunosuppressive\x20therapy\x20with\x20horse\x20anti-thymocyte\x20globulin\x20(ATG)\x20followed\x20by\x20cyclosporin</span></p>','BUgkM','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20conditions\x20would\x20result\x20in\x20a\x20microcytic\x20anemia\x20with\x20a\x20normal/high\x20ferritin?</span></p>','jEpMZ','zLEmH','FKhxY','not_attempted','vYQPA','npJxr','<p><span\x20style=\x22font-size:12.0pt;\x22>Donath-Landsteiner\x20antibody</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>&beta;\x20-Thalassemia\x20major</span></p>','xJMnz','<p><strong>Explanation:</strong></p>\x0a<p>The\x20given\x20peripheral\x20smear\x20findings\x20of\x20target\x20cells\x20and\x20Howell-Jolly\x20bodies\x20along\x20leukocytosis\x20and\x20thrombocytosis\x20are\x20suggestive\x20of<strong>\x20hyposplenism</strong>.</p>\x0a<ul>\x0a<li>Hyposplenism\x20refers\x20to\x20a\x20state\x20of\x20reduced\x20or\x20absent\x20splenic\x20function,\x20which\x20may\x20result\x20from\x20<strong>splenectomy\x20</strong>or\x20diseases\x20such\x20as\x20sickle\x20cell\x20disease\x20that\x20lead\x20to\x20<strong>autoinfarction\x20of\x20the\x20spleen</strong>.</li>\x0a<li>It\x20is\x20associated\x20with\x20the\x20presence\x20of\x20<strong>Howell-Jolly\x20bodies</strong>\x20which\x20are\x20nuclear\x20remnants\x20seen\x20in\x20erythrocytes,\x20indicative\x20of\x20impaired\x20splenic\x20filtration.</li>\x0a<li>Other\x20erythrocyte\x20abnormalities\x20seen\x20include\x20<strong>target\x20cells</strong>,\x20basophilic\x20stippling,\x20anisocytosis,\x20poikilocytosis,\x20and\x20occasional\x20nucleated\x20cells.</li>\x0a<li>Hyposplenism\x20compromises\x20immune\x20surveillance\x20and\x20filtration,\x20leading\x20to\x20<strong>leukocytosis</strong>\x20and<strong>\x20thrombocytosis</strong>,\x20particularly\x20in\x20the\x20initial\x20postoperative\x20period.</li>\x0a<li>Patients\x20with\x20hyposplenism\x20are\x20more\x20susceptible\x20to\x20severe\x20infections,\x20especially\x20from\x20<strong>encapsulated\x20bacteria</strong>\x20like\x20Streptococcus\x20pneumoniae,\x20Haemophilus\x20influenzae,\x20and\x20Neisseria\x20meningitidis.</li>\x0a<li>The\x20risk\x20of\x20sepsis\x20is\x20highest\x20in\x20children\x20under\x2020,\x20particularly\x20within\x20the\x20first\x203\x20years\x20after\x20splenectomy.</li>\x0a<li>Preventive\x20measures\x20include\x20<strong>vaccinations</strong>\x20(preferably\x20administered\x202\x20weeks\x20prior\x20to\x20splenectomy)\x20and,\x20in\x20certain\x20cases,\x20prophylactic\x20antibiotics\x20like\x20oral\x20penicillin.</li>\x0a<li>The\x20identification\x20of\x20hyposplenism\x20is\x20critical\x20because\x20of\x20its\x20associated\x20high\x20risk\x20of\x20infection\x20and\x20the\x20need\x20for\x20preventive\x20care,\x20especially\x20in\x20those\x20who\x20are\x20asplenic\x20or\x20functionally\x20hyposplenic\x20due\x20to\x20underlying\x20hematologic\x20or\x20autoimmune\x20disorders.</li>\x0a</ul>\x0a<p><strong>Explanations\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Alcoholic\x20liver\x20disease\x20(Option\x20A):\x20</strong>Liver\x20disease\x20is\x20associated\x20with\x20target\x20cells\x20and\x20stomatocytes.</p>\x0a<p><strong>Aplastic\x20anemia\x20(Option\x20B):\x20</strong>The\x20peripheral\x20smear\x20in\x20aplastic\x20anemia\x20reveals\x20<strong>large\x20red\x20blood\x20cells</strong>\x20with\x20a\x20reduced\x20number\x20of\x20platelets\x20and\x20granulocytes.\x20Reticulocytes\x20are\x20scarce\x20or\x20absent,\x20and\x20lymphocytes\x20may\x20appear\x20normal\x20or\x20decreased.\x20The\x20presence\x20of\x20nucleated\x20red\x20blood\x20cells\x20suggests\x20underlying\x20marrow\x20fibrosis\x20or\x20infiltration,\x20while\x20immature\x20myeloid\x20cells\x20may\x20point\x20to\x20leukemia\x20or\x20myelodysplastic\x20syndrome\x20(MDS).\x20Abnormal\x20platelet\x20morphology\x20indicates\x20possible\x20peripheral\x20destruction\x20or\x20MDS.</p>\x0a<p><strong>Primary\x20myelofibrosis\x20(Option\x20C):</strong>\x20In\x20primary\x20myelofibrosis\x20(PMF),\x20the\x20peripheral\x20blood\x20smear\x20typically\x20demonstrates\x20signs\x20of\x20<strong>extramedullary\x20hematopoiesis</strong>.\x20Characteristic\x20findings\x20include\x20<strong>teardrop-shaped\x20red\x20blood\x20cells</strong>,\x20nucleated\x20red\x20cells,\x20and\x20immature\x20myeloid\x20precursors\x20such\x20as\x20myelocytes\x20and\x20promyelocytes.\x20Myeloblasts\x20may\x20also\x20be\x20seen.\x20These\x20features\x20reflect\x20the\x20marrow\x20fibrosis\x20and\x20compensatory\x20blood\x20cell\x20production\x20occurring\x20outside\x20the\x20bone\x20marrow.</p>','markReviewBtn','KzSSO','solutionContainer','MtnAF','<p><span\x20style=\x22font-size:12.0pt;\x22>Low\x20levels\x20of\x20lgG\x20monoclonal\x20protein\x20with\x20clonal\x20bone\x20marrow\x20cells\x20<\x2010%</span></p>','hidden','bsNwa','zlzRa','title','div','vyydG','<p><span\x20style=\x22font-size:12.0pt;\x22>Arsenic\x20trioxide</span></p>','border-green-500','azbNB','Medicine','explanationVideoPlayer','sdvBT','<p><span\x20style=\x22font-size:12.0pt;\x22>Deletion\x2017</span></p>','IXcPW','join','\x20>\x20','stringify','now','TjyLV','red','cNkfn','timeSpent','nav-btn-marked-review','eXQKO','<p><span\x20style=\x22font-size:12.0pt;\x22>30%</span></p>','lKSui','question_video','getElementById','dItFT','vQLKh','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','KZKMn','XNbvt','DOMContentLoaded','customQuizData','block','<p><span\x20style=\x22font-size:12.0pt;\x22>The\x20blood\x20film\x20of\x20a\x2067-year-old\x20man\x20is\x20reported\x20to\x20show\x20target\x20cells\x20and\x20Howell-Jolly\x20bodies.\x20He\x20is\x20also\x20noted\x20to\x20have\x20leukocytosis\x20and\x20mild\x20thrombocytosis.\x20What\x20is\x20the\x20most\x20likely\x20cause\x20of\x20this\x20picture?</span></p>','add','xdYDU','oifxW','table','JwkcX','<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li><strong>Hemophilia</strong>\x20is\x20an<strong>\x20X-linked\x20recessive</strong>\x20bleeding\x20disorder\x20caused\x20by\x20mutations\x20in\x20the\x20F8\x20gene\x20(hemophilia\x20A)\x20or\x20F9\x20gene\x20(hemophilia\x20B),\x20with\x20hemophilia\x20A\x20accounting\x20for\x20about\x2080%\x20of\x20cases.</li>\x0a<li>Males\x20are\x20usually\x20symptomatic,\x20while\x20female\x20carriers\x20are\x20typically\x20asymptomatic.</li>\x0a<li>A\x20common\x20mutation\x20in\x20severe\x20hemophilia\x20A\x20involves\x20an<strong>\x20inversion\x20in\x20intron\x2022</strong>.\x20Clinically,\x20hemophilia\x20A\x20and\x20B\x20appear\x20identical,\x20with\x20severity\x20categorized\x20based\x20on\x20factor\x20VIII\x20or\x20IX\x20activity\x20levels:</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240327d775337d-e673-4dc7-9f10-a85df199eafa.jpg\x22>\x0a<ul>\x0a<li>Severe\x20and\x20moderate\x20forms\x20frequently\x20present\x20with\x20spontaneous\x20or\x20trauma-induced\x20bleeding\x20into<strong>\x20joints</strong>\x20(hemarthrosis),\x20<strong>muscles</strong>,\x20or\x20soft\x20tissues.</li>\x0a<li>Mild\x20cases\x20usually\x20only\x20bleed\x20after\x20major\x20trauma\x20or\x20surgery.\x20Bleeding\x20into\x20joints\x20may\x20lead\x20to\x20joint\x20pain,\x20swelling,\x20and\x20<strong>progressive\x20deformities</strong>.\x20Hemorrhages\x20may\x20also\x20affect\x20muscles,\x20leading\x20to\x20compartment\x20syndrome.</li>\x0a<li>Serious\x20complications\x20include\x20bleeding\x20into\x20the\x20CNS,\x20retroperitoneum,\x20and\x20oropharyngeal\x20spaces,\x20which\x20can\x20be\x20life-threatening.\x20Retroperitoneal\x20bleeds\x20may\x20form\x20calcified\x20masses\x20(pseudotumors)\x20that\x20compress\x20nearby\x20structures,\x20such\x20as\x20the\x20femoral\x20nerve\x20or\x20bones.</li>\x0a</ul>','<p><span\x20style=\x22font-size:12.0pt;\x22>Immune-mediated\x20destruction\x20of\x20platelets\x20via\x20anti-GPIIb/IIIa\x20antibodies</span></p>','performanceModal','uxdZy','<p><span\x20style=\x22font-size:12.0pt;\x22>Formation\x20of\x20microthrombi\x20due\x20to\x20deficient\x20vWF\x20cleavage\x20by\x20ADAMTS13</span></p>','MZeWr','qBank','strokeDasharray','faOdO','Correct','canPlayType','dDSyp','GviId','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','SVAAl','No\x20questions\x20available\x20for\x20this\x20quiz.','pop','ZFiIM','<p><strong>Explanation:</strong></p>\x0a<p>Factor\x20VII\x20deficiency\x20should\x20be\x20considered\x20with\x20isolated\x20abnormal\x20prothrombin\x20time.</p>\x0a<ul>\x0a<li>Deficiencies\x20in\x20coagulation\x20factors,\x20especially\x20inherited\x20forms,\x20have\x20long\x20been\x20identified\x20as\x20causes\x20of\x20recurrent\x20spontaneous\x20or\x20post-traumatic\x20bleeding\x20into\x20joints,\x20muscles,\x20and\x20body\x20cavities.</li>\x0a<li>The\x20most\x20common\x20inherited\x20forms\x20are\x20hemophilia\x20A\x20(deficiency\x20of\x20factor\x20VIII)\x20and\x20hemophilia\x20B\x20(deficiency\x20of\x20factor\x20IX),\x20both\x20of\x20which\x20follow\x20an\x20X-linked\x20inheritance\x20pattern.</li>\x0a<li>Additional\x20congenital\x20bleeding\x20disorders\x20may\x20involve\x20deficiencies\x20in\x20factors\x20such\x20as\x20prothrombin\x20(FII),\x20FV,\x20FVII,\x20FX,\x20FXI,\x20FXIII,\x20and\x20fibrinogen,\x20which\x20tend\x20to\x20follow\x20autosomal\x20recessive\x20inheritance.</li>\x0a<li>Factor\x20levels\x20often\x20correlate\x20with\x20disease\x20severity.\x20Some\x20individuals\x20with\x20<strong>significant\x20prolongation\x20of\x20aPTT</strong>,\x20like\x20those\x20deficient\x20in\x20FXII,\x20may\x20not\x20exhibit\x20bleeding\x20due\x20to\x20compensatory\x20mechanisms\x20within\x20the\x20coagulation\x20cascade.</li>\x0a<li>The\x20initial\x20screening\x20for\x20factor\x20deficiencies\x20usually\x20involves\x20prothrombin\x20time\x20(PT)\x20and\x20activated\x20partial\x20thromboplastin\x20time\x20(aPTT).</li>\x0a<li>A\x20<strong>prolonged\x20PT\x20alone\x20points\x20to\x20FVII\x20deficiency</strong>,\x20while\x20an\x20isolated\x20prolonged\x20aPTT\x20suggests\x20<strong>intrinsic\x20pathway\x20deficiencies\x20like\x20FVIII\x20</strong>(hemophilia\x20A),\x20<strong>FIX\x20</strong>(hemophilia\x20B),\x20or\x20<strong>FXI</strong>.\x20(Options\x20B\x20and\x20D\x20ruled\x20out)</li>\x0a<li>If\x20both\x20PT\x20and\x20aPTT\x20are\x20prolonged,\x20broader\x20abnormalities\x20such\x20as<strong>\x20FV</strong>,\x20<strong>FX</strong>,\x20FII,\x20or\x20fibrinogen\x20deficiency\x20may\x20be\x20suspected.\x20(Option\x20C\x20ruled\x20out)</li>\x0a<li>A\x20<strong>mixing\x20study</strong>,\x20where\x20normal\x20plasma\x20is\x20added\x20to\x20patient\x20plasma,\x20helps\x20distinguish\x20between\x20true\x20factor\x20deficiencies\x20and\x20inhibitors\x20or\x20anticoagulants.\x20If\x20clotting\x20time\x20normalizes,\x20a\x20deficiency\x20is\x20likely\x20while\x20<strong>failure\x20to\x20normalize</strong>\x20implies\x20the\x20presence\x20of\x20an\x20<strong>inhibitor</strong>.</li>\x0a<li>Development\x20of\x20inhibitors\x20(alloantibodies)\x20against\x20coagulation\x20factors\x20is\x20rare\x20but\x20can\x20occur\x20in\x20hemophilia\x20A\x20or\x20B,\x20or\x20FXI\x20deficiency,\x20particularly\x20after\x20repeated\x20factor\x20replacement.</li>\x0a<li>Some\x20autoimmune\x20or\x20idiopathic\x20settings,\x20as\x20well\x20as\x20postpartum\x20states,\x20may\x20also\x20lead\x20to\x20inhibitor\x20formation.</li>\x0a<li>Acquired\x20factor\x20deficiencies\x20are\x20more\x20common\x20than\x20inherited\x20forms\x20and\x20include\x20those\x20due\x20to\x20<strong>liver\x20disease</strong>,\x20DIC,\x20or\x20vitamin\x20K\x20deficiency,\x20which\x20typically\x20involve\x20multiple\x20clotting\x20factor\x20deficits.</li>\x0a</ul>','oWijX','prevBtn','<p><span\x20style=\x22font-size:12.0pt;\x22>CML</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Deletion\x2011</span></p>','2|1|3|5|4|0','dxkqs','uiVph','cdPqy','\x20-\x20Brain\x20And\x20Scalpel','attachMedia','cRMow','<p><strong>Explanation:</strong></p>\x0a<p>The\x20given\x20clinical\x20features\x20of\x20fatigue,\x20cough,\x20night\x20sweats,\x20and\x20laboratory\x20findings\x20with\x20peripheral\x20blood\x20smear\x20showing\x20cells\x20with\x20irregular\x20nuclei\x20and\x20cytoplasmic\x20projects\x20suggests\x20a\x20diagnosis\x20of\x20<strong>hairy\x20cell\x20leukemia</strong>.</p>\x0a<ul>\x0a<li>Hairy\x20cell\x20leukemia\x20is\x20an\x20uncommon\x20B-cell\x20neoplasm\x20that\x20typically\x20affects\x20<strong>middle-aged\x20males</strong>\x20and\x20accounts\x20for\x20around\x202%\x20of\x20leukemias.</li>\x0a<li>It\x20is\x20marked\x20by\x20lymphoid\x20cells\x20with\x20<strong>oval\x20nuclei</strong>,\x20abundant\x20pale\x20cytoplasm,\x20and\x20distinctive\x20<strong>cytoplasmic\x20projection</strong>s\x20visible\x20under\x20phase-contrast\x20microscopy.</li>\x0a<li>Clinically,\x20patients\x20often\x20present\x20with\x20<strong>splenomegaly</strong>,\x20<strong>pancytopenia</strong>,\x20and\x20<strong>monocytopenia</strong>,\x20and\x20bone\x20marrow\x20aspiration\x20may\x20yield\x20a\x20\x27<strong>dry\x20tap</strong>\x27\x20due\x20to\x20reticulin\x20fibrosis.</li>\x0a<li>Immunophenotypically,\x20the\x20tumor\x20cells\x20express\x20CD19,\x20CD20,\x20CD22,\x20CD25,\x20CD103,\x20and\x20<strong>annexin\x20A1</strong>,\x20and\x20exhibit\x20<strong>tartrate-resistant\x20acid\x20phosphatase</strong></li>\x0a<li>Nearly\x20all\x20cases\x20harbor\x20the\x20<strong>BRAF\x20V600E</strong>\x20mutation,\x20activating\x20the\x20MAPK\x20pathway.</li>\x0a<li>Histologically,\x20the\x20marrow\x20and\x20spleen\x20show\x20diffuse\x20infiltration\x20by\x20these\x20cells,\x20and\x20hepatomegaly\x20and\x20portal\x20triads\x20may\x20also\x20be\x20involved.</li>\x0a<li>Treatment\x20includes\x20nucleoside\x20analogs\x20like\x20cladribine\x20or\x20deoxycoformycin,\x20which\x20yield\x20durable\x20remissions\x20though\x20they\x20may\x20increase\x20susceptibility\x20to\x20infections.\x20Interferon-&alpha;\x20has\x20some\x20efficacy\x20but\x20is\x20less\x20potent.</li>\x0a<li>Refractory\x20cases\x20have\x20shown\x20positive\x20responses\x20to\x20the\x20BRAF\x20inhibitor\x20<strong>vemurafenib</strong>,\x20with\x20even\x20more\x20sustained\x20remissions\x20when\x20combined\x20with\x20rituximab.</li>\x0a<li>The\x20disease\x20follows\x20an\x20indolent\x20course\x20and\x20responds\x20well\x20to\x20re-treatment,\x20contributing\x20to\x20its\x20overall\x20excellent\x20prognosis.</li>\x0a</ul>\x0a<p><strong>Explanations\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Acute\x20lymphoid\x20leukemia\x20(Option\x20A):</strong>\x20Acute\x20lymphoblastic\x20leukemia\x20(ALL)\x20is\x20a\x20malignancy\x20of\x20immature\x20lymphoid\x20cells,\x20primarily\x20affecting\x20<strong>children</strong>.\x20Peripheral\x20smear\x20typically\x20reveals\x20<strong>lymphoblasts</strong>\x20with\x20condensed\x20nuclear\x20chromatin,\x20small\x20nucleoli,\x20and\x20scant\x20basophilic\x20cytoplasm.</p>\x0a<p><strong>Idiopathic\x20thrombocytopenic\x20purpura\x20(Option\x20B):</strong>\x20Immune\x20thrombocytopenic\x20purpura\x20(ITP)\x20is\x20a\x20condition\x20marked\x20by<strong>\x20immune-mediated\x20destruction</strong>\x20of\x20platelets\x20and\x20occasionally\x20impaired\x20platelet\x20production.\x20In\x20children,\x20it\x20often\x20follows\x20an\x20infection\x20and\x20resolves\x20spontaneously,\x20while\x20in\x20adults,\x20it\x20tends\x20to\x20be\x20chronic\x20or\x20associated\x20with\x20secondary\x20causes\x20like\x20autoimmune\x20diseases\x20or\x20infections.\x20Clinically,\x20it\x20presents\x20with\x20mucocutaneous\x20bleeding\x20and\x20marked\x20thrombocytopenia,\x20while\x20peripheral\x20smear\x20typically\x20reveals\x20<strong>large\x20platelets</strong>\x20with\x20otherwise\x20normal\x20morphology.</p>\x0a<p><strong>Infectious\x20mononucleosis\x20(Option\x20D):</strong>\x20Infectious\x20mononucleosis,\x20caused\x20by\x20a\x20new\x20EBV\x20infection,\x20typically\x20affects\x20<strong>young\x20adults</strong>\x20and\x20is\x20characterized\x20by\x20malaise,\x20fever,\x20sore\x20throat,\x20and\x20prominent\x20<strong>cervical\x20lymphadenopathy</strong>.\x20Physical\x20findings\x20often\x20include\x20posterior\x20cervical\x20or\x20auricular\x20lymph\x20node\x20enlargement,\x20<strong>splenomegaly</strong>,\x20and\x20exudative\x20pharyngitis\x20with\x20palatine\x20petechiae\x20and\x20a\x20gelatinous\x20uvula.\x20Hematologic\x20features\x20include\x20<strong>lymphocytosis</strong>\x20with\x20&gt;50%\x20lymphocytes,\x20of\x20which\x20&gt;10%\x20show\x20atypical\x20morphology,\x20and\x20diagnosis\x20is\x20supported\x20by\x20detection\x20of\x20heterophil\x20antibodies,\x20which\x20become\x20positive\x20in\x20the\x20majority\x20of\x20cases\x20by\x20the\x20third\x20week.</p>','{}.constructor(\x22return\x20this\x22)(\x20)','replace','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2068-year-old\x20woman\x20with\x20rheumatoid\x20arthritis\x20has\x20been\x20found\x20to\x20have\x20low\x20hemoglobin.\x20Which\x20of\x20the\x20following\x20contributes\x20to\x20the\x20development\x20of\x20anemia\x20of\x20chronic\x20disease?</span></p>','UJYpP','pdsyD','apply','stats','<p><span\x20style=\x22font-size:12.0pt;\x22>Blood\x20cultures</span></p>','sOocG','oafqg','ROqwZ','vQpJZ','exception','<p><span\x20style=\x22font-size:12.0pt;\x22>Severe\x20Hemophilia\x20A\x20is\x20defined\x20as\x20factor\x208\x20levels\x20below?</span></p>','QovJh','CPOzX','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','zxAKC','correctResult','findIndex','iFBTy','316yANcnk','LPWSx','true','kVYbj','xHTTN','<p><span\x20style=\x22font-size:12.0pt;\x22>BCL-2</span></p>','DT1198221','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20is\x20not\x20a\x20cause\x20of\x20non-megaloblastic\x20macrocytic\x20anemia?</span></p>','wcLPu','ULnAb','<p><span\x20style=\x22font-size:12.0pt;\x22>1%</span></p>','totalQuestionsResult','SbiGk','pazMt','uwiII','qrXTI','yMhEL','incorrect','vpMtX','loadSource','<p><span\x20style=\x22font-size:12.0pt;\x22>Aplastic\x20anemia</span></p>','DT1198218','YLmpk','mUSUZ','4|1|0|2|3|5','hierarchy','textContent','RVZQN','CNIDb','timeDisplay','RZqPb','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','HFkeA','MRpmz','<p><span\x20style=\x22font-size:12.0pt;\x22>Antibody\x20formation\x20against\x20PF4-heparin\x20complex</span></p>','question_audio','TNQDu','MLrEE','aUxRz','MADtA','Incorrect','NOuon','.option-button','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x20young\x20girl\x20with\x20acute\x20promyelocytic\x20leukemia\x20develops\x20tachypnea,\x20weight\x20gain\x20and\x20fever\x20on\x20day\x203\x20of\x20treatment.\x20CXR\x20shows\x20bilateral\x20pulmonary\x20infiltrates.\x20What\x20is\x20the\x20best\x20management\x20for\x20the\x20patient?</span></p>','search','Bookmark','dimZW','YYfOQ','bONPY','osaAI','orgHQ','rlYDk','<p><strong>Explanation:</strong></p>\x0a<p>The\x20mechanism\x20of\x20action\x20of<strong>\x20dalteparin</strong>\x20is\x20antithrombin-dependent\x20inhibition\x20of\x20thrombin\x20and\x20factor\x20Xa.</p>\x0a<ul>\x0a<li><strong>Low-molecular-weight\x20heparins\x20(LMWH)</strong>,\x20such\x20as\x20dalteparin\x20and\x20enoxaparin,\x20are\x20anticoagulants\x20used\x20primarily\x20for\x20acute\x20coronary\x20syndromes\x20and\x20coronary\x20interventions.</li>\x0a<li>They\x20act\x20by\x20<strong>binding\x20to\x20antithrombin</strong>\x20and\x20enhancing\x20its\x20inhibition\x20of\x20coagulation\x20factors,\x20especially\x20factor\x20Xa\x20and\x20to\x20a\x20lesser\x20degree,\x20thrombin\x20(factor\x20IIa).</li>\x0a<li>Unlike\x20unfractionated\x20heparin,\x20LMWH\x20has\x20a\x20longer\x20half-life,\x20better\x20bioavailability,\x20and\x20is\x20primarily\x20cleared\x20renally,\x20necessitating\x20monitoring\x20in\x20renal\x20impairment\x20due\x20to\x20potential\x20accumulation.</li>\x0a<li>Dalteparin\x20has\x20a\x20more\x20predictable\x20anticoagulant\x20effect,\x20so\x20routine\x20monitoring\x20is\x20typically\x20not\x20required,\x20but\x20certain\x20populations\x20like\x20those\x20with\x20<strong>renal\x20dysfunction</strong>,\x20obesity,\x20pregnancy,\x20or\x20children\x20may\x20need\x20individualized\x20monitoring.</li>\x0a<li>Heparin,\x20LMWH,\x20and\x20fondaparinux\x20<strong>lack\x20intrinsic\x20anticoagulant\x20activity</strong>\x20but\x20accelerates\x20the\x20inhibition\x20of\x20coagulation\x20proteases\x20by\x20binding\x20to\x20antithrombin.</li>\x0a<li>Because\x20LMWH\x20molecules\x20are\x20shorter,\x20many\x20cannot\x20simultaneously\x20bind\x20thrombin\x20and\x20antithrombin,\x20resulting\x20in\x20a\x20higher\x20anti-factor\x20Xa\x20to\x20anti-factor\x20IIa\x20activity\x20ratio,\x20typically\x20between\x202:1\x20and\x203:1\x20depending\x20on\x20the\x20preparation.</li>\x0a<li><strong>Platelet\x20factor\x204</strong>,\x20a\x20positively\x20charged\x20protein\x20released\x20from\x20alpha\x20granules\x20during\x20platelet\x20activation,\x20binds\x20to\x20heparin\x20and\x20interferes\x20with\x20its\x20ability\x20to\x20engage\x20with\x20antithrombin.</li>\x0a<li>This\x20interaction\x20can\x20reduce\x20heparin\x27s\x20effectiveness\x20near\x20thrombi\x20rich\x20in\x20platelets.\x20In\x20contrast,\x20low-molecular-weight\x20heparins\x20(LMWH)\x20and\x20fondaparinux\x20exhibit\x20a\x20<strong>weaker\x20affinity\x20for\x20platelet\x20factor\x204</strong>,\x20allowing\x20them\x20to\x20maintain\x20their\x20anticoagulant\x20activity\x20more\x20effectively\x20in\x20thrombus\x20rich\x20regions.</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403278845c693-cb0f-4c6d-b556-22ac22955c6a.jpg\x22>\x0a<p>PCC:\x20Prothrombin\x20Complex\x20Concentrates</p>\x0a<p>FFP:\x20Fresh\x20Frozen\x20Plasma</p>\x0a<p><strong>Explanation\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Apixaban\x20(Option\x20A):\x20</strong>Direct\x20acting\x20inhibitor\x20of\x20factor\x20Xa\x20used\x20orally.</p>\x0a<p><strong>Bivalirudin\x20(Option\x20B):\x20</strong>A\x20parenteral\x20direct\x20thrombin\x20inhibitor.</p>\x0a<p><strong>Dabigatran\x20(Option\x20C):\x20</strong>A\x20direct\x20thrombin\x20inhibitor\x20used\x20orally.</p>','tTrLF','CGRJa','FlFRC','jPPwW','button','zPkdu','BZroZ','Ghoyp','<p><strong>B12\x20deficiency</strong>\x20results\x20in\x20<strong>megaloblastic\x20macrocytic\x20anemia</strong>.</p>\x0a<p>Macrocytic\x20anemia\x20can\x20be\x20due\x20to\x20megaloblastic\x20or\x20non-megaloblastic\x20causes\x20as\x20given\x20below.</p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240327b00c274a-95f3-49c9-b20f-985edb799b1c.jpg\x22>','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','<p><span\x20style=\x22font-size:12.0pt;\x22>Bivalirudin</span></p>','HpQHT','includes','answered','ppcIV','markedForReview','eeHrv','emJlv','PQKPO','DT1198182','totalTime','correctCount','uKzyS','resume','review-question\x20','pLkvm','VKyUf','<p><strong>Explanation:</strong></p>\x0a<p><strong>Mantle\x20cell\x20lymphoma</strong>\x20tends\x20to\x20present\x20with\x20morphologically\x20small\x20lymphocytes\x20with\x20cleaved\x20nuclear\x20contours\x20that\x20are\x20positive\x20for\x20CD5\x20but\x20negative\x20for\x20CD23\x20and\x20harbors\x20the\x20translocation\x20t(11:14),\x20which\x20leads\x20to\x20overexpression\x20of\x20cyclin\x20D1.</p>\x0a<ul>\x0a<li>Mantle\x20cell\x20lymphoma\x20is\x20an\x20uncommon\x20B-cell\x20non-Hodgkin\x20lymphoma\x20with\x20a\x20male\x20predominance\x20and\x20typical\x20onset\x20in\x20the\x20fifth\x20to\x20sixth\x20decades.</li>\x0a<li>It\x20is\x20classified\x20as\x20an\x20<strong>intermediate-grade\x20lymphoma</strong>\x20that\x20is\x20not\x20usually\x20curable\x20with\x20conventional\x20therapies\x20and\x20often\x20requires\x20aggressive\x20chemoimmunotherapy\x20or\x20stem\x20cell\x20transplantation.</li>\x0a<li>The\x20median\x20overall\x20survival\x20ranges\x20from\x205\x20to\x2010\x20years,\x20with\x20a\x20particularly\x20poor\x20prognosis\x20in\x20the\x20blastic\x20variant,\x20which\x20is\x20marked\x20by\x20<strong>high\x20Ki-67\x20expression</strong>.</li>\x0a<li>A\x20more\x20indolent\x20subtype\x20with\x20<strong>SOX11\x20negativity</strong>,\x20low\x20Ki-67,\x20and\x20splenomegaly\x20but\x20no\x20lymphadenopathy\x20behaves\x20more\x20like\x20indolent\x20NHLs.</li>\x0a<li>Mantle\x20cell\x20lymphoma\x20is\x20typically\x20associated\x20with\x20<strong>t(11;14)</strong>(q13;q32)\x20translocation,\x20which\x20juxtaposes\x20the\x20<strong>cyclin\x20D1</strong>\x20gene\x20on\x20chromosome\x2011\x20with\x20the\x20IGH\x20locus\x20on\x20chromosome\x2014,\x20resulting\x20in\x20<strong>overexpression\x20of\x20cyclin\x20D1</strong>\x20that\x20promotes\x20G1-to-S\x20phase\x20progression.</li>\x0a<li>Morphologically,\x20the\x20lymph\x20node\x20shows\x20a\x20homogeneous\x20proliferation\x20of\x20<strong>small\x20lymphocytes\x20with\x20irregular\x20(often\x20cleaved)\x20nuclear\x20contours</strong>,\x20condensed\x20chromatin,\x20and\x20scant\x20cytoplasm.\x20Large\x20blast-like\x20or\x20centroblast-like\x20cells\x20and\x20proliferation\x20centers\x20are\x20absent.</li>\x0a<li>The\x20tumor\x20may\x20form\x20nodular\x20or\x20diffuse\x20growth\x20patterns\x20and\x20often\x20involves\x20extranodal\x20sites\x20such\x20as\x20bone\x20marrow,\x20GI\x20tract\x20(notably\x20polyps),\x20liver,\x20and\x20spleen.</li>\x0a<li>Immunophenotypically,\x20MCL\x20expresses\x20<strong>cyclin\x20D1</strong>,\x20CD5,\x20CD19,\x20and\x20CD20,\x20but\x20<strong>lacks\x20CD10</strong>\x20and<strong>\x20CD23</strong>,\x20helping\x20to\x20differentiate\x20it\x20from\x20follicular\x20lymphoma\x20and\x20CLL/SLL.\x20Most\x20cases\x20express\x20surface\x20IgM\x20or\x20IgD.</li>\x0a<li>The\x20blastic\x20variant\x20has\x20high\x20proliferation\x20and\x20poor\x20prognosis,\x20while\x20those\x20with\x20TP53\x20mutations\x20or\x20complex\x20karyotypes\x20are\x20considered\x20high\x20risk.</li>\x0a<li>Clinically,\x20MCL\x20presents\x20with\x20<strong>painless\x20lymphadenopathy</strong>\x20and\x20may\x20involve\x20the\x20spleen\x20or\x20gastrointestinal\x20tract\x20in\x20about\x2050%\x20of\x20cases.</li>\x0a<li>Treatment\x20options\x20include\x20BR\x20(bendamustine\x20and\x20rituximab),\x20often\x20preferred\x20over\x20R-CHOP,\x20with\x20autologous\x20stem\x20cell\x20transplant\x20in\x20eligible\x20cases.\x20Maintenance\x20rituximab\x20may\x20prolong\x20response.</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024032765200454-76f3-44e2-a0cb-ff175ed51674.jpg\x22>\x0a<p><strong>Explanations\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Chronic\x20lymphocytic\x20leukemia\x20(Option\x20B):\x20</strong>Chronic\x20lymphocytic\x20leukemia\x20exhibits\x20a\x20characteristic\x20immunophenotype\x20marked\x20by\x20the\x20expression\x20of\x20pan\x20B-cell\x20markers\x20CD19\x20and\x20CD20,\x20along\x20with<strong>\x20CD23\x20</strong>and\x20<strong>CD5</strong>,\x20the\x20latter\x20normally\x20found\x20on\x20a\x20minor\x20subset\x20of\x20B\x20cells.\x20These\x20tumor\x20cells\x20typically\x20show\x20low\x20levels\x20of\x20surface\x20immunoglobulin\x20(usually\x20IgM\x20or\x20both\x20IgM\x20and\x20IgD)\x20and\x20high\x20expression\x20of\x20the\x20anti-apoptotic\x20protein\x20BCL2.</p>\x0a<p><strong>Diffuse\x20large\x20B-cell\x20NHL\x20(Option\x20C):\x20</strong>Diffuse\x20large\x20B-cell\x20lymphomas\x20(DLBCL)\x20typically\x20express\x20CD19\x20and\x20CD20,\x20with\x20variable\x20expression\x20of\x20germinal\x20center\x20markers\x20like<strong>\x20CD10</strong>\x20and\x20BCL6.\x20Most\x20tumor\x20cells\x20also\x20display\x20surface\x20immunoglobulin.\x20Morphologically\x20the\x20cells\x20are<strong>\x20large\x20</strong>with\x20an\x20oval\x20or\x20round\x20nucleus\x20which\x20appears\x20vesicular\x20due\x20to\x20margination\x20of\x20chromatin\x20to\x20the\x20nuclear\x20membrane.</p>\x0a<p><strong>Follicular\x20lymphoma\x20(Option\x20D):\x20</strong>Follicular\x20lymphoma\x20cells\x20closely\x20mimic\x20normal\x20germinal\x20center\x20B\x20cells\x20and\x20typically\x20express\x20CD19,\x20CD20,\x20CD10,\x20surface\x20immunoglobulin,\x20and\x20BCL6.\x20Unlike\x20CLL/SLL\x20and\x20mantle\x20cell\x20lymphoma,\x20they\x20<strong>do\x20not\x20express\x20CD5</strong>.\x20Additionally,\x20BCL2\x20is\x20expressed\x20in\x20over\x2090%\x20of\x20cases,\x20which\x20contrasts\x20with\x20normal\x20follicular\x20center\x20B\x20cells\x20that\x20are\x20BCL2-negative.</p>','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','Hematology\x20Part\x202','tcvgN','test','ZsPlR','floor','<p><span\x20style=\x22font-size:12.0pt;\x22>Direct\x20thrombin\x20inhibition</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Meningococcal\x20sepsis</span></p>','XxPAT','TuAge','XKnxQ','__proto__','location','<p><span\x20style=\x22font-size:12.0pt;\x22>Idarucizumab\x20is\x20a\x20monoclonal\x20antibody\x20useful\x20for\x20reversal\x20of\x20an\x20anticoagulant.\x20The\x20mechanism\x20of\x20action\x20of\x20this\x20anticoagulant\x20is?</span></p>','remove','sDDzk','currentMode','<p><span\x20style=\x22font-size:12.0pt;\x22>Adalimumab</span></p>','qeJrM','<p><span\x20style=\x22font-size:12.0pt;\x22>Whole\x20blood\x20transfusion</span></p>','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','sXNbE','correctAnswers','<p><span\x20style=\x22font-size:12.0pt;\x22>Antibiotics</span></p>','Gggvl','getAttribute','incomplete','TSAWc','HtTyz','push','uhXCj','TtPNY','keydown','<p><span\x20style=\x22font-size:12.0pt;\x22>Vitamin\x20B12\x20deficiency</span></p>','custom_quiz.html','jiJLH','<p><strong>Explanation:\x20</strong></p>\x0a<p>The\x20first-line\x20therapy\x20for\x20a\x2025-year\x20old\x20male\x20patient\x20with\x20severe\x20aplastic\x20anemia\x20is\x20<strong>hematopoietic\x20stem\x20cell\x20transplantation</strong>.</p>\x0a<ul>\x0a<li>Severe\x20acquired\x20aplastic\x20anemia\x20may\x20be\x20managed\x20through\x20either\x20hematopoietic\x20stem\x20cell\x20transplantation\x20or\x20immunosuppressive\x20therapy.</li>\x0a<li>Stem\x20cell\x20transplantation\x20is\x20<strong>preferred\x20in\x20younger\x20patients</strong>\x20with\x20a\x20fully\x20matched\x20sibling\x20donor,\x20while\x20older\x20individuals\x20or\x20those\x20without\x20a\x20suitable\x20donor\x20are\x20managed\x20with<strong>\x20immunosuppression\x20using\x20antithymocyte\x20globulin\x20(ATG)\x20and\x20cyclosporine</strong>.\x20(Option\x20C\x20ruled\x20out)</li>\x0a<li><strong>Glucocorticoids\x20are\x20not\x20recommended</strong>\x20as\x20primary\x20therapy,\x20and\x20suspected\x20drug\x20or\x20chemical\x20exposures\x20should\x20be\x20discontinued.\x20(OPtion\x20B\x20ruled\x20out)</li>\x0a<li>If\x20the\x20disease\x20is\x20diagnosed\x20early\x20in\x20a\x20child\x20or\x20young\x20adult,\x20HLA\x20typing\x20should\x20be\x20initiated\x20immediately,\x20and\x20blood\x20transfusions\x20from\x20family\x20members\x20avoided\x20to\x20reduce\x20sensitization.</li>\x0a<li>When\x20no\x20sibling\x20donor\x20is\x20available,\x20unrelated\x20donors\x20or\x20cord\x20blood\x20may\x20be\x20considered,\x20especially\x20in\x20pediatric\x20cases.\x20Transplantation\x20from\x20haploidentical\x20donors\x20is\x20also\x20emerging\x20as\x20a\x20feasible\x20option.</li>\x0a<li><strong>Eltrombopag</strong>,\x20a\x20thrombopoietin\x20mimetic,\x20is\x20useful\x20in\x20<strong>refractory\x20cases</strong>\x20or\x20as\x20part\x20of\x20initial\x20therapy.\x20(Option\x20D\x20ruled\x20out)</li>\x0a<li>Androgens\x20may\x20benefit\x20some\x20patients,\x20particularly\x20those\x20with\x20telomere\x20shortening.</li>\x0a<li><strong>Supportive\x20care</strong>\x20includes\x20prompt\x20treatment\x20of\x20infections\x20and\x20transfusions\x20to\x20maintain\x20adequate\x20blood\x20counts.\x20Platelet\x20transfusions\x20aim\x20to\x20keep\x20counts\x20above\x2010,000/&mu;L,\x20and\x20menstrual\x20suppression\x20is\x20necessary\x20in\x20thrombocytopenic\x20females.</li>\x0a<li><strong>RBC\x20transfusions</strong>\x20are\x20used\x20to\x20maintain\x20hemoglobin\x20at\x20functional\x20levels,\x20with\x20iron\x20chelation\x20added\x20after\x20approximately\x2050\x20transfusions\x20to\x20prevent\x20iron\x20overload.</li>\x0a</ul>','DT1198264','onclick','<p><strong>Explanation:</strong></p>\x0a<p>The\x20presence\x20of\x20<strong>deletion\x2013</strong>\x20in\x20CLL\x20is\x20associated\x20with\x20good\x20prognosis.</p>\x0a<ul>\x0a<li>Cytogenetic\x20alterations,\x20alongside\x20IGHV\x20mutation\x20status,\x20serve\x20as\x20key\x20<strong>prognostic\x20markers\x20</strong>in\x20chronic\x20lymphocytic\x20leukemia\x20(CLL).</li>\x0a<li>These\x20abnormalities\x20are\x20commonly\x20detected\x20using\x20FISH,\x20though\x20metaphase\x20karyotyping\x20also\x20provides\x20valuable\x20insights.</li>\x0a<li>Among\x20the\x20most\x20significant\x20findings\x20are\x20del(13q14.3),\x20trisomy\x2012,\x20del(11q22.3),\x20and\x20del(17p13.1).</li>\x0a<li><strong>Isolated\x20deletion\x20of\x2013q14.3</strong>,\x20often\x20undetectable\x20by\x20routine\x20karyotyping,\x20is\x20linked\x20with\x20<strong>favorable\x20prognosis\x20</strong>and\x20long\x20survival.</li>\x0a<li>In\x20contrast,\x20trisomy\x2012\x20correlates\x20with\x20intermediate\x20outcomes.\x20(Option\x20D\x20ruled\x20out)</li>\x0a<li>Deletion\x20of\x2011q22.3,\x20involving\x20the\x20<strong>ATM\x20gene</strong>,\x20tends\x20to\x20occur\x20in\x20younger\x20individuals\x20with\x20bulky\x20lymphadenopathy\x20and\x20portends\x20a\x20more\x20aggressive\x20disease\x20course\x20and\x20worse\x20outcomes.\x20(Option\x20B\x20ruled\x20out)</li>\x0a<li>Deletion\x20of\x2017p13.1,\x20affecting\x20the\x20<strong>TP53\x20gene</strong>,\x20signifies\x20the\x20most\x20unfavorable\x20prognosis\x20with\x20rapid\x20progression,\x20treatment\x20resistance,\x20and\x20reduced\x20survival.\x20(Option\x20A\x20ruled\x20out)</li>\x0a<li>Complex\x20karyotypes\x20which\x20are\x20defined\x20by\x20the\x20presence\x20of\x20three\x20or\x20more\x20cytogenetic\x20abnormalities\x20also\x20predict\x20poor\x20response\x20and\x20reduced\x20survival.</li>\x0a</ul>','YJHIP','WMXVa','application/vnd.apple.mpegurl','LHCfh','<p><span\x20style=\x22font-size:12.0pt;\x22>Mantle\x20cell\x20lymphoma</span></p>','quizFile','<p><span\x20style=\x22font-size:12.0pt;\x22>Dalteparin</span></p>','mlOUJ','DuuJB','JFoMF','LsMDo','vukOA','reload','<p><strong>Explanation:</strong></p>\x0a<p>The\x20given\x20clinical\x20scenario\x20of\x20fever,\x20confusion,\x20thrombocytopenia,\x20elevated\x20lactate\x20dehydrogenase,\x20and\x20schistocytes\x20on\x20peripheral\x20smear\x20suggests\x20a\x20diagnosis\x20of<strong>\x20thrombotic\x20thrombocytopenic\x20purpura\x20</strong>which\x20leads\x20to\x20<strong>formation\x20of\x20microthrombi\x20due\x20to\x20deficient\x20vWF\x20cleavage\x20by\x20ADAMTS13</strong>.</p>\x0a<ul>\x0a<li>Thrombotic\x20Thrombocytopenic\x20Purpura\x20(TTP)\x20is\x20a\x20form\x20of\x20thrombotic\x20microangiopathy\x20characterized\x20by\x20microangiopathic\x20hemolytic\x20anemia\x20(MAHA),\x20thrombocytopenia,<strong>\x20neurologic\x20symptoms</strong>,\x20<strong>renal\x20dysfunction</strong>,\x20and\x20fever.</li>\x0a<li>Peripheral\x20smear\x20typically\x20shows\x20fragmented\x20RBCs,\x20while\x20lab\x20findings\x20suggest\x20hemolysis\x20with\x20elevated\x20LDH,\x20indirect\x20hyperbilirubinemia,\x20and\x20reduced\x20haptoglobin.\x20Coagulation\x20studies\x20(PT,\x20aPTT)\x20usually\x20remain\x20within\x20normal\x20limits,\x20distinguishing\x20TTP\x20from\x20DIC.</li>\x0a<li>The\x20pathogenesis\x20of\x20TTP\x20revolves\x20around\x20a\x20marked\x20deficiency\x20of\x20the\x20<strong>metalloprotease\x20ADAMTS13\x20</strong>(activity\x20&lt;10%),\x20either\x20due\x20to\x20inherited\x20mutations\x20(congenital\x20TTP\x20or\x20cTTP/Upshaw-Schulman\x20syndrome)\x20or\x20acquired\x20autoantibodies\x20(idiopathic\x20TTP\x20or\x20iTTP).</li>\x0a<li>ADAMTS13\x20<strong>cleaves\x20ultra-large\x20von\x20Willebrand\x20factor</strong>\x20(vWF)\x20multimers.</li>\x0a<li>In\x20its\x20absence,\x20these\x20multimers\x20accumulate,\x20promoting\x20<strong>abnormal\x20platelet\x20adhesion\x20</strong>and\x20aggregation,\x20leading\x20to\x20widespread\x20microthrombi.</li>\x0a<li>Though\x20the\x20ADAMTS13\x20deficiency\x20is\x20pivotal,\x20clinical\x20disease\x20often\x20requires\x20an\x20additional\x20trigger\x20such\x20as\x20<strong>pregnancy,</strong>\x20infection,\x20or\x20inflammation.</li>\x0a<li>Idiopathic\x20TTP\x20is\x20more\x20common\x20in\x20women\x20and\x20individuals\x20with\x20HIV,\x20with\x20a\x20higher\x20incidence\x20among\x20Black\x20individuals.</li>\x0a<li>Drug-induced\x20forms\x20may\x20result\x20from\x20agents\x20causing\x20direct\x20endothelial\x20injury\x20(e.g.\x20mitomycin,\x20tacrolimus,\x20cyclosporine)\x20or\x20formation\x20of\x20autoantibodies\x20(e.g.\x20quinine,\x20clopidogrel),\x20and\x20can\x20mimic\x20TTP\x20pathophysiology.\x20Quinine-related\x20TTP\x20tends\x20to\x20affect\x20women\x20more\x20commonly.</li>\x0a<li>Therapeutic\x20plasma\x20exchange\x20(TPE)\x20is\x20the\x20cornerstone\x20of\x20treatment,\x20continued\x20until\x20normalization\x20of\x20platelet\x20counts\x20and\x20resolution\x20of\x20hemolysis.\x20Glucocorticoids\x20are\x20often\x20added\x20as\x20adjuncts,\x20and\x20rituximab\x20helps\x20reduce\x20TPE\x20duration\x20and\x20relapse\x20rates.</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Immune-mediated\x20destruction\x20of\x20platelets\x20via\x20anti-GPIIb/IIIa\x20antibodies\x20(Option\x20A):\x20</strong>Implicated\x20in\x20immune\x20thrombocytopenic\x20purpura,</p>\x0a<p><strong>Shiga-toxin-mediated\x20endothelial\x20injury\x20(Option\x20C):\x20</strong>Characteristic\x20of\x20typical\x20hemolytic-uremic\x20syndrome.</p>\x0a<p><strong>Antibody\x20formation\x20against\x20PF4-heparin\x20complex\x20(Option\x20D):\x20</strong>Describes\x20the\x20pathogenesis\x20of\x20heparin\x20induced\x20thrombocytopenia.</p>','FcWli','filter','990395iTzsJE','explanation_audio_eng','key','veytR','vlXAs','padStart','azLJi','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','<p><strong>Explanation:</strong></p>\x0a<p>L-asparaginase\x20is\x20used\x20in\x20the\x20treatment\x20of\x20ALL.</p>\x0a<ul>\x0a<li>Treatment\x20of\x20acute\x20lymphoblastic\x20leukemia\x20(ALL)\x20generally\x20involves\x20<strong>four\x20stages</strong>:\x20pre-phase\x20therapy,\x20induction,\x20consolidation,\x20and\x20maintenance.</li>\x0a<li><strong>Pre-phase\x20therapy</strong>\x20with\x20glucocorticoids\x20(prednisone\x20or\x20dexamethasone)\x20alone\x20or\x20in\x20combination\x20with\x20agents\x20like\x20vincristine\x20or\x20cyclophosphamide\x20is\x20given\x20for\x205-7\x20days\x20to\x20prevent\x20tumor\x20lysis\x20syndrome,\x20initiate\x20supportive\x20care,\x20and\x20allow\x20time\x20for\x20diagnostics.</li>\x0a<li><strong>Induction</strong>\x20aims\x20for\x20complete\x20or\x20molecular\x20remission\x20and\x20includes\x20vincristine,\x20glucocorticoids,\x20anthracyclines,\x20and\x20possibly\x20cyclophosphamide\x20or\x20cytarabine.</li>\x0a<li>L-asparaginase\x20is\x20a\x20key\x20agent\x20in\x20treating\x20ALL,\x20as\x20lymphoid\x20leukemia\x20cells\x20rely\x20on\x20external\x20sources\x20of\x20asparagine.</li>\x0a<li>The\x20drug\x20works\x20by\x20<strong>hydrolyzing\x20circulating\x20asparagine</strong>\x20to\x20aspartic\x20acid\x20and\x20ammonia,\x20thus\x20depriving\x20tumor\x20cells\x20of\x20this\x20essential\x20amino\x20acid\x20and\x20inducing\x20cell\x20death.</li>\x0a<li>Pegaspargase,\x20a\x20PEGylated\x20form,\x20offers\x20a\x20longer\x20half-life\x20and\x20reduced\x20immunogenicity,\x20allowing\x20administration\x20every\x2014\x20days,\x20while\x20calaspargase\x20pegol\x20lasts\x20up\x20to\x2021\x20days.</li>\x0a<li><strong>Consolidation</strong>\x20typically\x20involves\x20six\x20to\x20eight\x20cycles\x20of\x20high-dose\x20methotrexate\x20and/or\x20cytarabine\x20to\x20achieve\x20therapeutic\x20levels\x20in\x20sanctuary\x20sites\x20such\x20as\x20the\x20CNS.</li>\x0a<li><strong>Maintenance\x20therapy</strong>,\x20essential\x20even\x20in\x20adults,\x20includes\x206-mercaptopurine,\x20methotrexate,\x20and\x20intrathecal\x20treatment,\x20with\x20tyrosine\x20kinase\x20inhibitors\x20added\x20in\x20Ph+\x20cases.\x20Maintenance\x20lasts\x202\x20-\x202.5\x20years,\x20guided\x20by\x20MRD\x20monitoring,\x20and\x20tyrosine\x20kinase\x20inhibitors\x20may\x20be\x20adjusted\x20based\x20on\x20tolerability.</li>\x0a</ul>\x0a<p><strong>Explanations\x20of\x20other\x20options:</strong></p>\x0a<p><strong>CML\x20(Option\x20B):\x20</strong>Medical\x20treatment\x20in\x20CML\x20include\x20tyrosine\x20kinase\x20inhibitors\x20and\x20Omacetaxine\x20mepesuccinate</p>\x0a<p><strong>CLL\x20(Option\x20C):\x20</strong>Currently,\x20the\x20majority\x20of\x20patients\x20receive\x20oral\x20treatments\x20directed\x20at\x20BTK\x20or\x20BCL2,\x20either\x20alone\x20or\x20in\x20combination\x20with\x20a\x20CD20\x20monoclonal\x20antibody.</p>\x0a<p><strong>AML\x20(Option\x20D):\x20</strong>The\x20main\x20drugs\x20used\x20in\x20AML\x20treatment\x20include\x20<strong>cytarabine</strong>\x20and\x20<strong>anthracyclines</strong>\x20(such\x20as\x20daunorubicin\x20or\x20idarubicin)\x20as\x20the\x20backbone\x20of\x20induction\x20therapy.</p>','innerHTML','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','etjtJ','sbQKV','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','imkmR','incorrectResult','slVIv','SBsXA','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','fDoIZ','jZPtt','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','GpLmW','timed_exam','incorrectAnswers','solution','YCbHO','HzGYK','bookmarkText','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','SbeFo','hematology-part-2-7cf4394d.html','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','FsxJM','solutionText','<p><span\x20style=\x22font-size:12.0pt;\x22>ALL</span></p>','progressBar','tFXds','DczIK','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20monoclonal\x20antibodies\x20is\x20approved\x20for\x20patients\x20with\x20hemophilia\x20A\x20with\x20or\x20without\x20inhibitors?</span></p>','qGThl','EsTYL','ArrowRight','questionIndex','17191QkZPWL','constructor','Marked','xHDVF','WOMak','EzUoX','<p><span\x20style=\x22font-size:12.0pt;\x22>Copper\x20deficiency</span></p>','UyRpC','<p><strong>Explanation:</strong></p>\x0a<p>The\x20given\x20clinical\x20scenario\x20of\x20fever,\x20neck\x20rigidity,\x20elevated\x20WBC\x20count,\x20and\x20low\x20blood\x20pressure\x20suggests\x20a\x20diagnosis\x20of\x20meningococcal\x20sepsis.</p>\x0a<ul>\x0a<li>Patients\x20with\x20<strong>sickle-cell\x20disease</strong>\x20have\x20compromised\x20splenic\x20function\x20resulting\x20from\x20microvascular\x20occlusion\x20which\x20puts\x20them\x20at\x20risk\x20of\x20life-threatening\x20infections\x20from\x20capsulated\x20organisms\x20such\x20as\x20<strong>Neisseria\x20meningitidis</strong>\x20(meningococcal\x20meningitis).</li>\x0a<li>Sickle\x20cell\x20disease\x20is\x20an\x20inherited\x20disorder\x20caused\x20by\x20a\x20<strong>point\x20mutation</strong>\x20in\x20the\x20&beta;-globin\x20gene,\x20resulting\x20in\x20the\x20production\x20of\x20hemoglobin\x20S\x20(HbS).</li>\x0a<li>This\x20mutant\x20hemoglobin\x20polymerizes\x20under\x20low\x20oxygen\x20conditions,\x20leading\x20to\x20red\x20cell\x20deformation,\x20hemolytic\x20anemia,\x20<strong>microvascular\x20occlusion</strong>,\x20and\x20tissue\x20injury.</li>\x0a<li>The\x20condition\x20is\x20most\x20common\x20in\x20individuals\x20of\x20African\x20descent\x20with\x20heterozygotes\x20(sickle\x20cell\x20trait)\x20showing\x20resistance\x20to\x20Plasmodium\x20falciparum\x20malaria.\x20Homozygous\x20individuals\x20produce\x20mostly\x20HbS\x20and\x20suffer\x20from\x20symptomatic\x20disease.</li>\x0a<li>Sickle\x20cell\x20disease\x20manifests\x20with\x20chronic\x20hemolytic\x20anemia\x20(hematocrit\x2018-30%),\x20reticulocytosis,\x20hyperbilirubinemia,\x20and\x20frequent\x20vaso-occlusive\x20crises.</li>\x0a<li>These\x20crises\x20cause\x20<strong>severe\x20pain</strong>\x20due\x20to\x20ischemic\x20injury\x20in\x20various\x20organs.\x20Common\x20sites\x20include\x20<strong>bones</strong>,\x20<strong>lungs</strong>\x20(acute\x20chest\x20syndrome),\x20brain,\x20spleen,\x20and\x20penis.\x20(Option\x20D\x20ruled\x20out)</li>\x0a<li>Complications\x20include\x20priapism,\x20stroke,\x20infections,\x20<strong>autosplenectomy</strong>,\x20and\x20chronic\x20organ\x20damage.\x20Sequestration\x20crises\x20and\x20<strong>aplastic\x20crises</strong>\x20(due\x20to\x20parvovirus\x20B19)\x20may\x20occur.\x20Children\x20are\x20especially\x20susceptible\x20to\x20infections\x20by\x20<strong>encapsulated\x20organisms</strong>\x20due\x20to<strong>\x20splenic\x20dysfunction</strong>.</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Aplastic\x20crisis\x20(Option\x20A):</strong>\x20Aplastic\x20crises\x20are\x20triggered\x20by\x20parvovirus\x20B19\x20infection,\x20which\x20temporarily\x20halts\x20red\x20blood\x20cell\x20production,\x20leading\x20to\x20an\x20<strong>abrupt\x20decline\x20in\x20hemoglobin\x20levels</strong>.</p>\x0a<p><strong>Sequestration\x20crisis\x20(Option\x20B):\x20</strong>In\x20children\x20with\x20functional\x20spleens,\x20sequestration\x20crises\x20arise\x20from\x20the\x20sudden\x20trapping\x20of\x20large\x20numbers\x20of\x20sickled\x20red\x20blood\x20cells\x20in\x20the\x20spleen,\x20resulting\x20in\x20<strong>rapid\x20splenic\x20enlargement</strong>,\x20<strong>reduced\x20blood\x20volume</strong>,\x20and\x20potentially\x20shock.\x20These\x20crises,\x20along\x20with\x20acute\x20chest\x20syndrome,\x20can\x20be\x20life-threatening\x20and\x20may\x20necessitate\x20urgent\x20exchange\x20transfusions.</p>\x0a<p><strong>Painful\x20vaso-occlusive\x20crisis\x20(Option\x20C):</strong>\x20There\x20is\x20no\x20history\x20of\x20joint\x20pain\x20or\x20shortness\x20of\x20breath\x20to\x20suggest\x20a\x20vaso-occlusive\x20painful\x20crisis\x20or\x20sickle\x20chest\x20syndrome.</p>','toLowerCase','rMiRo','1|2|0|5|3|4','studyModeLegend','questionText','MOOXN','<p><span\x20style=\x22font-size:12.0pt;\x22>Triple\x20hit\x20lymphoma\x20includes\x20all\x20except?</span></p>','rHdAL','jckDh','nav-btn-incorrect','isSupported','xgEQp','DT1198260','UGQry','log','none','appendChild','<p><span\x20style=\x22font-size:12.0pt;\x22>Homozygosity\x20for\x20hemoglobin\x20E\x20(HbEE)</span></p>','OsQUO','bJfea','forEach','23151282tHVhFi','oRsGT','setItem','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20cytogenetic\x20abnormality\x20in\x20CLL\x20is\x20associated\x20with\x20good\x20prognosis?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>The\x20first-line\x20therapy\x20for\x20a\x2025-year\x20old\x20male\x20patient\x20with\x20severe\x20aplastic\x20anemia\x20is?</span></p>','userHistory','<p><span\x20style=\x22font-size:12.0pt;\x22>Shiga-toxin-mediated\x20endothelial\x20injury</span></p>','length','TFMuT','IDxxW','rYBXL','display','vceLD','DT1198250','Kxord','DT1198208','Mark\x20for\x20Review','NLYzB','Ariff','<p><span\x20style=\x22font-size:12.0pt;\x22>Sideroblastic\x20anemia</span></p>','VhzBe','RCIvu','RTuKj','nav-btn-bookmarked','cELIY','click','solutionAudio','split','DT1198238','SaGaY','<p><span\x20style=\x22font-size:12.0pt;\x22>Diffuse\x20large\x20B-cell\x20NHL</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Prolongation\x20of\x20both\x20PT\x20and\x20aPTT</span></p>','zXuJU','xTKbk','<p><span\x20style=\x22font-size:12.0pt;\x22>An\x2018-year-old\x20woman\x20from\x20Pakistan\x20is\x20admitted\x20for\x20evaluation\x20of\x20chronic\x20severe\x20microcytic\x20and\x20hypochromic\x20anemia.\x20Her\x20hemoglobin\x20levels\x20have\x20generally\x20been\x20in\x20the\x20range\x20of\x207\x20to\x2010\x20g/dL,\x20and\x20she\x20recalls\x20needing\x20blood\x20transfusions\x20only\x20twice\x20in\x20her\x20life,\x20on\x20both\x20occasions\x20after\x20traumatic\x20bone\x20fractures.\x20Physical\x20examination\x20shows\x20marked\x20hepatosplenomegaly;\x20laboratory\x20test\x20abnormalities\x20include\x20indirect\x20hyperbilirubinemia.\x20HbA2\x20and\x20HbE\x20levels\x20are\x20found\x20to\x20be\x20normal.\x20What\x20is\x20the\x20most\x20likely\x20diagnosis?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>L-Asparaginase\x20is\x20used\x20in\x20the\x20treatment\x20of?</span></p>','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','LcdQS','style','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','notAttempted','SljlN','CgAXU','wRCCb','trace','optionsContainer','<p><span\x20style=\x22font-size:12.0pt;\x22>BCL-6</span></p>','xOjsU','hCeWu','rsXBA'];_0x1ca1=function(){return _0xeb5586;};return _0x1ca1();}function initializeQuiz(){const _0x121411=_0x31277a,_0x169e51={'xdYDU':'2|3|1|5|4|0','KlWTS':'totalQuestions','eXQKO':function(_0x29a519,_0x454b49){return _0x29a519+_0x454b49;},'nsdiO':_0x121411(0x144),'PmpVO':_0x121411(0x392),'zIHsF':_0x121411(0x3c7),'MOOXN':_0x121411(0x2d4),'UJYpP':function(_0x13af88,_0x4d5d1f){return _0x13af88===_0x4d5d1f;},'xHTTN':_0x121411(0x1b1),'jEpMZ':_0x121411(0x1fd),'sbQKV':'none','RVZQN':_0x121411(0x3ef),'jXqdY':_0x121411(0x21e),'TSAWc':_0x121411(0x308),'zlzRa':'submitSection','VhzBe':_0x121411(0x3a6),'hFbYQ':function(_0x32f513,_0x57cb79){return _0x32f513===_0x57cb79;},'kVYbj':'timerContainer','QovJh':function(_0x2bac7a,_0x53640b){return _0x2bac7a(_0x53640b);},'LcdQS':function(_0x4442b7,_0x36374a){return _0x4442b7<_0x36374a;},'ZFiIM':_0x121411(0x362),'OzRCJ':function(_0x2eaade){return _0x2eaade();},'bowQB':function(_0xbea3f){return _0xbea3f();}};quizStartTime=Date[_0x121411(0x3dd)]();const _0x192133=document['getElementById'](_0x169e51[_0x121411(0x2ac)]),_0x310f47=document[_0x121411(0x3e7)](_0x169e51['zIHsF']),_0x449daa=document['getElementById'](_0x169e51[_0x121411(0x220)]),_0x4a2447=_0x169e51[_0x121411(0x14b)](currentMode,_0x169e51[_0x121411(0x161)])||_0x169e51[_0x121411(0x14b)](currentMode,_0x169e51['jEpMZ']);document['getElementById'](_0x121411(0x31c))['style'][_0x121411(0x23b)]=_0x4a2447?_0x169e51['sbQKV']:_0x169e51['RVZQN'],document[_0x121411(0x3e7)](_0x169e51['jXqdY'])[_0x121411(0x256)][_0x121411(0x23b)]=_0x4a2447?_0x169e51['sbQKV']:_0x169e51[_0x121411(0x178)],document['getElementById'](_0x169e51[_0x121411(0x1c9)])[_0x121411(0x256)][_0x121411(0x23b)]=_0x4a2447?_0x169e51['RVZQN']:_0x121411(0x22a),document[_0x121411(0x3e7)](_0x169e51[_0x121411(0x3ce)])[_0x121411(0x256)][_0x121411(0x23b)]=_0x4a2447?_0x169e51['RVZQN']:_0x169e51[_0x121411(0x1f2)],_0x192133['style'][_0x121411(0x23b)]=_0x4a2447?_0x169e51[_0x121411(0x1f2)]:_0x169e51[_0x121411(0x244)],_0x310f47[_0x121411(0x256)][_0x121411(0x23b)]=_0x4a2447?_0x169e51['VhzBe']:_0x169e51[_0x121411(0x1f2)],_0x449daa[_0x121411(0x256)][_0x121411(0x23b)]=_0x4a2447?_0x169e51['VhzBe']:_0x121411(0x22a);(_0x169e51['hFbYQ'](currentMode,'timed_study')||_0x169e51[_0x121411(0x312)](currentMode,_0x169e51[_0x121411(0x3bd)]))&&document[_0x121411(0x3e7)](_0x169e51[_0x121411(0x160)])[_0x121411(0x3b5)][_0x121411(0x1bc)](_0x121411(0x3cc));if(!_0x169e51[_0x121411(0x156)](isNaN,startAt)&&startAt>=0x0&&_0x169e51[_0x121411(0x255)](startAt,questionsData[_0x121411(0x237)])){if(_0x169e51['UJYpP'](_0x121411(0x362),_0x169e51[_0x121411(0x13a)]))currentQuestionIndex=startAt;else{const _0x98ab1c=_0x169e51[_0x121411(0x3f2)][_0x121411(0x24b)]('|');let _0x462de5=0x0;while(!![]){switch(_0x98ab1c[_0x462de5++]){case'0':_0x10ccf9[_0x121411(0x3e7)](_0x121411(0x265))['textContent']=_0x347c73[_0x121411(0x3da)](_0x121411(0x3db));continue;case'1':_0x46c672=_0x1137fb['hierarchy'];continue;case'2':_0x363ef7=_0x408e4b[_0x121411(0x2d5)];continue;case'3':_0x295cb2=_0x3a0d14[_0x121411(0x2cc)];continue;case'4':_0x482e1f[_0x121411(0x3e7)](_0x169e51['KlWTS'])[_0x121411(0x177)]=_0x455ef8[_0x121411(0x237)];continue;case'5':_0x50700e[_0x121411(0x3cf)]=_0x169e51[_0x121411(0x3e3)](_0x25f384,_0x169e51['nsdiO']);continue;}break;}}}_0x169e51[_0x121411(0x2b1)](loadBookmarkedQuestions),_0x169e51[_0x121411(0x2d8)](generateQuestionNav),updateStats(),displayQuestion();}function generateQuestionNav(){const _0x338b7c=_0x31277a,_0x73defb={'bONPY':function(_0x27cf2f,_0x4be844){return _0x27cf2f<_0x4be844;},'VVthT':function(_0x3f2432,_0x137d3d){return _0x3f2432!==_0x137d3d;},'Lqkhu':_0x338b7c(0x2cf),'DLquR':_0x338b7c(0x196),'WYyum':function(_0x299cb7,_0x360ab3){return _0x299cb7+_0x360ab3;},'HFkeA':function(_0x31573f){return _0x31573f();}},_0x27c0ba=document[_0x338b7c(0x3e7)]('questionNav');_0x27c0ba['innerHTML']='';for(let _0x50e5c5=0x0;_0x73defb[_0x338b7c(0x18d)](_0x50e5c5,questionsData[_0x338b7c(0x237)]);_0x50e5c5++){if(_0x73defb[_0x338b7c(0x31f)](_0x338b7c(0x2cf),_0x73defb['Lqkhu'])){if(_0x50c1e6){const _0x1020fc=_0x588af2[_0x338b7c(0x14d)](_0x4c858f,arguments);return _0x28931d=null,_0x1020fc;}}else{const _0x1be15f=document[_0x338b7c(0x389)](_0x73defb['DLquR']);_0x1be15f[_0x338b7c(0x177)]=_0x73defb['WYyum'](_0x50e5c5,0x1),_0x1be15f[_0x338b7c(0x36a)]='w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200',_0x1be15f[_0x338b7c(0x1d4)]=()=>jumpToQuestion(_0x50e5c5),_0x1be15f['id']=_0x338b7c(0x2ec)+_0x50e5c5,_0x27c0ba[_0x338b7c(0x22b)](_0x1be15f);}}_0x73defb[_0x338b7c(0x17d)](updateQuestionNav);}function updateQuestionNav(){const _0xfa7c1e=_0x31277a,_0x452d4a={'eCkBz':_0xfa7c1e(0x397),'TuAge':_0xfa7c1e(0x16e),'mUSUZ':_0xfa7c1e(0x392),'qGThl':_0xfa7c1e(0x3c7),'osaAI':_0xfa7c1e(0x2d4),'pLkvm':function(_0x2cf667,_0x5ace15){return _0x2cf667===_0x5ace15;},'KCxGI':_0xfa7c1e(0x1b1),'KasWl':function(_0x2b27e0,_0x2101bd){return _0x2b27e0===_0x2101bd;},'WOQsX':_0xfa7c1e(0x31c),'Heqbm':_0xfa7c1e(0x22a),'CJgdp':'studyModeLegend','yMhEL':_0xfa7c1e(0x3ef),'Amgnn':'testModeLegend','SdWtQ':_0xfa7c1e(0x3b2),'kFtLE':_0xfa7c1e(0x3a6),'YBirg':_0xfa7c1e(0x351),'CkGEA':function(_0x40ff6f,_0x52d100){return _0x40ff6f===_0x52d100;},'zXwHV':_0xfa7c1e(0x1fd),'qPdFo':_0xfa7c1e(0x314),'vdBwH':function(_0x255b33,_0x113cec){return _0x255b33(_0x113cec);},'XijYr':function(_0x26cec4,_0x39ead0){return _0x26cec4<_0x39ead0;},'GpLmW':function(_0x3d9dcf){return _0x3d9dcf();},'vXkcm':function(_0x1990fc,_0x5d9221){return _0x1990fc<_0x5d9221;},'dltYY':function(_0x299837,_0x9b0941){return _0x299837===_0x9b0941;},'CltAL':_0xfa7c1e(0x3ae),'XLoxa':function(_0x14dbc2,_0x39cd87){return _0x14dbc2===_0x39cd87;},'oifxW':_0xfa7c1e(0x24d),'kpufn':_0xfa7c1e(0x3e2),'STVlh':_0xfa7c1e(0x268),'uiVph':function(_0x5abf4a,_0x35b06c){return _0x5abf4a===_0x35b06c;},'cvqmE':_0xfa7c1e(0x3f9),'qRIQv':_0xfa7c1e(0x294),'rHdAL':_0xfa7c1e(0x2dc),'AlqSW':function(_0x2ae4ac,_0x9795a2){return _0x2ae4ac!==_0x9795a2;},'XxPAT':'nav-btn-answered'};for(let _0x12f4fe=0x0;_0x452d4a['vXkcm'](_0x12f4fe,questionsData[_0xfa7c1e(0x237)]);_0x12f4fe++){const _0x39ef53=document[_0xfa7c1e(0x3e7)](_0xfa7c1e(0x2ec)+_0x12f4fe),_0x2d0a41=questionStates[_0x12f4fe];let _0x505637='';if(_0x452d4a[_0xfa7c1e(0x377)](_0x12f4fe,currentQuestionIndex))_0x505637=_0x452d4a['CltAL'];else{if(_0x2d0a41['bookmarked'])_0x505637='nav-btn-bookmarked';else{if(_0x2d0a41[_0xfa7c1e(0x1a1)]){if(_0x452d4a['XLoxa'](_0x452d4a['oifxW'],_0x452d4a[_0xfa7c1e(0x3f3)]))_0x505637=_0x452d4a[_0xfa7c1e(0x369)];else{const _0x4003bc=_0x16969f[_0x5f2303];_0x4003bc[_0xfa7c1e(0x382)]!==null&&(_0x1d3575[_0xfa7c1e(0x34e)][_0x4003bc['selectedAnswer']]['id']===_0x2bf041[_0xfa7c1e(0x352)]?(_0x229e55++,_0x4003bc['status']=_0x452d4a[_0xfa7c1e(0x35c)]):(_0x1f3600++,_0x4003bc[_0xfa7c1e(0x371)]=_0x452d4a[_0xfa7c1e(0x1b7)]));}}else{if(currentMode===_0x452d4a['STVlh']||_0x452d4a[_0xfa7c1e(0x142)](currentMode,_0x452d4a[_0xfa7c1e(0x279)])){if(_0x452d4a[_0xfa7c1e(0x394)]===_0x452d4a[_0xfa7c1e(0x394)]){if(_0x2d0a41[_0xfa7c1e(0x371)]==='correct')_0x505637=_0x452d4a[_0xfa7c1e(0x2f0)];else{if(_0x2d0a41['status']===_0xfa7c1e(0x16e))_0x505637='nav-btn-incorrect';else _0x505637=_0x452d4a[_0xfa7c1e(0x222)];}}else{_0x68c8ae=_0x2788a3[_0xfa7c1e(0x3dd)]();const _0x519691=_0x276fc6[_0xfa7c1e(0x3e7)](_0x452d4a[_0xfa7c1e(0x174)]),_0x2bfbca=_0x4b714d[_0xfa7c1e(0x3e7)](_0x452d4a[_0xfa7c1e(0x20e)]),_0x17c9f0=_0x2b75b9[_0xfa7c1e(0x3e7)](_0x452d4a[_0xfa7c1e(0x18e)]),_0x17571b=_0x452d4a[_0xfa7c1e(0x1ab)](_0x3b4d8c,_0x452d4a['KCxGI'])||_0x452d4a['KasWl'](_0xaf1d16,_0xfa7c1e(0x1fd));_0x276dea['getElementById'](_0x452d4a[_0xfa7c1e(0x326)])[_0xfa7c1e(0x256)][_0xfa7c1e(0x23b)]=_0x17571b?_0x452d4a[_0xfa7c1e(0x2ba)]:_0xfa7c1e(0x3ef),_0x17911f[_0xfa7c1e(0x3e7)](_0x452d4a[_0xfa7c1e(0x2a5)])[_0xfa7c1e(0x256)][_0xfa7c1e(0x23b)]=_0x17571b?_0x452d4a[_0xfa7c1e(0x2ba)]:_0x452d4a['yMhEL'],_0x1a78e9[_0xfa7c1e(0x3e7)](_0x452d4a[_0xfa7c1e(0x2d3)])[_0xfa7c1e(0x256)][_0xfa7c1e(0x23b)]=_0x17571b?_0x452d4a[_0xfa7c1e(0x16d)]:_0xfa7c1e(0x22a),_0x4d30c5[_0xfa7c1e(0x3e7)](_0x452d4a['SdWtQ'])[_0xfa7c1e(0x256)][_0xfa7c1e(0x23b)]=_0x17571b?_0x452d4a['yMhEL']:_0x452d4a[_0xfa7c1e(0x2ba)],_0x519691[_0xfa7c1e(0x256)][_0xfa7c1e(0x23b)]=_0x17571b?_0x452d4a[_0xfa7c1e(0x2ba)]:_0xfa7c1e(0x3a6),_0x2bfbca[_0xfa7c1e(0x256)][_0xfa7c1e(0x23b)]=_0x17571b?_0x452d4a['kFtLE']:_0xfa7c1e(0x22a),_0x17c9f0[_0xfa7c1e(0x256)][_0xfa7c1e(0x23b)]=_0x17571b?_0x452d4a[_0xfa7c1e(0x350)]:_0x452d4a[_0xfa7c1e(0x2ba)],(_0x89fcbe===_0x452d4a[_0xfa7c1e(0x279)]||_0x452d4a[_0xfa7c1e(0x306)](_0x568fd9,_0x452d4a[_0xfa7c1e(0x383)]))&&_0x58f87b[_0xfa7c1e(0x3e7)](_0x452d4a[_0xfa7c1e(0x36d)])[_0xfa7c1e(0x3b5)][_0xfa7c1e(0x1bc)](_0xfa7c1e(0x3cc)),!_0x452d4a[_0xfa7c1e(0x3a4)](_0xd65735,_0x37e60f)&&_0x5db9cc>=0x0&&_0x452d4a[_0xfa7c1e(0x32a)](_0x3b2c69,_0x4ffc2b[_0xfa7c1e(0x237)])&&(_0x487f6d=_0xb317d9),_0x452d4a[_0xfa7c1e(0x1fc)](_0x3a8319),_0x452d4a['GpLmW'](_0x3ff1f5),_0x2fe2d8(),_0x20c403();}}else{if(_0x452d4a[_0xfa7c1e(0x357)](_0x2d0a41[_0xfa7c1e(0x382)],null))_0x505637=_0x452d4a[_0xfa7c1e(0x1b6)];else _0x505637=_0x452d4a['rHdAL'];}}}}_0x39ef53[_0xfa7c1e(0x36a)]=_0xfa7c1e(0x254)+_0x505637;}}function jumpToQuestion(_0x79515){const _0x3706fb=_0x31277a,_0x48c9ac={'LMnCM':function(_0x57b787,_0x59e921){return _0x57b787>=_0x59e921;},'dVKEW':function(_0x4c4207,_0x7e81be){return _0x4c4207<_0x7e81be;},'omhYD':function(_0x5e5081){return _0x5e5081();}};_0x48c9ac[_0x3706fb(0x2e9)](_0x79515,0x0)&&_0x48c9ac[_0x3706fb(0x2ee)](_0x79515,questionsData[_0x3706fb(0x237)])&&(questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=Date['now']()-questionStartTime),currentQuestionIndex=_0x79515,_0x48c9ac[_0x3706fb(0x330)](displayQuestion),saveProgress());}function updateStats(){const _0x4af6aa=_0x31277a,_0x458bdb={'HDjbF':_0x4af6aa(0x19f),'wcLPu':_0x4af6aa(0x351),'ACiJj':_0x4af6aa(0x323),'lgBpD':'ZLNaJ','eeHrv':_0x4af6aa(0x1a7),'dItFT':_0x4af6aa(0x373),'oWijX':function(_0x32a07f,_0x2d3ac2){return _0x32a07f>_0x2d3ac2;},'JFoMF':function(_0x5214cf,_0x5f3f51){return _0x5214cf+_0x5f3f51;},'DDCav':function(_0x47a008,_0x414c44){return _0x47a008/_0x414c44;},'CQbci':function(_0x2b6031,_0x2e0739){return _0x2b6031%_0x2e0739;},'KKkBA':function(_0x33995c,_0x41320b){return _0x33995c+_0x41320b;}};if(currentMode===_0x4af6aa(0x268)||currentMode===_0x458bdb[_0x4af6aa(0x165)]){if(_0x458bdb['ACiJj']===_0x458bdb['lgBpD'])_0x11dafb[_0x3c4ea9][_0x4af6aa(0x371)]=_0x458bdb['HDjbF'],_0x2889fd[_0x4af6aa(0x373)]++,_0x16fcb[_0x4af6aa(0x258)]--;else{document[_0x4af6aa(0x3e7)](_0x458bdb[_0x4af6aa(0x1a2)])[_0x4af6aa(0x177)]=stats[_0x4af6aa(0x1c4)],document[_0x4af6aa(0x3e7)](_0x4af6aa(0x2aa))[_0x4af6aa(0x177)]=stats[_0x4af6aa(0x1fe)],document[_0x4af6aa(0x3e7)](_0x458bdb[_0x4af6aa(0x3e8)])[_0x4af6aa(0x177)]=stats[_0x4af6aa(0x373)];const _0x562f68=_0x458bdb[_0x4af6aa(0x13c)](stats[_0x4af6aa(0x373)],0x0)?Math['round'](stats[_0x4af6aa(0x1c4)]/stats[_0x4af6aa(0x373)]*0x64):0x0;document['getElementById']('accuracy')[_0x4af6aa(0x177)]=_0x458bdb['JFoMF'](_0x562f68,'%'),stats[_0x4af6aa(0x1a6)]=questionStates['reduce']((_0x151a70,_0x2a64b3)=>_0x151a70+_0x2a64b3[_0x4af6aa(0x3e1)],0x0);const _0x53d42c=Math[_0x4af6aa(0x1b3)](_0x458bdb[_0x4af6aa(0x386)](stats[_0x4af6aa(0x1a6)],0x3e8)),_0x1fd4ec=Math[_0x4af6aa(0x1b3)](_0x458bdb['DDCav'](_0x53d42c,0x3c)),_0x22f714=_0x458bdb['CQbci'](_0x53d42c,0x3c);document[_0x4af6aa(0x3e7)](_0x4af6aa(0x3e1))[_0x4af6aa(0x177)]=_0x458bdb[_0x4af6aa(0x1df)](_0x458bdb[_0x4af6aa(0x2a6)](_0x1fd4ec,':'),_0x22f714[_0x4af6aa(0x267)]()['padStart'](0x2,'0'));}}}function setupVideo(_0x48b399,_0x2a9504){const _0x3e516e=_0x31277a,_0x5d5b2e={'kJyjB':_0x3e516e(0x1d8)};if(Hls[_0x3e516e(0x225)]()){const _0x4b29b0=new Hls();_0x4b29b0[_0x3e516e(0x170)](_0x2a9504),_0x4b29b0[_0x3e516e(0x145)](_0x48b399);}else _0x48b399[_0x3e516e(0x400)](_0x5d5b2e['kJyjB'])&&(_0x48b399['src']=_0x2a9504);}function displayQuestion(){const _0x24289d=_0x31277a,_0x25cb37={'Wrooh':function(_0xacf16a,_0x133d0a){return _0xacf16a(_0x133d0a);},'CPOzX':'customQuizData','EzUoX':function(_0x227381){return _0x227381();},'sXNbE':function(_0x226d3f,_0x514e13){return _0x226d3f+_0x514e13;},'GPwSt':function(_0x147ce4,_0x1f7ad8){return _0x147ce4===_0x1f7ad8;},'xQEez':_0x24289d(0x3d0),'dyGBv':'selected','jzszW':'Option\x20','LPWSx':function(_0x2cd89d,_0x36eca1){return _0x2cd89d===_0x36eca1;},'OjfXi':_0x24289d(0x335),'oeVRr':_0x24289d(0x235),'TFMuT':_0x24289d(0x1c8),'vDsKx':function(_0x83c4a1,_0x42298f){return _0x83c4a1!==_0x42298f;},'HzGYK':_0x24289d(0x334),'ixoID':function(_0x2705f1,_0x34190d){return _0x2705f1===_0x34190d;},'pfDqf':function(_0x5492b4,_0x21dafb){return _0x5492b4+_0x21dafb;},'YYfOQ':function(_0x142174,_0x5a55d1){return _0x142174+_0x5a55d1;},'mkXMB':function(_0xdb120,_0x2c406e){return _0xdb120+_0x2c406e;},'wRCCb':_0x24289d(0x249),'bJfea':'bookmarkedQuestions','ZxEEP':function(_0x99a2a){return _0x99a2a();},'CulqE':_0x24289d(0x187),'CGRJa':'data-option-index','NxJQj':_0x24289d(0x345),'JWYdS':_0x24289d(0x39e),'xNzla':_0x24289d(0x21f),'bznuA':_0x24289d(0x138),'OBupz':function(_0x3ded0c,_0x5cffc2){return _0x3ded0c/_0x5cffc2;},'rMiRo':function(_0x3b953e,_0x328534){return _0x3b953e+_0x328534;},'ddcvh':_0x24289d(0x20a),'SVmdP':function(_0x42640a,_0x1e215d){return _0x42640a+_0x1e215d;},'etjtJ':function(_0x53bc43){return _0x53bc43();},'mrJtA':_0x24289d(0x13d),'rYUew':function(_0x45da65,_0x10d0c7){return _0x45da65===_0x10d0c7;},'GukxZ':_0x24289d(0x3cc),'cRMow':'No\x20question\x20text\x20available','ppcIV':'questionMedia','YXfWM':_0x24289d(0x19f),'lASqJ':_0x24289d(0x1fd),'FJmgp':_0x24289d(0x30f)};if(!questionsData||_0x25cb37[_0x24289d(0x15e)](questionsData[_0x24289d(0x237)],0x0)){document[_0x24289d(0x3e7)](_0x25cb37[_0x24289d(0x2d9)])[_0x24289d(0x1ef)]=_0x25cb37[_0x24289d(0x2b9)];return;};const _0x5223e9=questionsData[currentQuestionIndex];questionStartTime=Date[_0x24289d(0x3dd)](),selectedOption=questionStates[currentQuestionIndex]['selectedAnswer'];const _0x4d7bb2=_0x25cb37[_0x24289d(0x33a)](_0x25cb37[_0x24289d(0x21c)](currentQuestionIndex,0x1),questionsData[_0x24289d(0x237)])*0x64;document[_0x24289d(0x3e7)](_0x25cb37['ddcvh'])[_0x24289d(0x256)]['width']=_0x25cb37[_0x24289d(0x30e)](_0x4d7bb2,'%'),document[_0x24289d(0x3e7)]('currentQuestion')[_0x24289d(0x177)]=currentQuestionIndex+0x1,_0x25cb37[_0x24289d(0x1f1)](updateQuestionNav),document[_0x24289d(0x3e7)](_0x25cb37['mrJtA'])[_0x24289d(0x317)]=_0x25cb37['rYUew'](currentQuestionIndex,0x0),document[_0x24289d(0x3e7)](_0x24289d(0x3c9))[_0x24289d(0x3b5)]['add'](_0x25cb37['GukxZ']),document[_0x24289d(0x3e7)]('questionText')[_0x24289d(0x1ef)]=_0x5223e9[_0x24289d(0x37a)]||_0x25cb37[_0x24289d(0x146)];let _0x4a634c='';if(_0x5223e9['question_audio'])_0x4a634c+=_0x24289d(0x2e5)+_0x5223e9[_0x24289d(0x180)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';if(_0x5223e9[_0x24289d(0x3e6)])_0x4a634c+=_0x24289d(0x1f3)+_0x5223e9[_0x24289d(0x3e6)]+_0x24289d(0x3a0);_0x5223e9[_0x24289d(0x2da)]&&(_0x24289d(0x33e)!==_0x24289d(0x33e)?_0x25cb37['Wrooh'](_0x54a155,_0x24289d(0x257))&&(_0x286bdd[_0x24289d(0x1ba)][_0x24289d(0x385)][_0x24289d(0x36b)](_0x24289d(0x1d0))&&_0x4274ad[_0x24289d(0x28b)](_0x25cb37[_0x24289d(0x157)]),_0x25cb37[_0x24289d(0x217)](_0x17cd91),_0x58d9c0[_0x24289d(0x1e2)]()):_0x5223e9['question_images']['forEach'](_0xff2365=>{const _0x2afc52=_0x24289d;if(_0x25cb37['LPWSx'](_0x25cb37[_0x2afc52(0x2e8)],_0x25cb37['OjfXi'])){if(_0xff2365)_0x4a634c+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22'+_0xff2365+_0x2afc52(0x136);}else{const _0x3575da=_0x97100[_0x2afc52(0x311)](_0x25cb37[_0x2afc52(0x1c3)](0x41,_0x3513bc)),_0x3fb68f=_0x25cb37['GPwSt'](_0x599470,_0x1e567f),_0x336d54=_0x1d441d['createElement'](_0x25cb37['xQEez']);_0x336d54[_0x2afc52(0x1ef)]=_0x2afc52(0x3ad)+(_0x3fb68f?_0x25cb37['dyGBv']:'')+_0x2afc52(0x277)+_0x53fc71+_0x2afc52(0x206)+_0x3575da+_0x2afc52(0x361)+(_0x557618[_0x2afc52(0x37a)]||_0x25cb37[_0x2afc52(0x34b)]+_0x25cb37[_0x2afc52(0x1c3)](_0x41fc74,0x1))+_0x2afc52(0x158),_0x4e7332['appendChild'](_0x336d54);}}));document[_0x24289d(0x3e7)](_0x25cb37[_0x24289d(0x1a0)])[_0x24289d(0x1ef)]=_0x4a634c;const _0x43c7ae=document[_0x24289d(0x3e7)](_0x24289d(0x25d));_0x43c7ae[_0x24289d(0x1ef)]='',_0x43c7ae[_0x24289d(0x3b5)][_0x24289d(0x1bc)](_0x25cb37['YXfWM']),_0x5223e9[_0x24289d(0x34e)]&&Array[_0x24289d(0x35b)](_0x5223e9[_0x24289d(0x34e)])&&(_0x5223e9[_0x24289d(0x34e)]['forEach']((_0x313307,_0x140d95)=>{const _0x4ae663=_0x24289d;if(_0x25cb37['vDsKx'](_0x25cb37[_0x4ae663(0x201)],_0x25cb37['HzGYK'])){if(_0x3daa4c)return;const _0x590b0b=_0x5b4189[_0x4ae663(0x388)](_0x36bec9['getItem'](_0x25cb37[_0x4ae663(0x336)]))||{};_0x590b0b[_0xd4fd4b]={'questionStates':_0x5b8830,'stats':_0x5a7164,'currentQuestionIndex':_0x382df9,'currentMode':_0x53c6af,'status':_0x25cb37[_0x4ae663(0x238)],'lastSeen':new _0x3f2833()[_0x4ae663(0x28c)]()},_0x16bcae[_0x4ae663(0x232)](_0x25cb37['oeVRr'],_0x162e88['stringify'](_0x590b0b));}else{const _0x36be4a=String[_0x4ae663(0x311)](_0x25cb37[_0x4ae663(0x1c3)](0x41,_0x140d95)),_0x3f5621=_0x25cb37[_0x4ae663(0x341)](selectedOption,_0x140d95),_0x340cc2=document[_0x4ae663(0x389)](_0x25cb37['xQEez']);_0x340cc2[_0x4ae663(0x1ef)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20'+(_0x3f5621?_0x25cb37[_0x4ae663(0x3ab)]:'')+'\x22\x20data-option-index=\x22'+_0x140d95+_0x4ae663(0x206)+_0x36be4a+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>'+(_0x313307[_0x4ae663(0x37a)]||_0x25cb37[_0x4ae663(0x2e2)](_0x25cb37[_0x4ae663(0x34b)],_0x25cb37[_0x4ae663(0x18c)](_0x140d95,0x1)))+_0x4ae663(0x158),_0x43c7ae[_0x4ae663(0x22b)](_0x340cc2);}}),_0x43c7ae['addEventListener'](_0x24289d(0x249),function(_0x4753df){const _0x2d8a45=_0x24289d,_0x37e7b8={'gknqo':_0x25cb37[_0x2d8a45(0x22e)],'rOotW':function(_0x10312d){return _0x25cb37['ZxEEP'](_0x10312d);},'uhXCj':_0x25cb37[_0x2d8a45(0x2f2)],'ghLNJ':_0x25cb37['CGRJa'],'sxjTh':function(_0x4ba9ba,_0x3dfa92){return _0x25cb37['Wrooh'](_0x4ba9ba,_0x3dfa92);}};if(_0x25cb37[_0x2d8a45(0x2f4)]===_0x2d8a45(0x345)){const _0x58d939=_0x4753df[_0x2d8a45(0x368)][_0x2d8a45(0x2fc)](_0x25cb37[_0x2d8a45(0x2f2)]);if(_0x58d939){if(_0x25cb37['vDsKx'](_0x2d8a45(0x39e),_0x25cb37[_0x2d8a45(0x35e)])){const _0x2aebdb=!_0x5634d2[_0x1905fe][_0x2d8a45(0x39b)];_0xdf7e7e[_0x560104][_0x2d8a45(0x39b)]=_0x2aebdb;let _0x55e679=_0x4a6b35[_0x2d8a45(0x388)](_0x13220b[_0x2d8a45(0x266)](_0x37e7b8[_0x2d8a45(0x32e)]))||[];if(_0x2aebdb){const _0x338332={'quizName':_0x599d50,'quizFile':_0x54808a['location']['pathname'][_0x2d8a45(0x24b)]('/')[_0x2d8a45(0x139)](),'questionIndex':_0x42c15d,'question':_0x323662[_0x4ec2e8],'hierarchy':_0x2fd95b,'timestamp':_0x40464c[_0x2d8a45(0x3dd)]()};_0x55e679['push'](_0x338332);}else _0x55e679=_0x55e679['filter'](_0x3e1099=>!(_0x3e1099['quizFile'][_0x2d8a45(0x19e)](_0x3a12d3['toLowerCase']()[_0x2d8a45(0x149)](/ /g,'-'))&&_0x3e1099['questionIndex']===_0x207c6a));_0x24a8be['setItem'](_0x2d8a45(0x2fd),_0x1007ba[_0x2d8a45(0x3dc)](_0x55e679)),_0x37e7b8[_0x2d8a45(0x38e)](_0x40a487),_0x37e7b8[_0x2d8a45(0x38e)](_0x2e7394);}else{const _0x1fa463=_0x25cb37[_0x2d8a45(0x283)](parseInt,_0x58d939[_0x2d8a45(0x1c7)](_0x25cb37[_0x2d8a45(0x193)]));_0x25cb37[_0x2d8a45(0x283)](selectOption,_0x1fa463);}}}else{const _0x325d72={'KSXUX':function(_0x3b5e90,_0xbc2ac0){return _0x3b5e90+_0xbc2ac0;},'kBtFx':_0x25cb37[_0x2d8a45(0x391)],'FeNLx':_0x25cb37['dyGBv'],'tLXZB':function(_0x1bef08,_0x31345b){return _0x25cb37['mkXMB'](_0x1bef08,_0x31345b);},'NXnBb':_0x25cb37['jzszW']};_0x5cc77f['choices'][_0x2d8a45(0x22f)]((_0x4b3da1,_0x487d58)=>{const _0x2c858b=_0x2d8a45,_0x2a4dea=_0xf609d0[_0x2c858b(0x311)](_0x325d72[_0x2c858b(0x27d)](0x41,_0x487d58)),_0x2769ec=_0x4ba4fe===_0x487d58,_0x5c5ebb=_0x25862a[_0x2c858b(0x389)](_0x325d72[_0x2c858b(0x275)]);_0x5c5ebb['innerHTML']=_0x2c858b(0x3ad)+(_0x2769ec?_0x325d72[_0x2c858b(0x396)]:'')+_0x2c858b(0x277)+_0x487d58+_0x2c858b(0x206)+_0x2a4dea+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>'+(_0x4b3da1[_0x2c858b(0x37a)]||_0x325d72[_0x2c858b(0x2bf)](_0x325d72[_0x2c858b(0x2de)],_0x325d72[_0x2c858b(0x27d)](_0x487d58,0x1)))+_0x2c858b(0x158),_0x40b534[_0x2c858b(0x22b)](_0x5c5ebb);}),_0x4a1786[_0x2d8a45(0x2a9)](_0x25cb37[_0x2d8a45(0x25b)],function(_0x3667ab){const _0x4cf056=_0x2d8a45,_0x4c67fc=_0x3667ab['target']['closest'](_0x37e7b8[_0x4cf056(0x1cc)]);if(_0x4c67fc){const _0x365255=_0x4c5dd4(_0x4c67fc[_0x4cf056(0x1c7)](_0x37e7b8['ghLNJ']));_0x37e7b8[_0x4cf056(0x2a8)](_0x272a1d,_0x365255);}});}})),_0x25cb37[_0x24289d(0x1f1)](updateBookmarkButton),updateMarkReviewButton(),(_0x25cb37[_0x24289d(0x15e)](currentMode,_0x24289d(0x351))||_0x25cb37['rYUew'](currentMode,_0x25cb37[_0x24289d(0x2dd)]))&&!isQuizCompleted&&(_0x25cb37['LPWSx'](_0x24289d(0x30f),_0x25cb37[_0x24289d(0x2c5)])?_0x25cb37[_0x24289d(0x1f1)](startTimer):_0x522524[_0x30ac7e[_0x24289d(0x211)]][_0x24289d(0x39b)]=!![]);}function _0x5d42(_0x31eabc,_0x1ac344){const _0x5ba3fe=_0x1ca1();return _0x5d42=function(_0x1a3a8c,_0x539883){_0x1a3a8c=_0x1a3a8c-0x136;let _0x2a4212=_0x5ba3fe[_0x1a3a8c];return _0x2a4212;},_0x5d42(_0x31eabc,_0x1ac344);}function selectOption(_0x5ae9ea){const _0x44df9f=_0x31277a,_0x142e75={'TNQDu':function(_0x99fc89){return _0x99fc89();},'uazok':'modeModal','NOuon':function(_0x27f95b,_0x3f3474){return _0x27f95b===_0x3f3474;},'IXcPW':_0x44df9f(0x228),'UEtle':'selected','vukOA':function(_0x560f60,_0xa52bef){return _0x560f60===_0xa52bef;},'OiVYw':_0x44df9f(0x2c7),'xTRFa':function(_0x32789a,_0x588b90){return _0x32789a<_0x588b90;},'dVuGL':_0x44df9f(0x196),'Yvbhx':function(_0x49289c,_0x2214a9){return _0x49289c+_0x2214a9;},'pWWvd':_0x44df9f(0x25d),'qrXTI':'answered','GNKCE':'XlFMH','xLtrK':_0x44df9f(0x187),'XRUCZ':_0x44df9f(0x268),'BKCGw':_0x44df9f(0x351),'WMXVa':'iDxoG','DczIK':_0x44df9f(0x231),'aklSq':function(_0x50f799,_0x1cf170){return _0x50f799===_0x1cf170;},'vQLKh':'not_attempted','UzPkj':function(_0x39af05){return _0x39af05();}},_0x18533=document[_0x44df9f(0x3e7)](_0x142e75[_0x44df9f(0x37c)]);if(_0x18533[_0x44df9f(0x3b5)][_0x44df9f(0x2c8)](_0x142e75[_0x44df9f(0x16c)]))return;questionStartTime&&(_0x142e75[_0x44df9f(0x186)](_0x142e75[_0x44df9f(0x343)],_0x142e75[_0x44df9f(0x343)])?(questionStates[currentQuestionIndex][_0x44df9f(0x3e1)]+=Date[_0x44df9f(0x3dd)]()-questionStartTime,questionStartTime=Date[_0x44df9f(0x3dd)]()):(_0x142e75[_0x44df9f(0x181)](_0x1cece6),_0x35ef52[_0x44df9f(0x3e7)](_0x142e75['uazok'])[_0x44df9f(0x256)][_0x44df9f(0x23b)]=_0x44df9f(0x3a6)));selectedOption=_0x5ae9ea,questionStates[currentQuestionIndex][_0x44df9f(0x382)]=_0x5ae9ea,document[_0x44df9f(0x2e4)](_0x142e75[_0x44df9f(0x26e)])[_0x44df9f(0x22f)]((_0x5b4273,_0x19217f)=>{const _0x129b8b=_0x44df9f,_0x79ae81={'CNIDb':function(_0x5ad4f8,_0x1ceec2){return _0x5ad4f8<_0x1ceec2;}};_0x142e75[_0x129b8b(0x186)](_0x142e75[_0x129b8b(0x3d9)],_0x129b8b(0x29e))?_0x79ae81[_0x129b8b(0x179)](_0x50709d[_0x129b8b(0x211)],_0xdfc972[_0x129b8b(0x237)])&&(_0x432a93[_0x3c4f0f[_0x129b8b(0x211)]][_0x129b8b(0x39b)]=!![]):_0x5b4273[_0x129b8b(0x3b5)]['toggle'](_0x142e75[_0x129b8b(0x301)],_0x142e75[_0x129b8b(0x1e1)](_0x19217f,_0x5ae9ea));});if(_0x142e75[_0x44df9f(0x1e1)](currentMode,_0x142e75[_0x44df9f(0x3a8)])||_0x142e75[_0x44df9f(0x1e1)](currentMode,_0x142e75['BKCGw']))_0x142e75['TNQDu'](processAnswer);else{if(_0x142e75['NOuon'](_0x142e75[_0x44df9f(0x1d7)],_0x142e75[_0x44df9f(0x20c)])){const _0x370d36=_0x4b1689[_0x44df9f(0x3e7)](_0x142e75[_0x44df9f(0x3a1)]);_0x370d36['innerHTML']='';for(let _0x2d357d=0x0;_0x142e75['xTRFa'](_0x2d357d,_0x341b32[_0x44df9f(0x237)]);_0x2d357d++){const _0x127e82=_0x186d6e[_0x44df9f(0x389)](_0x142e75[_0x44df9f(0x2a1)]);_0x127e82[_0x44df9f(0x177)]=_0x142e75['Yvbhx'](_0x2d357d,0x1),_0x127e82[_0x44df9f(0x36a)]=_0x44df9f(0x315),_0x127e82[_0x44df9f(0x1d4)]=()=>_0x2556f2(_0x2d357d),_0x127e82['id']='navBtn_'+_0x2d357d,_0x370d36['appendChild'](_0x127e82);}_0x5c0367();}else _0x142e75[_0x44df9f(0x26b)](questionStates[currentQuestionIndex][_0x44df9f(0x371)],_0x142e75[_0x44df9f(0x3e9)])&&(questionStates[currentQuestionIndex][_0x44df9f(0x371)]=_0x142e75[_0x44df9f(0x16c)],stats[_0x44df9f(0x373)]++,stats[_0x44df9f(0x258)]--),_0x142e75[_0x44df9f(0x372)](updateQuestionNav);}saveProgress();}function processAnswer(){const _0x1f6a11=_0x31277a,_0x25161e={'ULnAb':function(_0xcd528d,_0x183883){return _0xcd528d===_0x183883;},'Glivr':function(_0x4610b9,_0x30db2d){return _0x4610b9===_0x30db2d;},'htWaX':_0x1f6a11(0x3c0),'PNCXk':'correct','zXuJU':function(_0x444073){return _0x444073();},'vYQPA':function(_0x12e8fd,_0xc8c9a4){return _0x12e8fd(_0xc8c9a4);}},_0x794c75=questionsData[currentQuestionIndex],_0xf5c2c5=_0x794c75['correct_choice_id'];if(_0x25161e[_0x1f6a11(0x166)](selectedOption,null))return;const _0x54d921=_0x794c75[_0x1f6a11(0x34e)][selectedOption],_0x2c9372=_0x25161e['ULnAb'](_0x54d921['id'],_0xf5c2c5);if(_0x25161e['Glivr'](questionStates[currentQuestionIndex][_0x1f6a11(0x371)],_0x25161e[_0x1f6a11(0x302)])){stats[_0x1f6a11(0x373)]++,stats[_0x1f6a11(0x258)]--;if(_0x2c9372)stats[_0x1f6a11(0x1c4)]++;else stats[_0x1f6a11(0x1fe)]++;}questionStates[currentQuestionIndex]['status']=_0x2c9372?_0x25161e['PNCXk']:_0x1f6a11(0x16e),_0x25161e[_0x1f6a11(0x250)](updateStats),_0x25161e[_0x1f6a11(0x3c1)](showInlineFeedback,_0x2c9372),updateQuestionNav();}function showInlineFeedback(_0x20ecaf){const _0x3630a5=_0x31277a,_0x1e2b3c={'FoCoU':function(_0x6e291,_0x5ab62d){return _0x6e291!==_0x5ab62d;},'fDoIZ':'MdaUa','RTuKj':_0x3630a5(0x2d1),'JbwIZ':function(_0x307170,_0x2532e1){return _0x307170===_0x2532e1;},'dOZGK':_0x3630a5(0x397),'Ztcma':function(_0x5417ef,_0x472e2f){return _0x5417ef!==_0x472e2f;},'pPdHW':_0x3630a5(0x268),'HtTyz':_0x3630a5(0x351),'cWJNM':'optionsContainer','hSGiT':_0x3630a5(0x19f),'zxAKC':function(_0x15d7fd){return _0x15d7fd();}};if(_0x1e2b3c[_0x3630a5(0x2ef)](currentMode,_0x1e2b3c[_0x3630a5(0x30a)])&&_0x1e2b3c[_0x3630a5(0x399)](currentMode,_0x1e2b3c[_0x3630a5(0x1ca)]))return;const _0x43c91b=document[_0x3630a5(0x3e7)](_0x1e2b3c[_0x3630a5(0x2f1)]),_0x3da2f3=_0x43c91b[_0x3630a5(0x2e4)]('.option-button'),_0x5bacf6=questionsData[currentQuestionIndex],_0x328697=_0x5bacf6['correct_choice_id'];let _0x2342d8=_0x5bacf6[_0x3630a5(0x34e)][_0x3630a5(0x15b)](_0x294d98=>_0x294d98['id']===_0x328697);_0x43c91b['classList'][_0x3630a5(0x3f1)](_0x1e2b3c[_0x3630a5(0x3b7)]),_0x3da2f3['forEach']((_0x26b3a0,_0x11f0da)=>{const _0x4cc73e=_0x3630a5;if(_0x1e2b3c[_0x4cc73e(0x399)](_0x1e2b3c[_0x4cc73e(0x1f9)],_0x1e2b3c[_0x4cc73e(0x1f9)]))_0x510397=_0x4cc73e(0x247);else{_0x26b3a0[_0x4cc73e(0x3b5)][_0x4cc73e(0x1bc)](_0x1e2b3c[_0x4cc73e(0x246)]);if(_0x1e2b3c[_0x4cc73e(0x2bd)](_0x11f0da,_0x2342d8))_0x26b3a0[_0x4cc73e(0x3b5)][_0x4cc73e(0x3f1)](_0x1e2b3c[_0x4cc73e(0x3a7)]);else{if(_0x11f0da===selectedOption&&!_0x20ecaf)_0x26b3a0['classList'][_0x4cc73e(0x3f1)](_0x4cc73e(0x16e));}}}),_0x1e2b3c[_0x3630a5(0x159)](showSolution);}function showSolution(){const _0xc1f188=_0x31277a,_0x5acc92={'rgqCH':function(_0x128e17,_0x5a4ddb){return _0x128e17!==_0x5a4ddb;},'lqWye':'study','rsXBA':_0xc1f188(0x208),'Bjqxt':_0xc1f188(0x39f),'AwBIa':_0xc1f188(0x3d6),'yxhJe':_0xc1f188(0x3cc),'cNkfn':'.m3u8','Vcqcx':function(_0x4fddb7,_0x51dd3b,_0x24e4fe){return _0x4fddb7(_0x51dd3b,_0x24e4fe);},'SVAAl':_0xc1f188(0x141),'FEQBp':'OowJH','WOMak':_0xc1f188(0x24a),'Kxord':'solutionImages','FKhxY':_0xc1f188(0x3c9)};if(_0x5acc92[_0xc1f188(0x3aa)](currentMode,_0x5acc92[_0xc1f188(0x31b)])&&currentMode!==_0xc1f188(0x351))return;const _0x29a1d5=questionsData[currentQuestionIndex];document['getElementById'](_0x5acc92[_0xc1f188(0x261)])[_0xc1f188(0x1ef)]=_0x29a1d5[_0xc1f188(0x1ff)]||_0x5acc92[_0xc1f188(0x37d)];const _0x19abec=document[_0xc1f188(0x3e7)]('solutionVideo'),_0x33bf83=document[_0xc1f188(0x3e7)](_0x5acc92[_0xc1f188(0x32f)]),_0x31da3c=_0x29a1d5[_0xc1f188(0x2f3)];if(_0x31da3c){_0x19abec[_0xc1f188(0x3b5)][_0xc1f188(0x1bc)](_0x5acc92[_0xc1f188(0x2db)]);if(_0x31da3c['includes'](_0x5acc92[_0xc1f188(0x3e0)]))_0x5acc92['Vcqcx'](setupVideo,_0x33bf83,_0x31da3c);else _0x33bf83[_0xc1f188(0x34d)]=_0x31da3c;}else _0x5acc92[_0xc1f188(0x137)]===_0x5acc92[_0xc1f188(0x2c6)]?_0x37ad25[_0xc1f188(0x3b5)][_0xc1f188(0x3f1)](_0xc1f188(0x3cc)):_0x19abec[_0xc1f188(0x3b5)][_0xc1f188(0x3f1)](_0x5acc92[_0xc1f188(0x2db)]);const _0x2a9a55=document[_0xc1f188(0x3e7)](_0x5acc92[_0xc1f188(0x216)]);_0x2a9a55['innerHTML']='';_0x29a1d5[_0xc1f188(0x1e7)]&&(_0x2a9a55[_0xc1f188(0x1ef)]+=_0xc1f188(0x1ae)+_0x29a1d5[_0xc1f188(0x1e7)]+_0xc1f188(0x2c1));_0x29a1d5['explanation_audio_hin']&&(_0x2a9a55[_0xc1f188(0x1ef)]+=_0xc1f188(0x17c)+_0x29a1d5[_0xc1f188(0x278)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>');const _0x57ca92=document[_0xc1f188(0x3e7)](_0x5acc92[_0xc1f188(0x23e)]);_0x57ca92['innerHTML']='',_0x29a1d5['explanation_images']&&_0x29a1d5['explanation_images']['forEach'](_0x4c0e09=>{const _0x8e9995=_0xc1f188;if(_0x4c0e09)_0x57ca92['innerHTML']+=_0x8e9995(0x282)+_0x4c0e09+_0x8e9995(0x327);}),document[_0xc1f188(0x3e7)](_0x5acc92[_0xc1f188(0x3bf)])[_0xc1f188(0x3b5)][_0xc1f188(0x1bc)](_0x5acc92['yxhJe']);}function submitQuiz(){const _0x883823=_0x31277a,_0x4accd9={'cdMOx':_0x883823(0x235),'FlFRC':_0x883823(0x309),'pdsyD':function(_0x10c259){return _0x10c259();},'uzGiH':function(_0x46edc5,_0x3e7009){return _0x46edc5!==_0x3e7009;},'MADtA':_0x883823(0x199),'NkSQD':function(_0x3b36ce,_0x26f8bf){return _0x3b36ce!==_0x26f8bf;},'xTKbk':'FPNrB','WMeEE':function(_0x9c5fd1,_0xeab348){return _0x9c5fd1!==_0xeab348;},'NLYzB':_0x883823(0x3ec),'xOjsU':'correct','uizkr':function(_0xf17f83,_0x1c591f){return _0xf17f83(_0x1c591f);},'FZEyu':'Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','GlwOR':function(_0x28373f,_0x445148){return _0x28373f-_0x445148;},'BCUAc':function(_0x306a3d,_0x53a163){return _0x306a3d-_0x53a163;},'EuRrk':function(_0x301331,_0x4b0888){return _0x301331+_0x4b0888;},'nTjuG':'quizPerformanceData','HvoOW':function(_0x47d178,_0x4067b5,_0x2ed4c3,_0x19866c,_0x3493a6){return _0x47d178(_0x4067b5,_0x2ed4c3,_0x19866c,_0x3493a6);}};if(timer)_0x4accd9[_0x883823(0x27c)](clearInterval,timer);if(!confirm(_0x4accd9[_0x883823(0x358)]))return;isQuizCompleted=!![];let _0x513eb5=0x0,_0x2906a0=0x0;const _0x174245=_0x4accd9[_0x883823(0x338)](Date[_0x883823(0x3dd)](),quizStartTime);questionsData['forEach']((_0x5e7663,_0x3a6dfb)=>{const _0x1e4f6a=_0x883823;if(_0x4accd9[_0x1e4f6a(0x38a)](_0x1e4f6a(0x2d2),_0x4accd9[_0x1e4f6a(0x184)])){const _0x21e3d0=questionStates[_0x3a6dfb];if(_0x4accd9[_0x1e4f6a(0x38a)](_0x21e3d0[_0x1e4f6a(0x382)],null)){if(_0x4accd9['NkSQD'](_0x1e4f6a(0x3fe),_0x4accd9[_0x1e4f6a(0x251)])){if(_0x5e7663[_0x1e4f6a(0x34e)][_0x21e3d0['selectedAnswer']]['id']===_0x5e7663[_0x1e4f6a(0x352)]){if(_0x4accd9['WMeEE']('ZTUwE',_0x4accd9[_0x1e4f6a(0x241)]))_0x513eb5++,_0x21e3d0[_0x1e4f6a(0x371)]=_0x4accd9[_0x1e4f6a(0x25f)];else{const _0x9bb8b8=_0x4934c0?function(){const _0x2fb75b=_0x1e4f6a;if(_0x1640b6){const _0x1607c6=_0x2ad7d2[_0x2fb75b(0x14d)](_0x401761,arguments);return _0x41f1c7=null,_0x1607c6;}}:function(){};return _0xd1f05f=![],_0x9bb8b8;}}else _0x2906a0++,_0x21e3d0[_0x1e4f6a(0x371)]=_0x1e4f6a(0x16e);}else{const _0x5de514=_0x13e225[_0x1e4f6a(0x388)](_0x2444c6[_0x1e4f6a(0x266)](_0x4accd9['cdMOx']))||{},_0x1a8788=_0x5de514[_0x1192f6];if(_0x1a8788)return _0x373c85=_0x1a8788[_0x1e4f6a(0x37f)],_0x5bdb93=_0x1a8788[_0x1e4f6a(0x14e)],_0x25f8bf=_0x1a8788[_0x1e4f6a(0x2c9)],_0x14daff=_0x1a8788[_0x1e4f6a(0x1be)],_0x54ee1b['log'](_0x4accd9[_0x1e4f6a(0x194)]),!![];return![];}}}else _0x4accd9[_0x1e4f6a(0x14c)](_0x306a2a);});const _0x4e1049=JSON[_0x883823(0x388)](localStorage[_0x883823(0x266)]('quizPerformanceData'))||[];_0x4e1049[_0x883823(0x1cb)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date['now'](),'totalTime':_0x174245,'stats':{'correct':_0x513eb5,'incorrect':_0x2906a0,'notAttempted':_0x4accd9[_0x883823(0x2f6)](questionsData[_0x883823(0x237)],_0x4accd9[_0x883823(0x3b3)](_0x513eb5,_0x2906a0))}}),localStorage[_0x883823(0x232)](_0x4accd9['nTjuG'],JSON[_0x883823(0x3dc)](_0x4e1049)),stats['correctAnswers']=_0x513eb5,stats[_0x883823(0x1fe)]=_0x2906a0,markQuizAsCompleted(),_0x4accd9[_0x883823(0x2ce)](showPerformanceAnalysis,_0x513eb5,_0x2906a0,_0x4accd9[_0x883823(0x338)](questionsData[_0x883823(0x237)],_0x4accd9[_0x883823(0x3b3)](_0x513eb5,_0x2906a0)),_0x174245);}function showPerformanceAnalysis(_0x329581,_0x4291a2,_0x373ba0,_0x330887){const _0x5d4a17=_0x31277a,_0x2acccc={'KVHAj':_0x5d4a17(0x3f8),'LtZui':function(_0x166b8b,_0x92a189){return _0x166b8b>_0x92a189;},'UyRpC':function(_0x29a9dd,_0x5110c1){return _0x29a9dd/_0x5110c1;},'TIjWL':function(_0x2ad7e0,_0x3f1d4c){return _0x2ad7e0+_0x3f1d4c;},'zLEmH':function(_0x376b34,_0x569d68){return _0x376b34*_0x569d68;},'QQaDJ':function(_0x4337be,_0x332c6a){return _0x4337be*_0x332c6a;},'SyUTl':'accuracyScore','Exvcj':_0x5d4a17(0x168),'NZMwj':_0x5d4a17(0x15a),'gRlLB':_0x5d4a17(0x1f5),'slVIv':_0x5d4a17(0x366),'LJbXz':function(_0x59e9df,_0x4fe1e9){return _0x59e9df/_0x4fe1e9;},'ZTQac':function(_0x305dc4,_0x3fcc2b){return _0x305dc4%_0x3fcc2b;},'lgsRn':_0x5d4a17(0x33c),'vQpJZ':function(_0x35bcb8,_0xb6a70d){return _0x35bcb8/_0xb6a70d;},'zNhSH':function(_0x381736,_0x5dd178){return _0x381736%_0x5dd178;},'BypXk':_0x5d4a17(0x3cc)},_0x411fdd=document[_0x5d4a17(0x3e7)](_0x2acccc[_0x5d4a17(0x393)]),_0xca3cdc=_0x2acccc[_0x5d4a17(0x3a9)](_0x329581+_0x4291a2,0x0)?Math[_0x5d4a17(0x272)](_0x2acccc[_0x5d4a17(0x219)](_0x329581,_0x2acccc['TIjWL'](_0x329581,_0x4291a2))*0x64):0x0,_0xc68c35=_0x2acccc[_0x5d4a17(0x3be)](_0x2acccc['QQaDJ'](0x2,Math['PI']),0x41),_0x552f46=document[_0x5d4a17(0x3e7)]('scoreCircle');_0x552f46['style'][_0x5d4a17(0x3fd)]=_0xc68c35+'\x20'+_0xc68c35,_0x552f46[_0x5d4a17(0x256)][_0x5d4a17(0x29d)]=_0xc68c35-_0x2acccc[_0x5d4a17(0x219)](_0xca3cdc,0x64)*_0xc68c35,document['getElementById'](_0x2acccc[_0x5d4a17(0x26a)])[_0x5d4a17(0x177)]=_0xca3cdc+'%',document[_0x5d4a17(0x3e7)](_0x2acccc['Exvcj'])[_0x5d4a17(0x177)]=questionsData['length'],document['getElementById'](_0x2acccc['NZMwj'])['textContent']=_0x329581,document[_0x5d4a17(0x3e7)](_0x2acccc[_0x5d4a17(0x349)])['textContent']=_0x4291a2,document[_0x5d4a17(0x3e7)](_0x2acccc[_0x5d4a17(0x1f6)])[_0x5d4a17(0x177)]=_0x373ba0;const _0x4f7886=Math['floor'](_0x2acccc[_0x5d4a17(0x2d0)](_0x330887,0xea60)),_0x4ba16f=Math['floor'](_0x2acccc[_0x5d4a17(0x2d0)](_0x2acccc[_0x5d4a17(0x319)](_0x330887,0xea60),0x3e8));document[_0x5d4a17(0x3e7)](_0x2acccc['lgsRn'])[_0x5d4a17(0x177)]=_0x4f7886+':'+_0x4ba16f[_0x5d4a17(0x267)]()['padStart'](0x2,'0');const _0x5224b7=_0x2acccc[_0x5d4a17(0x153)](_0x330887,questionsData[_0x5d4a17(0x237)]),_0x36497f=Math[_0x5d4a17(0x1b3)](_0x2acccc[_0x5d4a17(0x153)](_0x5224b7,0xea60)),_0x187aa1=Math[_0x5d4a17(0x1b3)](_0x2acccc[_0x5d4a17(0x219)](_0x2acccc['zNhSH'](_0x5224b7,0xea60),0x3e8));document[_0x5d4a17(0x3e7)](_0x5d4a17(0x270))[_0x5d4a17(0x177)]=_0x36497f+':'+_0x187aa1[_0x5d4a17(0x267)]()[_0x5d4a17(0x1eb)](0x2,'0'),_0x411fdd[_0x5d4a17(0x3b5)][_0x5d4a17(0x1bc)](_0x2acccc['BypXk']);}function closePerformanceModal(){const _0xe2a15d=_0x31277a,_0x1891e6={'TaTJW':_0xe2a15d(0x3cc)};document[_0xe2a15d(0x3e7)](_0xe2a15d(0x3f8))[_0xe2a15d(0x3b5)][_0xe2a15d(0x3f1)](_0x1891e6[_0xe2a15d(0x38b)]);}function reviewQuestions(){const _0xf37c83=_0x31277a,_0x15601d={'oafqg':function(_0x1f0325,_0x3ac84e){return _0x1f0325===_0x3ac84e;},'SbiGk':'border-gray-600','XPIrb':_0xf37c83(0x3d3),'nJVAk':_0xf37c83(0x293),'LsMDo':function(_0x1f6cec,_0x278d9f){return _0x1f6cec!==_0x278d9f;},'ZsPlR':_0xf37c83(0x397),'cvfSq':_0xf37c83(0x3ff),'sfCaV':_0xf37c83(0x3d0),'jzeok':'green','uUxnk':function(_0x3c5831,_0x176617){return _0x3c5831===_0x176617;},'xgEQp':'incorrect','tjkhm':_0xf37c83(0x3df),'iQgMl':'gray','AOFbL':'No\x20solution\x20available.','RCIvu':'questionReviewSection','HpQHT':_0xf37c83(0x3cc),'ghvlW':_0xf37c83(0x2ea),'SbeFo':function(_0x19d227){return _0x19d227();}};document[_0xf37c83(0x3e7)](_0x15601d[_0xf37c83(0x245)])[_0xf37c83(0x3b5)][_0xf37c83(0x1bc)](_0x15601d[_0xf37c83(0x19d)]);const _0x2c6a24=document['getElementById'](_0x15601d[_0xf37c83(0x2a7)]);_0x2c6a24[_0xf37c83(0x1ef)]='',questionsData[_0xf37c83(0x22f)]((_0x3ce807,_0x5be699)=>{const _0x242cc2=_0xf37c83,_0x1f3585={'IDxxW':function(_0x290a53,_0x3d9af2){return _0x15601d['oafqg'](_0x290a53,_0x3d9af2);},'bfJKG':function(_0x18182e,_0xc0de52){return _0x18182e===_0xc0de52;},'byBns':_0x15601d[_0x242cc2(0x169)],'azbNB':_0x15601d[_0x242cc2(0x2fa)],'GFjhR':function(_0x128fb2,_0x39b718){return _0x128fb2+_0x39b718;}},_0x1cc978=questionStates[_0x5be699],_0x56b767=_0x3ce807[_0x242cc2(0x352)];let _0x12a396=_0x242cc2(0x346),_0x572cb5=_0x15601d[_0x242cc2(0x274)];if(_0x15601d[_0x242cc2(0x1e0)](_0x1cc978['selectedAnswer'],null)){const _0x114a66=_0x3ce807[_0x242cc2(0x34e)][_0x1cc978['selectedAnswer']];_0x15601d[_0x242cc2(0x151)](_0x114a66['id'],_0x56b767)?(_0x12a396=_0x15601d['ZsPlR'],_0x572cb5=_0x15601d[_0x242cc2(0x390)]):(_0x12a396=_0x242cc2(0x16e),_0x572cb5=_0x242cc2(0x185));}const _0x32b668=document[_0x242cc2(0x389)](_0x15601d['sfCaV']);_0x32b668[_0x242cc2(0x36a)]=_0x242cc2(0x1aa)+_0x12a396;let _0x62449f=(_0x3ce807['choices']||[])[_0x242cc2(0x296)]((_0x2810b1,_0x5791fa)=>{const _0x43e45a=_0x242cc2,_0x18754d=_0x1f3585[_0x43e45a(0x239)](_0x1cc978[_0x43e45a(0x382)],_0x5791fa),_0x35ec2b=_0x1f3585[_0x43e45a(0x281)](_0x2810b1['id'],_0x56b767);let _0x19717a=_0x1f3585['byBns'];if(_0x35ec2b)_0x19717a=_0x1f3585[_0x43e45a(0x3d4)];else{if(_0x18754d)_0x19717a=_0x43e45a(0x280);}return _0x43e45a(0x3ea)+_0x19717a+'\x22><span\x20class=\x22font-bold\x20mr-3\x22>'+String[_0x43e45a(0x311)](_0x1f3585['GFjhR'](0x41,_0x5791fa))+_0x43e45a(0x30c)+_0x2810b1['text']+_0x43e45a(0x2c4);})[_0x242cc2(0x3da)]('');const _0x1d2783=_0x3ce807[_0x242cc2(0x2f3)]?_0x242cc2(0x1f8)+_0x5be699+'\x22\x20data-src=\x22'+_0x3ce807[_0x242cc2(0x2f3)]+_0x242cc2(0x1fb):'';let _0x41198b='';if(_0x3ce807[_0x242cc2(0x1e7)])_0x41198b+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22'+_0x3ce807['explanation_audio_eng']+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';if(_0x3ce807['explanation_audio_hin'])_0x41198b+=_0x242cc2(0x3a2)+_0x3ce807[_0x242cc2(0x278)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';let _0x177f93=(_0x3ce807[_0x242cc2(0x285)]||[])[_0x242cc2(0x296)](_0x2b6c58=>_0x2b6c58?'<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x2b6c58+_0x242cc2(0x327):'')[_0x242cc2(0x3da)]('');_0x32b668[_0x242cc2(0x1ef)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20'+(_0x5be699+0x1)+_0x242cc2(0x203)+(_0x12a396===_0x15601d[_0x242cc2(0x1b2)]?_0x15601d[_0x242cc2(0x2b4)]:_0x15601d[_0x242cc2(0x304)](_0x12a396,_0x15601d[_0x242cc2(0x226)])?_0x15601d[_0x242cc2(0x378)]:_0x15601d['iQgMl'])+_0x242cc2(0x337)+_0x572cb5+'</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>'+_0x3ce807[_0x242cc2(0x37a)]+_0x242cc2(0x340)+_0x62449f+_0x242cc2(0x1c2)+(_0x3ce807['solution']||_0x15601d[_0x242cc2(0x360)])+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x1d2783+_0x242cc2(0x19b)+_0x41198b+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x177f93+_0x242cc2(0x333),_0x2c6a24[_0x242cc2(0x22b)](_0x32b668);}),_0x15601d[_0xf37c83(0x204)](initializeReviewVideos);}function initializeReviewVideos(){const _0xd5cd2a=_0x31277a,_0x3731b8={'cEUjm':'.m3u8','YCbHO':function(_0xae69c1,_0x570fdd,_0x3cfbcf){return _0xae69c1(_0x570fdd,_0x3cfbcf);}};document[_0xd5cd2a(0x2e4)]('video[data-src]')[_0xd5cd2a(0x22f)](_0x30eed6=>{const _0x1bd206=_0xd5cd2a,_0x3bd759=_0x30eed6[_0x1bd206(0x26d)]['src'];if(_0x3bd759&&_0x3bd759[_0x1bd206(0x19e)](_0x3731b8['cEUjm']))_0x3731b8[_0x1bd206(0x200)](setupVideo,_0x30eed6,_0x3bd759);else _0x3bd759&&(_0x30eed6[_0x1bd206(0x34d)]=_0x3bd759);});}function retakeQuiz(){const _0x3cdd58=_0x31277a,_0x252e08={'yUYnN':function(_0x2a5d81,_0x191a58){return _0x2a5d81(_0x191a58);},'lsPXV':_0x3cdd58(0x257),'vyydG':_0x3cdd58(0x1d0)};_0x252e08[_0x3cdd58(0x2ff)](confirm,_0x252e08[_0x3cdd58(0x2ad)])&&(window[_0x3cdd58(0x1ba)]['pathname'][_0x3cdd58(0x36b)](_0x252e08[_0x3cdd58(0x3d1)])&&localStorage[_0x3cdd58(0x28b)](_0x3cdd58(0x3ee)),clearProgress(),location[_0x3cdd58(0x1e2)]());}function loadBookmarkedQuestions(){const _0x1ebb07=_0x31277a,_0x27a43f={'cNjIJ':function(_0x356bfb,_0x9bf2bd){return _0x356bfb===_0x9bf2bd;},'tcvgN':_0x1ebb07(0x397),'Gggvl':_0x1ebb07(0x294),'euceY':'incorrect','qeJrM':'nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','avoFu':function(_0x36f224,_0x2d82b3){return _0x36f224<_0x2d82b3;},'gqaMc':function(_0x4f93fb,_0xa3ffdf){return _0x4f93fb===_0xa3ffdf;},'hCeWu':_0x1ebb07(0x271)},_0x3e2fda=JSON[_0x1ebb07(0x388)](localStorage[_0x1ebb07(0x266)](_0x1ebb07(0x2fd)))||[];_0x3e2fda['forEach'](_0x8649f=>{const _0xc89c59=_0x1ebb07;if(_0x8649f[_0xc89c59(0x1db)][_0xc89c59(0x19e)](quizName[_0xc89c59(0x21b)]()[_0xc89c59(0x149)](/ /g,'-'))){if(_0x27a43f['avoFu'](_0x8649f[_0xc89c59(0x211)],questionsData['length'])){if(_0x27a43f['gqaMc'](_0xc89c59(0x271),_0x27a43f[_0xc89c59(0x260)]))questionStates[_0x8649f['questionIndex']][_0xc89c59(0x39b)]=!![];else{if(_0x27a43f['cNjIJ'](_0xef0177['status'],_0x27a43f[_0xc89c59(0x1b0)]))_0x57d3bf=_0x27a43f[_0xc89c59(0x1c6)];else{if(_0x27a43f['cNjIJ'](_0x5e583e[_0xc89c59(0x371)],_0x27a43f['euceY']))_0xf52caf=_0xc89c59(0x224);else _0x181e51=_0x27a43f[_0xc89c59(0x1c0)];}}}}});}function toggleBookmark(){const _0x2d1734=_0x31277a,_0x3ce1da={'gqzft':_0x2d1734(0x309),'YwDwn':_0x2d1734(0x2fd),'xJMnz':function(_0x48f10d,_0x4a2bdd){return _0x48f10d!==_0x4a2bdd;},'npJxr':_0x2d1734(0x192),'UlpVe':_0x2d1734(0x264),'jPPwW':_0x2d1734(0x2e0),'KsFzF':function(_0x1ab075){return _0x1ab075();}},_0x34d4a3=!questionStates[currentQuestionIndex][_0x2d1734(0x39b)];questionStates[currentQuestionIndex][_0x2d1734(0x39b)]=_0x34d4a3;let _0x19099d=JSON[_0x2d1734(0x388)](localStorage[_0x2d1734(0x266)](_0x3ce1da[_0x2d1734(0x2f7)]))||[];if(_0x34d4a3){if(_0x3ce1da[_0x2d1734(0x3c5)](_0x3ce1da['npJxr'],_0x3ce1da[_0x2d1734(0x3c2)])){const _0x105495=_0x2d1734(0x140)[_0x2d1734(0x24b)]('|');let _0x291078=0x0;while(!![]){switch(_0x105495[_0x291078++]){case'0':return!![];case'1':_0x1ebb2d=_0x9efb86[_0x2d1734(0x14e)];continue;case'2':_0x2cd219=_0x100470['questionStates'];continue;case'3':_0x1cb44a=_0x23e852[_0x2d1734(0x2c9)];continue;case'4':_0x535fb8[_0x2d1734(0x229)](_0x3ce1da[_0x2d1734(0x35f)]);continue;case'5':_0x5ca8e0=_0x46a45c[_0x2d1734(0x1be)];continue;}break;}}else{const _0x597a7b={'quizName':quizName,'quizFile':window[_0x2d1734(0x1ba)][_0x2d1734(0x385)][_0x2d1734(0x24b)]('/')['pop'](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x2d1734(0x3dd)]()};_0x19099d['push'](_0x597a7b);}}else{if(_0x3ce1da[_0x2d1734(0x284)]!==_0x3ce1da[_0x2d1734(0x195)])_0x19099d=_0x19099d[_0x2d1734(0x1e5)](_0x1a43b7=>!(_0x1a43b7[_0x2d1734(0x1db)][_0x2d1734(0x19e)](quizName[_0x2d1734(0x21b)]()['replace'](/ /g,'-'))&&_0x1a43b7['questionIndex']===currentQuestionIndex));else{const _0x3d3d08=_0x5320ca[_0x2d1734(0x213)][_0x2d1734(0x305)][_0x2d1734(0x262)](_0x2c7f92),_0x88b130=_0x11a9b9[_0x3340ac],_0x325cde=_0x351997[_0x88b130]||_0x3d3d08;_0x3d3d08[_0x2d1734(0x1b9)]=_0x57c82e['bind'](_0x31721f),_0x3d3d08[_0x2d1734(0x267)]=_0x325cde[_0x2d1734(0x267)][_0x2d1734(0x262)](_0x325cde),_0x3679cc[_0x88b130]=_0x3d3d08;}}localStorage[_0x2d1734(0x232)]('bookmarkedQuestions',JSON[_0x2d1734(0x3dc)](_0x19099d)),_0x3ce1da[_0x2d1734(0x298)](updateBookmarkButton),_0x3ce1da[_0x2d1734(0x298)](updateQuestionNav);}function updateBookmarkButton(){const _0xca8c88=_0x31277a,_0x36d8d2={'VCNSb':_0xca8c88(0x392),'Ariff':_0xca8c88(0x202),'sOocG':'gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','XCkTP':_0xca8c88(0x2c2),'BZroZ':_0xca8c88(0x29b),'EHMql':_0xca8c88(0x18a)},_0x31d286=document['getElementById'](_0x36d8d2[_0xca8c88(0x332)]),_0x12910c=document['getElementById'](_0x36d8d2[_0xca8c88(0x242)]),_0x2340b7=questionStates[currentQuestionIndex]['bookmarked'];_0x31d286['className']=_0x2340b7?_0x36d8d2[_0xca8c88(0x150)]:_0x36d8d2[_0xca8c88(0x30d)],_0x12910c['textContent']=_0x2340b7?_0x36d8d2[_0xca8c88(0x198)]:_0x36d8d2[_0xca8c88(0x353)];}function toggleMarkForReview(){const _0xaa49b0=_0x31277a,_0x2bac92={'veytR':function(_0x252310){return _0x252310();},'IYmyf':function(_0x37e769){return _0x37e769();}};questionStates[currentQuestionIndex][_0xaa49b0(0x1a1)]=!questionStates[currentQuestionIndex][_0xaa49b0(0x1a1)],_0x2bac92[_0xaa49b0(0x1e9)](updateMarkReviewButton),_0x2bac92[_0xaa49b0(0x318)](updateQuestionNav);}function updateMarkReviewButton(){const _0x40dfb0=_0x31277a,_0x42bca5={'sDDzk':_0x40dfb0(0x3c7),'xWpYj':'markReviewText','kHrEd':_0x40dfb0(0x310),'InHQv':_0x40dfb0(0x1ed),'dimZW':_0x40dfb0(0x214),'vlXAs':_0x40dfb0(0x240)},_0x1b9d15=document[_0x40dfb0(0x3e7)](_0x42bca5[_0x40dfb0(0x1bd)]),_0x1c6958=document['getElementById'](_0x42bca5[_0x40dfb0(0x379)]),_0x23d55e=questionStates[currentQuestionIndex][_0x40dfb0(0x1a1)];_0x1b9d15[_0x40dfb0(0x36a)]=_0x23d55e?_0x42bca5['kHrEd']:_0x42bca5['InHQv'],_0x1c6958[_0x40dfb0(0x177)]=_0x23d55e?_0x42bca5[_0x40dfb0(0x18b)]:_0x42bca5[_0x40dfb0(0x1ea)];}function previousQuestion(){const _0x4e0b99=_0x31277a,_0x1cb1ab={'UjWGi':function(_0x3928fd,_0x24f439){return _0x3928fd>_0x24f439;},'PakoK':function(_0x3d521f,_0x24e955){return _0x3d521f-_0x24e955;},'KzSSO':function(_0x551462){return _0x551462();}};_0x1cb1ab[_0x4e0b99(0x2cd)](currentQuestionIndex,0x0)&&(questionStartTime&&(questionStates[currentQuestionIndex][_0x4e0b99(0x3e1)]+=_0x1cb1ab[_0x4e0b99(0x2a3)](Date[_0x4e0b99(0x3dd)](),questionStartTime)),currentQuestionIndex--,_0x1cb1ab[_0x4e0b99(0x3c8)](displayQuestion),_0x1cb1ab[_0x4e0b99(0x3c8)](saveProgress));}function nextQuestion(){const _0x2c2faa=_0x31277a,_0x4532a1={'vceLD':_0x2c2faa(0x235),'YJHIP':_0x2c2faa(0x395),'KwpSP':function(_0x262f2c,_0x5a1d62){return _0x262f2c-_0x5a1d62;},'TpNDT':function(_0xecf1b7){return _0xecf1b7();},'BUgkM':function(_0x2f3ca3,_0x4f85a7){return _0x2f3ca3===_0x4f85a7;},'Tjgfp':_0x2c2faa(0x1b1),'rYBXL':function(_0x54101f,_0x3cb933){return _0x54101f===_0x3cb933;},'rlYDk':_0x2c2faa(0x1fd),'eOSFL':function(_0x13020e,_0x5d6649){return _0x13020e(_0x5d6649);},'RHdrZ':_0x2c2faa(0x380),'loDAJ':_0x2c2faa(0x2cb),'OSXzs':function(_0x8e9d1d){return _0x8e9d1d();},'ojAPB':_0x2c2faa(0x1f0),'shdFM':function(_0x5b19ee){return _0x5b19ee();},'CgAXU':function(_0x1b9679){return _0x1b9679();}};questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=_0x4532a1[_0x2c2faa(0x299)](Date[_0x2c2faa(0x3dd)](),questionStartTime)),currentQuestionIndex<_0x4532a1[_0x2c2faa(0x299)](questionsData[_0x2c2faa(0x237)],0x1)?(currentQuestionIndex++,_0x4532a1['TpNDT'](displayQuestion),saveProgress()):_0x4532a1[_0x2c2faa(0x3bb)](currentMode,_0x4532a1[_0x2c2faa(0x286)])||_0x4532a1[_0x2c2faa(0x23a)](currentMode,_0x4532a1[_0x2c2faa(0x190)])?_0x4532a1[_0x2c2faa(0x359)](confirm,_0x4532a1[_0x2c2faa(0x2fb)])&&(_0x4532a1[_0x2c2faa(0x3bb)]('TqCLw',_0x4532a1[_0x2c2faa(0x35a)])?_0x4532a1[_0x2c2faa(0x356)](submitQuiz):(delete _0x34156d[_0xcc93ff],_0x4861fc['setItem'](_0x4532a1[_0x2c2faa(0x23c)],_0x5dd37b[_0x2c2faa(0x3dc)](_0xf0acd2)),_0x147fa6[_0x2c2faa(0x229)](_0x4532a1[_0x2c2faa(0x1d6)]))):confirm(_0x4532a1['ojAPB'])&&(currentQuestionIndex=0x0,_0x4532a1['shdFM'](displayQuestion),_0x4532a1[_0x2c2faa(0x25a)](saveProgress));}function startTimer(){const _0x52a806=_0x31277a,_0x34b042={'dDSyp':function(_0x2e9c76,_0x855e23){return _0x2e9c76/_0x855e23;},'sdvBT':function(_0x255685,_0x4a0237){return _0x255685%_0x4a0237;},'pkBZB':function(_0x2ccf06,_0x71230b){return _0x2ccf06+_0x71230b;},'BWfpR':function(_0x551706){return _0x551706();},'fWZKU':'Ogfwu','KTJCI':function(_0x4669d4){return _0x4669d4();},'orgHQ':function(_0x19677b,_0x5cc3a8){return _0x19677b<=_0x5cc3a8;},'dgfii':function(_0xb7bdc2,_0x751e0d){return _0xb7bdc2(_0x751e0d);},'gkbtn':function(_0x17b044,_0x15f495){return _0x17b044===_0x15f495;},'tFXds':_0x52a806(0x1fd),'mlOUJ':_0x52a806(0x223),'Gozlz':function(_0x32c8a0){return _0x32c8a0();},'KTOER':function(_0x4053da,_0x4ee137,_0x52118e){return _0x4053da(_0x4ee137,_0x52118e);}};if(timer)_0x34b042[_0x52a806(0x3b9)](clearInterval,timer);timeRemaining=0x78,updateTimerDisplay(),timer=_0x34b042['KTOER'](setInterval,()=>{const _0x26554e=_0x52a806,_0x78f6ef={'gumkT':function(_0x983529){const _0xa63151=_0x5d42;return _0x34b042[_0xa63151(0x28a)](_0x983529);},'CURUr':_0x26554e(0x2b0)};if(_0x34b042['fWZKU']==='ZOPeS'){const _0x4779cf=_0x1fe753['floor'](_0x34b042[_0x26554e(0x401)](_0x16569a,0x3c)),_0x2a1d6d=_0x34b042[_0x26554e(0x3d7)](_0x39ac38,0x3c);_0x5522fd[_0x26554e(0x3e7)](_0x26554e(0x17a))['textContent']=_0x34b042[_0x26554e(0x295)](_0x4779cf+':',_0x2a1d6d[_0x26554e(0x267)]()['padStart'](0x2,'0'));}else timeRemaining--,_0x34b042[_0x26554e(0x31d)](updateTimerDisplay),_0x34b042[_0x26554e(0x18f)](timeRemaining,0x0)&&(_0x34b042[_0x26554e(0x3b9)](clearInterval,timer),_0x34b042['gkbtn'](currentMode,_0x34b042[_0x26554e(0x20b)])?_0x34b042[_0x26554e(0x2bb)](_0x26554e(0x223),_0x34b042[_0x26554e(0x1dd)])?_0x34b042[_0x26554e(0x322)](submitQuiz):(_0x78f6ef[_0x26554e(0x36c)](_0x207ba3),_0x2b27e2[_0x26554e(0x3e7)](_0x78f6ef['CURUr'])['style'][_0x26554e(0x23b)]=_0x26554e(0x3a6)):_0x34b042[_0x26554e(0x322)](nextQuestion));},0x3e8);}function updateTimerDisplay(){const _0x39b561=_0x31277a,_0x19ca82={'imkmR':function(_0x54f505,_0x29684c){return _0x54f505%_0x29684c;},'hRaUx':_0x39b561(0x17a),'EZezL':function(_0xb48a82,_0x1c5ed2){return _0xb48a82+_0x1c5ed2;},'DuuJB':function(_0x2acd24,_0x11f1ec){return _0x2acd24+_0x11f1ec;}},_0x490b49=Math[_0x39b561(0x1b3)](timeRemaining/0x3c),_0x3bf021=_0x19ca82[_0x39b561(0x1f4)](timeRemaining,0x3c);document[_0x39b561(0x3e7)](_0x19ca82['hRaUx'])[_0x39b561(0x177)]=_0x19ca82[_0x39b561(0x316)](_0x19ca82[_0x39b561(0x1de)](_0x490b49,':'),_0x3bf021[_0x39b561(0x267)]()[_0x39b561(0x1eb)](0x2,'0'));}function toggleSidebar(){const _0x45bccd=_0x31277a,_0x3b8905={'WsUMl':'quizSidebar','FgWKh':_0x45bccd(0x37b)};document[_0x45bccd(0x3e7)](_0x3b8905['WsUMl'])[_0x45bccd(0x3b5)]['toggle'](_0x3b8905[_0x45bccd(0x2b3)]);}document['addEventListener'](_0x31277a(0x3ed),()=>{const _0x6518f1=_0x31277a,_0x5d27dd={'jiJLH':function(_0x90a55,_0x1ca1e7){return _0x90a55-_0x1ca1e7;},'YbQvZ':function(_0x42af95,_0x37dd58){return _0x42af95===_0x37dd58;},'OIWeZ':'ayTpP','ROqwZ':_0x6518f1(0x1e4),'PQKPO':_0x6518f1(0x2b0),'uKzyS':function(_0x355ed9){return _0x355ed9();},'emJlv':function(_0x5dc092,_0x34950b){return _0x5dc092!==_0x34950b;},'RVlgT':'azLJi','UmRJc':_0x6518f1(0x3a6),'xHDVF':_0x6518f1(0x1d0),'NVTRO':function(_0x4fd7ac,_0x39c49c){return _0x4fd7ac===_0x39c49c;},'tvrDt':'UOsvR','AovUe':function(_0x4d60bc){return _0x4d60bc();}};if(resume){if(loadProgress()){if(_0x5d27dd[_0x6518f1(0x398)](_0x5d27dd[_0x6518f1(0x28e)],_0x5d27dd[_0x6518f1(0x152)])){const _0x2d3854=new _0xb6ca1b();_0x2d3854[_0x6518f1(0x170)](_0x4d5321),_0x2d3854[_0x6518f1(0x145)](_0x78f73e);}else document[_0x6518f1(0x3e7)](_0x5d27dd[_0x6518f1(0x1a4)])['style'][_0x6518f1(0x23b)]=_0x6518f1(0x22a),_0x5d27dd['uKzyS'](initializeQuiz);}else _0x5d27dd[_0x6518f1(0x1a3)](_0x6518f1(0x1ec),_0x5d27dd['RVlgT'])?_0x29cdd2[_0x4596b5][_0x6518f1(0x3e1)]+=_0x5d27dd[_0x6518f1(0x1d1)](_0x25c818['now'](),_0x36e957):(_0x5d27dd[_0x6518f1(0x1a8)](clearProgress),document['getElementById'](_0x5d27dd[_0x6518f1(0x1a4)])[_0x6518f1(0x256)][_0x6518f1(0x23b)]=_0x5d27dd['UmRJc']);}else{if(!window[_0x6518f1(0x1ba)]['pathname'][_0x6518f1(0x36b)](_0x5d27dd[_0x6518f1(0x215)])){if(_0x5d27dd['NVTRO'](_0x5d27dd[_0x6518f1(0x39d)],_0x6518f1(0x3b0))){const _0x450657=_0x34a377?function(){const _0x3b00ad=_0x6518f1;if(_0x2fa242){const _0x51fd3f=_0x26d151[_0x3b00ad(0x14d)](_0x28fb15,arguments);return _0x9ca47=null,_0x51fd3f;}}:function(){};return _0x46c0bd=![],_0x450657;}else _0x5d27dd[_0x6518f1(0x1a8)](clearProgress),document[_0x6518f1(0x3e7)](_0x6518f1(0x2b0))[_0x6518f1(0x256)][_0x6518f1(0x23b)]=_0x5d27dd[_0x6518f1(0x347)];}else _0x5d27dd[_0x6518f1(0x374)](initializeQuiz);}}),document[_0x31277a(0x2a9)](_0x31277a(0x1ce),function(_0x264934){const _0x28ed0d=_0x31277a,_0x45bab9={'PirTh':'correct','TjyLV':_0x28ed0d(0x3ff),'yYHVt':function(_0x4cde2d,_0x3a712a){return _0x4cde2d!==_0x3a712a;},'acKDA':'modeModal','zIciC':'none','Kwpzl':function(_0x24fe2a,_0x2ce6ef){return _0x24fe2a===_0x2ce6ef;},'SljlN':_0x28ed0d(0x3f8),'rcecl':function(_0x3e8f84,_0xbc208f){return _0x3e8f84>=_0xbc208f;},'hTzxV':function(_0x302ea7,_0x2581c7){return _0x302ea7<=_0x2581c7;},'QJNKo':function(_0x5068ea,_0xb05cc8){return _0x5068ea-_0xb05cc8;},'TeYmt':function(_0x58e5b6,_0x5feef3){return _0x58e5b6(_0x5feef3);},'gixJp':_0x28ed0d(0x187),'KlvOU':function(_0x551eea,_0x3aea74){return _0x551eea<_0x3aea74;},'EsTYL':function(_0x5a6dbc,_0x1809ea){return _0x5a6dbc===_0x1809ea;},'prQzD':function(_0x2ede10){return _0x2ede10();},'JXVJD':_0x28ed0d(0x210),'mCYNp':function(_0x5146a6){return _0x5146a6();},'XOxKv':function(_0xbecf3c,_0x28e116){return _0xbecf3c===_0x28e116;},'FSvHv':_0x28ed0d(0x268),'AOvFl':function(_0x207ff8,_0x20e639){return _0x207ff8===_0x20e639;},'anfRi':'timed_study','OOlmC':function(_0x1e8ebc){return _0x1e8ebc();},'YLmpk':function(_0x1799ff,_0x459393){return _0x1799ff===_0x459393;},'iFBTy':_0x28ed0d(0x1b1),'bsNwa':_0x28ed0d(0x1fd),'qPGLx':'cdPqy','qvAYg':function(_0x27e95d,_0x531b1e){return _0x27e95d===_0x531b1e;},'siDpI':function(_0x56992a,_0x1eb1af){return _0x56992a===_0x1eb1af;}};if(_0x45bab9['yYHVt'](document[_0x28ed0d(0x3e7)](_0x45bab9['acKDA'])[_0x28ed0d(0x256)][_0x28ed0d(0x23b)],_0x45bab9[_0x28ed0d(0x2df)]))return;if(_0x45bab9['Kwpzl'](document['getElementById'](_0x45bab9[_0x28ed0d(0x259)])[_0x28ed0d(0x3b5)][_0x28ed0d(0x2c8)](_0x28ed0d(0x3cc)),![]))return;if(_0x45bab9['rcecl'](_0x264934[_0x28ed0d(0x1e8)],'1')&&_0x45bab9[_0x28ed0d(0x324)](_0x264934[_0x28ed0d(0x1e8)],'4')){const _0x9ce01c=_0x45bab9[_0x28ed0d(0x32c)](_0x45bab9[_0x28ed0d(0x2e1)](parseInt,_0x264934[_0x28ed0d(0x1e8)]),0x1),_0x2d4a4d=document[_0x28ed0d(0x2e4)](_0x45bab9['gixJp']);if(_0x45bab9[_0x28ed0d(0x364)](_0x9ce01c,_0x2d4a4d[_0x28ed0d(0x237)]))_0x45bab9[_0x28ed0d(0x2e1)](selectOption,_0x9ce01c);}else{if(_0x45bab9[_0x28ed0d(0x20f)](_0x264934[_0x28ed0d(0x1e8)],_0x28ed0d(0x2c0)))_0x45bab9['prQzD'](previousQuestion);else{if(_0x264934[_0x28ed0d(0x1e8)]===_0x45bab9['JXVJD']||_0x45bab9[_0x28ed0d(0x26f)](_0x264934['key'],'\x20'))_0x264934[_0x28ed0d(0x2eb)](),_0x45bab9[_0x28ed0d(0x2f8)](nextQuestion);else{if(_0x45bab9[_0x28ed0d(0x300)](_0x264934['key'][_0x28ed0d(0x21b)](),'b')&&(currentMode===_0x45bab9['FSvHv']||_0x45bab9['AOvFl'](currentMode,_0x45bab9[_0x28ed0d(0x307)])))_0x45bab9[_0x28ed0d(0x297)](toggleBookmark);else{if(_0x45bab9[_0x28ed0d(0x173)](_0x264934[_0x28ed0d(0x1e8)][_0x28ed0d(0x21b)](),'m')&&(_0x45bab9['YLmpk'](currentMode,_0x45bab9[_0x28ed0d(0x15c)])||_0x45bab9[_0x28ed0d(0x20f)](currentMode,_0x45bab9[_0x28ed0d(0x3cd)])))_0x45bab9['qPGLx']!==_0x28ed0d(0x143)?(_0x594e70=_0x45bab9['PirTh'],_0x22e6b7=_0x45bab9[_0x28ed0d(0x3de)]):_0x45bab9[_0x28ed0d(0x297)](toggleMarkForReview);else _0x264934['key'][_0x28ed0d(0x21b)]()==='s'&&(_0x45bab9['qvAYg'](currentMode,_0x45bab9[_0x28ed0d(0x15c)])||_0x45bab9[_0x28ed0d(0x2c3)](currentMode,_0x45bab9[_0x28ed0d(0x3cd)]))&&_0x45bab9[_0x28ed0d(0x2f8)](submitQuiz);}}}}});</script>

</body></html>